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As a major cause of infectious diarrheal diseases, non-typhoidal Salmonella (NTS), such as S. enterica 
subsp. enterica serovar Typhimurium, are of global health concern for both human and veterinary 
medicine. Besides causing usually self-limiting gastroenteritis in immunocompetent adult individuals, 
infection of neonates with this pathogen can induce invasive and potentially life-threatening 
conditions. Invasive infection caused by NTS are predominantly observed in developing countries with 
poor hygiene standards, where the pathogen is frequently isolated from cases of neonatal sepsis and 
meningitis. The pathogenicity of Salmonella is conferred by certain virulence factors encoded on 
chromosomal regions acquired by horizontal gene transfer, called Salmonella pathogenicity islands 
(SPIs). Delivery of effector proteins of SPI-1 and SPI-2 into the host cell is enabled via own type three 
secretion systems (T3SSs). The role of SPI effectors in host-pathogen interactions has been extensively 
studied in vitro and it is widely accepted that SPI-2 is crucial for the establishment of an intracellular 
compartment, the Salmonella-containing vacuole (SCV), which allows the bacteria to survive and 
replicate inside the host cell. Besides this, the translocated effector proteins allow the pathogen to 
modulate and manipulate the host cell system in various respects.  
Knowledge about effector contribution and their distinct role in pathogenesis of invasive NTS 
infections in vivo is rather scant. Therefore, we applied the neonate mouse model, which, in contrast 
to the commonly used streptomycin adult mouse infection model, allows the formation of SCVs inside 
infected enterocytes, followed by mucosal barrier penetration and subsequent bacterial dissemination 
without previous antibiotic depletion of the resident gut microbiota. In this study, we used this 
infection model to extend our knowledge on the role of individual SPI-2 effector proteins in 
establishment and progression of systemic Salmonella infections in the neonate host.  
Oral infection of neonates with wildtype and ΔSPI-2 Salmonella resulted in similar bacterial loads of 
the gastrointestinal tract, but re-isolation rates of SPI-2-deficient mutants from systemic organs, such 
as liver and spleen, and expression of pro-inflammatory cytokines were significantly decreased. 
Interestingly, in contrast to the general understanding of SPI-2 as prerequisite for SCV formation in 
vitro, mutants were able to establish and maintain SCVs in neonatal intestinal enterocytes. In fact, 
SPI-2-deficient bacteria grow to high numbers inside SCVs, nonetheless, like in the adult host, are 
attenuated in virulence and hampered in disease progression. The establishment of an SCV is not only 
feasible in the absence of the SPI-2 effector protein subset, but also without the host adaptor protein 
myeloid differentiation primary response 88 (MYD88). The observation of enlarged SCV formation in 
the absence of SPI-2, however, is strictly limited to the neonatal period. This is due to the immature 
intestinal tract constituting a unique environment with pending epithelial renewal on the one hand, 
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whereas constant nutrient supply is ensured by fusion of the bacterial vacuole with transport vesicles 
on the other hand. By evaluating isogenic single SPI-2 effector protein mutants, we detected that SPI-2 
effectors enabling interaction with the host cell microtubule network and positioning of the SCV inside 
the host cell partly phenocopy the SPI-2 dependent phenotype in vivo. Results achieved in this study 
suggest that depletion of SPI-2 effectors involved in the interaction with the host cell transport 
machinery still allows bacterial replication in the neonate intestine. However, the absence of these 
effectors prevents SCV transmigration from the apical to the basolateral side of the enterocytes. 
Mutants are therefore “stuck” inside their SCVs, which ultimately diminishes systemic spread to liver 
and spleen and complete pathogenesis of Salmonella in vivo. Thereby, SPI-2 effector proteins are 
needless in terms of early steps in NTS pathogenesis in the neonate host, but become urgent for the 




Als einer der Haupterreger infektiöser Durchfallerkrankungen stellen nicht-typhöse Salmonellen (NTS), 
wie beispielweise Salmonella enterica subsp. enterica serovar Typhimurium, ein weltweites 
Gesundheitsproblem für Human- und Veterinärmedizin dar. Neben selbst-limitierender 
Gastroenteritis bei immunkompetenten Erwachsenen kann die Infektion von Neugeborenen mit 
diesem Erreger zu invasiven und potenziell lebensbedrohlichen Erkrankungen führen. Invasive 
Infektionen von Neugeborenen durch NTS treten vor allem in Entwicklungsländern mit geringen 
Hygienestandards und schlechter medizinischer Versorgung auf. Unter diesen Voraussetzungen kann 
der Pathogen häufig bei Fällen neonataler Sepsis und Meningitis isoliert werden. Die Pathogenität von 
Salmonella ist vor allem durch Virulenzfaktoren bedingt, die auf durch horizontalen Gentransfer 
erlangten chromosomalen Regionen, den sogenannten Salmonella Pathogenitäts Inseln (SPIs), kodiert 
sind. Die Effektorproteine von SPI-1 und SPI-2 werden dabei durch eigene Typ drei Sekretionssysteme 
(T3SS) in die Wirtszelle eingebracht. Die Funktion der SPI-kodierten Effektorproteine in der 
Wirt-Pathogen Interaktion wurde bereits in zahlreichen in vitro-Studien untersucht. SPI-2 Effektoren 
werden anhand dieser Studien als essenziell für den Aufbau eines besonderen intrazellulären 
Kompartiments, der „Salmonella-containing vacuole“ (SCV, engl. für Salmonella-beherbergende 
Vakuole) betrachtet, welche die bakterielle Replikation und das Überleben innerhalb der Wirtszelle 
ermöglicht. Ferner bewirken die translozierten Effektorproteine die Modulation und Manipulation 
verschiedener Wirtszellprozesse durch das Bakterium. 
Das Wissen über die Beteiligung einzelner Effektoren in invasiven NTS Infektionen in vivo ist insgesamt, 
trotz zahlloser Studien, eher gering. Daher fand in dieser Studie das zuvor etablierte neonatale 
Mausmodell Anwendung. Im Gegensatz zum vielfach verwendeten adulten Streptomycin-Modell wird 
dabei die Bildung von SCVs in Enterozyten, gefolgt von der Penetration des Darmepithels und 
anschließender bakterieller Dissemination ohne vorherige Antibiotika Behandlung zur Verminderung 
der intestinalen Mikrobiota, ermöglicht. In der vorliegenden Arbeit wurde dieses Modell daher 
eingesetzt, um das Wissen über die Funktion einzelner SPI-2 Effektor Proteine in der Etablierung und 
im Krankheitsverlauf systemischer Salmonelleninfektionen im neugeborenen Wirt auszuweiten.  
Während die orale Infektion von neugeborenen Mäusen mit Wildtyp und ΔSPI-2 Salmonellen hierbei 
zu ähnlicher bakterieller Belastung des Gastrointestinaltrakts führte, fielen sowohl die 
Re-Isolationsrate aus systemischen Organen wie Leber und Milz, als auch die Expression 
pro-inflammatorischer Zytokine im Falle der SPI-2-defizienten Mutante gegenüber dem Wildtyp 
deutlich geringer aus. Bemerkenswerterweise, und im Gegensatz zum weithin akzeptierten Dogma von 
SPI-2 als Voraussetzung für die Bildung von SCVs durch in vitro Daten, waren die SPI-2 defizienten 
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Bakterien in der Lage, SCVs in neonatalen intestinalen Enterozyten zu bilden und aufrecht zu erhalten. 
Tatsächlich wuchsen SPI-2 defiziente Bakterien innerhalb ihrer SCV zu einer großen Zellzahl heran, 
waren dabei jedoch, wie im adulten Wirt, avirulent und führten zu einem deutlich verminderten 
Krankheitsverlauf. Die Etablierung einer funktionalen SCV wurde nicht nur als unabhängig von SPI-2 
Effektoren beobachtet, sondern kann darüber hinaus ohne das Wirtsadapterprotein „myloid 
differentiation primary response gene 88“ (MYD88) stattfinden. Die Beobachtung vergrößerter SCVs 
in Abwesenheit von SPI-2 ist dabei strikt auf die neonatale Periode limitiert. Dies gründet sich auf die 
Besonderheiten, die das intestinale Epithel in dieser Phase als Lebensraum bietet, da die 
kontinuierliche Erneuerung des Epithels noch aussteht, gleichzeitig aber die Fusion der bakteriellen 
Vakuole mit Transportvesikeln der Epithelzelle die intrazelluläre Nährstoffversorgung des Pathogens 
sicherzustellen scheint. Durch die Auswertung von isogenen Einzeleffektor Mutanten konnten wir 
zeigen, dass die SPI-2 Effektorproteine, welche die Interaktion mit dem 
Wirtszell-Mikrotubuli-Netzwerk, sowie die korrekte Positionierung der SCV innerhalb der Wirtszelle, 
ermöglichen, signifikant zum beobachteten SPI-2-abhängigen Phänotyp in vivo beitragen. Die 
Ergebnisse, die im Rahmen dieser Studie erzielt wurden, deuten darauf hin, dass die Abwesenheit von 
SPI-2 Effektoren, die an der Interaktion mit dem Transportsystem der Wirtszelle beteiligt sind, zwar 
weiterhin intrazelluläre Replikation, jedoch keine Transmigration der Enterozyten von apikal nach 
basolateral erlaubt. Die Mutanten sind in ihrer SCV innerhalb der Wirtszelle fixiert, wodurch die 
systemische Verbreitung der Bakterien verhindert und die weitere Pathogenese von Salmonella 
blockiert ist. Hierdurch konnten SPI-2 Effektor Proteine als abdingbar für frühe Schritte der NTS 
Pathogenese im neonatalen Darmepithel identifiziert werden. Sie sind jedoch für den Pathogen nötig, 





“Research cannot be forced very much. There is always danger of too much foliage and too little fruit.” 
(Theobald Smith, discoverer of Salmonella)  
1.1 General and theoretical background 
1.1.1 Morphological and biochemical characteristics 
The genus Salmonella comprises rod-shaped, Gram negative, facultative anaerobic bacteria within the 
family of Enterobacteriaceae named after the American veterinary surgeon and pathologist Daniel 
Elmer Salmon (Barlow and Hall 2002; Eng et al. 2015). First microscopic evidence succeeded in 1880 
by Karl Eberth, who discovered the bacterium in the spleens of typhoid patients (Eberth 1880). Four 
years later, Georg Theodor Gaffky was the pioneer to successfully grow the pathogen in pure culture 
(Hardy 1999). With only rare exceptions, salmonellae are motile via peritrichous flagella and measure 
2 to 3 by 0.4 to 0.6 µm in size (Drevets, Leenen, and Greenfield 2004).  
Although considered a facultative intracellular pathogen, the lifestyle of Salmonella is non-fastidious 
and allows survival and even growth outside the living host under various environmental conditions 
(Jajere 2019). Salmonellae are highly resistant to different environmental stresses like temperature 
fluctuation, acidity, drought and limited nutrient availability (Fitzsimmons et al. 2018; Foster and Hall 
1991; Spector and Kenyon 2012). For instance, the majority of serovars is viable and thrives at 
temperature ranges from 5-47 °C and optimal conditions between 32-35 °C (Pui et al. 2011). The 
undemanding nature of Salmonella strains also holds true regarding pH range and water requirement. 
Growth is preserved between pH values from 4 to 9, ensuring survival during different phases of the 
infectious process e.g. in the stomach or in dried foods in addition (Juven et al. 1984; Keerthirathne et 
al. 2016). Furthermore, salmonellae evolved strategies like cellular proton pumps, potassium and 
sodium antiport systems and acid tolerance responses, further increasing resilience under various 
circumstances and exposure to environmental stresses of different nature (Booth 1985; Foster and 
Hall 1990).  
Versatility is additionally achieved by metabolism of a huge range of different substances. As 
chemoorganotrophs, salmonellae can utilize a huge variety of different substrates and nutrients by 
both respiratory and fermentative pathways (Ong et al. 2013). For most serotypes, this includes rapid 
reduction of nitrate to nitrite, fermentation of many different carbohydrates resulting in acid 
production, arginine, ornithine, dulcitol decarboxylate lysine, citrate and hydrogen sulfide utilization 
(Kim et al. 2013; Rivera-Chavez and Bäumler 2015; Warsi et al. 2019). In sum, these biochemical 
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features help provide high pathogenic potential to salmonellae with massive prevalence and clinical 
importance (Crump et al. 2015; Prager et al. 2000).  
1.1.2 Taxonomy and nomenclature 
Most Salmonella reference centers worldwide, including the Centers for Disease Control (CDC), 
adopted the nomenclatural system of salmonellae as recommended by the World Health Organization 
(WHO), although the nomenclature still remains disputable (Popoff, Bockemuhl, and Gheesling 2004). 
According to this nomenclatural system, the genus Salmonella consists of two broad species 
Salmonella enterica (S. enterica) and  Salmonella  bongori (S. bongori) based on 16S rRNA sequence 
analysis (Jajere 2019; Popoff, Bockemuhl, and Gheesling 2004). Further classification divides S. enterica 
into 7 subspecies (subsp.) and more than 2600 serovars/serotypes (ser.) to date (Table 1) (Gal-Mor 
2019; Mezal et al. 2014). Subspecies are usually omitted in literature, e.g. S. enterica subsp. enterica 
serotype Typhimurium is normally shortened to Salmonella ser. Typhimurium or S. Typhimurium. In 
addition to the classification system of subspecies on a phylogenic level, serotyping is based on 
somatic (O), capsular (K), and flagella (H) antigens on the bacterial cell surface by means of the 
White-Kauffmann-Le Minor Scheme (Brenner et al. 2000; Issenhuth-Jeanjean et al. 2014). Most of the 
genes among different serovars are highly conserved. For instance, S. Typhi and S. Typhimurium, both 
infecting warm-blooded animals including humans, share 90 % of their total genes and only differ in 
their virulence factors, determining pathogenicity and host specificity as described later (McClelland 
et al. 2001; Sabbagh et al. 2010). However, each serovar or serotype harbors a unique combination of 
at least O and H antigens, thereby facilitating characterization and identification of isolates. In total, 
more than 50 % of serotypes described so far belong to S. enterica subsp. enterica I (Table 1) and 
account for approximately 99 % of Salmonella infections in humans and warm-blooded animals in sum 
(Guibourdenche et al. 2010; McClelland et al. 2001; Velge et al. 2012). In contrast, other subsp. of 
S. enterica and serovars of S. bongori are rarely found in humans or warm-blooded animals, but 
preferably colonize and infect cold-blooded species or are isolated from different environmental 








Table 1: Classification of Salmonella species and the current number of serovars within each 
subspecies 
Species belonging to the genus Salmonella, the assignment of the eight subspecies and particular 
number of serovars per subspecies to date (Achtman et al. 2012). In total, 2610 distinct serovars are 
discriminated currently. 
genus species subspecies no. of serovars 
Salmonella 
S. enterica 
I enterica 1586 
II salamae 513 
IIIa arizonae 100 
IIIb diarizonae 341 
IV houtenae 73 
VI indica 13 
VII  
S. bongori V bongori 23 
1.2 Salmonella - a pathogen of global health concern 
1.2.1 Pathology of Salmonella  
Salmonella is an important pathogen for both humans and animals worldwide, causing diseases of 
varying clinical manifestations. Typically, S. enterica subsp. enterica serovars are subdivided into two 
distinct groups, typhoidal and non-typhoidal (Gal-Mor, Boyle, and Grassl 2014). Furthermore, some 
serovars are host adapted, whereas others harbor features enabling infection of a variety of different 
hosts by the same serovar (Bäumler et al. 1998; den Bakker et al. 2011; Wheeler, Gardner, and Barquist 
2018). For instance, typhoid fever is solely limited to humans and higher primates, whereas other 
warm-blooded vertebrate species are protected from infection by the causative agent S. Typhi and 
S. Paratyphi A and B (or uncommonly C), a pathogen eliciting the similar, but often less severe disease 
paratyphoid fever (Buckle, Walker, and Black 2012; Kingsley and Bäumler 2000).  
Typhoid fever is usually acquired after ingestion of contaminated food or water (Crump and Mintz 
2010). The acute illness is characterized by fever, headache, nausea, loss of appetite, constipation and 
sometimes diarrhea (Klotz et al. 1984). Symptoms are often non-specific and clinically 
non-distinguishable from other febrile illnesses and clinical severity is influenced by different factors, 
exacerbating documentation of both morbidity and mortality (Crump and Mintz 2010; Crump et al. 
2015; Gibani et al. 2019).  Symptoms of typhoid fever may vary from a mild illness with low grade fever, 
headache, fatigue, malaise, loss of appetite, cough, constipation and skin rash or rose spots (Klotz et 
al. 1984). In some fatal cases, severe complications including intestinal perforations, gastrointestinal 
hemorrhages, encephalitis and cranial neuritis can emerge, ultimately leading to potentially 
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life-threatening conditions and death in approximately 10 % of untreated and 1-2 % of hospitalized 
patients (Habte et al. 2018; Mogasale, Desai, et al. 2014). Typhoid occurs predominantly in low-income 
countries in association with poor sanitation, substandard hygiene, rather poor quality of life and lack 
of clean drinking water (Crump and Mintz 2010; Farooqui, Khan, and Kazmi 2009; Mogasale, Maskery, 
et al. 2014). According to the most recent estimates, between 11 and 21 million cases and 128 000 to 
161 000 typhoid-related deaths occur annually worldwide, especially if typhoid or, in some cases, 
paratyphoid fever are left untreated (Crump, Luby, and Mintz 2004; Crump and Mintz 2010; Gibani, 
Britto, and Pollard 2018). Summarized, typhoid fever has been a human health problem for centuries 
and remains of global health concern to date.  
On the other hand, S. Typhimurium, which is highly similar to S. Typhi on a genetic level, can infect 
multiple different warm-blooded hosts, including humans, cattle, pigs, sheep, horses, poultry and 
rodents (Edwards, Bruner, and Moran 1948; Hughes et al. 1971; Humphrey, Mead, and Rowe 1988; 
Sojka et al. 1977; Sojka et al. 1983; Sojka, Wray, and McLaren 1986; Wray, Sojka, and Bell 1981). 
Incidence of serovars in a certain species is not necessarily linked to virulence or pathogenicity. Two 
surveys in 1958 and 1966 investigated human clinical isolates and examined that two host adapted 
serotypes S. Dublin, primarily infecting cattle, and S. Choleraesuis, predominantly found in pigs, were 
only responsible for minor proportions of 0.6 % and 0.3 % of human Salmonellosis cases in England 
and Wales (Kingsley and Bäumler 2000). Despite this low incidence, both serovars are particularly 
invasive compared to others in men.  
Non-typhoidal Salmonella (NTS) serovars, such as S. Typhimurium investigated in this study, are a 
global cause of usually self-limiting gastroenteritis. NTS clearly belong to the leading causes of 
foodborne illnesses worldwide with an estimation of 93.8 million annual cases, considering 
under-reporting and under-diagnosis, and 155 000 deaths each year due to complications resulting 
from gastrointestinal infections (Lestari et al. 2009; Majowicz et al. 2010). In recent years, studies on 
the incidence of global NTS infections revealed increasing incidence, with the majority of NTS burden 
found in the Southeast Asian and the Western Pacific regions (Majowicz et al. 2010; Prestinaci, 
Pezzotti, and Pantosti 2015). Gastrointestinal infections, similar to typhoid fever, generally stem from 
exposure to contaminated food or water and of the almost 94 million NTS cases reported annually, 
more than 80 million were estimated being of foodborne origin (McNamee and Smyth 2000; Tennant 
et al. 2016). Predominantly, infections emanate from pets or livestock and are the result of 
consumption of dairy products or meat of clinically inconspicuous, yet colonized animals, especially 
poultry and poultry-derived products like eggs (Foley et al. 1999; Hartmann et al. 1996; Petrie et al. 
1977; Rice, Besser, and Hancock 1997; Wilcock, Armstrong, and Olander 1976). While the risk for 
Salmonella spp.-induced gastroenteritis is seen worldwide, incidence observed in places with reduced 
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sanitation and access to clean water is elevated. Thereby, NTS are of public health concern for human 
and veterinary medicine and lead to global economic losses in addition. Furthermore, they contribute 
to the economic burden of both industrialized and underdeveloped countries through the costs 
associated with surveillance, prevention and treatment of diseases (Crump, Luby, and Mintz 2004; 
Havelaar et al. 2015; Taitt et al. 2004). Besides self-limiting gastroenteritis, including onset of 
symptoms like diarrhea, vomiting, nausea, fever and abdominal pain within 6 to 72 hours following 
exposure, NTS can cause invasive diseases, dependent on e.g. age, gut flora and immune status of the 
host, as discussed later (Fluit 2005; Langridge, Wain, and Nair 2012; Strawn et al. 2014). However, 
gastroenteritis remains the most common manifestation of Salmonella infection worldwide, followed 
by bacteremia and enteric fever (Majowicz et al. 2010). Among NTS serovars, S. Typhimurium, 
S. Enteritidis, S. Heidelberg and S. Newport are of particular importance in an epidemiological regard 
(Eguale 2018; Galanis et al. 2006).   
1.2.2 Transmission 
From an evolutionary point of view, the success of bacterial pathogens is dependent on their ability to 
colonize and cause disease in susceptible hosts. Salmonella is ubiquitous and, as explained previously 
(1.1.1), highly persistent even in hostile and dry environments, where it can survive for periods from 
days up to several months (Davies and Wray 1996; Finn et al. 2013). Furthermore, especially serovars 
of S. enterica are broadly distributed among different host species, including diverse mammals and 
birds (Rabsch et al. 2002). Certain hosts can serve as reservoirs and, with only rare exceptions of 
host-restricted serovars like S. Typhi, the vast majority of S. enterica serovars displays a broad host 
range for infection and colonization in equal measure (Bäumler et al. 1998). In comparison to other 
pathogens, salmonellae are widely distributed in animals and the environment, exhibit a high tenacity 
and persistence and inhabit diverse biological niches (Waldner et al. 2012). Equally important as 
survival outside the living host even under harsh conditions is how effectively these pathogens are 
transmitted between individual hosts. The primary route of human infections is by the consumption 
of meat or animal products contaminated via contact with animal feces (Hornick et al. 1970). Hereby, 
butchering of clinically inapparent, yet colonized animals might lead on to entry into the grocery chain 
(Lawley et al. 2008). Consequently, an overwhelming amount of 94 % of Salmonella infections is 
estimated to be of foodborne origin and less common waterborne, via contact to farm or pet animals 
or environmental transmission (Hale et al. 2012; Hoelzer, Moreno Switt, and Wiedmann 2011; Pees et 
al. 2013). Furthermore, salmonellae have been detected in animal herds, e.g. of pigs and cattle, with 
animal-to-animal transmission in a serovar dependent manner (Hendriksen et al. 2004).  
NTS may have a broad host spectrum and are frequently zoonotic (Gordon 2011). A prominent 
example of a non-typhoidal, non-human-restricted or adapted salmonellae and perhaps the 
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best-studied is S. enterica subsp. enterica ser. Typhimurium (STy) (Finlay and Brumell 2000; Tsolis et 
al. 2011). In various studies, it has been investigated in infections of different cell types and animal 
models. Like other salmonellae, it is most probably acquired by food poisoning after oral ingestion of 
improperly cooked meat, raw milk, eggs or other dairy products or contaminated fruits and vegetables 
after manuring with animal feces and only to a minor extent via drinking or bath water (Wang et al. 
2008). The infectious dose varies dependent on host species, age and immune status (Byrd et al. 1998; 
Correia-Gomes et al. 2014; Fedorka-Cray et al. 1994). After oral uptake, infection with NTS like STy and 
other S. enterica subsp. enterica serovars as well, usually results in self-limiting gastroenteritis as global 
key players in infectious diarrheal diseases (Mead et al. 1999; Santos et al. 2009; Tauxe 1997). 
Furthermore, extra-intestinal and more invasive infections are also frequent in susceptible hosts, 
predominantly in sub-Saharan Africa, where NTS are associated with HIV in adults and malnutrition, 
anemia, malaria and HIV in children (Biggs et al. 2014; Feasey et al. 2015; Graham et al. 2000). 
1.2.3 Virulence factors and evolution 
Serovars within S. enterica subsp. enterica are closely related as shown by analysis of orthologous 
genes. The divergence in the nucleotide sequence ranges between 3.8 and 4.6 % and differences in 
deduced amino acid sequences between 0.7 and 1.3 % (Bäumler et al. 1998; Sabbagh et al. 2010; 
Wang, Huang, and Huo 2014). Genetic variation of different S. Typhi isolates from all over the world 
was extremely low, revealing a highly conserved and clonal relation among isolates and suggesting that 
they emerged from a single progenitor (Baker and Dougan 2007; Holt et al. 2008). Clonality is a 
characteristic feature of human-restricted pathogens (Achtman 2008). STy is capable of causing an 
invasive and systemic typhoid-like disease in susceptible mice and this murine model served in 
unraveling Salmonella genes involved in pathogenicity (Kaiser et al. 2012). In total, more than 100 
different genes have been implicated as contributors of Salmonella virulence. Of those, many are 
shared between both broad host range S. Typhimurium and other non-typhoidal S. enterica serovars 
and human restricted S. Typhi (Andrews-Polymenis et al. 2010; Bäumler et al. 1998; Sabbagh et al. 
2010; Tanner and Kingsley 2018). 
Certain genetic traits, however, distinguish S. enterica serotypes from S. bongori or other related 
Enterobacteriaceae like Escherichia coli (E. coli) or Shigella spp. (Langridge et al. 2015; Winfield and 
Groisman 2004). As holds true for very many other pathogens, successful colonization, invasion and 
infection of the host by salmonellae requires the expression and secretion of particular virulence 
factors. These factors enable distinct steps in pathogenesis and survival under various conditions inside 
the living host (Coleman and Haller 2018; Ilyas, Tsai, and Coombes 2017). Acquisition of genes in 
general, e.g. by horizontal transfer, can confer new phenotypes to the recipient bacteria, thereby 
offering chances of adaptive changes that maximize fitness in a given niche and increase pathogenicity 
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or virulence in a global manner (Groisman and Ochman 1996; Ochman, Lawrence, and Groisman 2000). 
The genome of STy, for instance, was modeled by various gene acquisition events and accrued DNA 
changes that have undergone selection by regulatory evolution, allowing survival in diverse niches via 
regulatory circuitry of gene expression (Bäumler 1997; Groisman and Ochman 1997).  
Virulence evolution of Salmonella after divergence from the closely related species E. coli by a 
speciation event from a common ancestor was proposed to have occurred in at least 3 stages between 
approximately 140 and 25 million years ago (Bäumler et al. 1998; Ehrbar and Hardt 2005; Winfield and 
Groisman 2004). Evolutionary steps are defined by the acquisition of certain genes and virulence traits 
expanding feasible niches to colonizing and infecting animals. Pathogenicity islands (PIs) are gene 
clusters encoding virulence factors incorporated in the genome of different bacteria acquired by 
horizontal gene transfer (Gal-Mor and Finlay 2006). In case of Salmonella genomics, 21 multi-gene loci 
linked to infection, called Salmonella Pathogenicity Islands (SPIs), have been identified mostly in both 
species and across all subspecies (McClelland et al. 2001). However, PIs are unequally critical in terms 
of pathogenesis and pathogenicity and genetic flux with the Salmonella species and subspecies sum 
up to define host range as well as disease phenotype (Figure 1) (Bäumler 1997; Fookes et al. 2011). 
 
Figure 1: Evolutionary history, phylogeny and host specificity of Salmonella spp. and serotypes 
Salmonella diverged from a common ancestor shared with Escherichia coli (E. coli) by development of 
Salmonella pathogenicity island-1 (SPI-1). Via horizontal gene transfer, a new niche could be colonized 
and gastrointestinal infections of cold-blooded animals became feasible. SPI-2 harbored by S. enterica, 
but not S. bongori serovars, enables systemic dissemination of the pathogen inside the living host. This 
feature was accomplished approximately 35 million years ago. The most eminent serovars for human 
and veterinary medicine belong to subspecies I of S. enterica. In the third phase of Salmonella 
evolution, the host range was expanded to allow infection of warm-blooded animals including humans 
by serovars of S. enterica subsp. enterica. While S. bongori and S. enterica subspecies II, IIIa, IIIb, IV, VI, 
and VII are mainly associated with cold-blooded vertebrates, members of S. enterica subspecies I are 
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most frequently isolated from avian and mammalian hosts . According to their host range and elicited 
disease, serovars of S. enterica subsp. enterica are clustered into host specific and broad host range, 
as well as typhoidal and non-typhoidal subgroups. In this and many other studies, S. Typhimurium 
(labeled in red) is used for infection of susceptible mice, causing a typhoid-like disease and potentially 
life-threatening conditions (modified from (Aleksic, Heinzerling, and Bockemuhl 1996; Bäumler et al. 
1998; Desai et al. 2013; Gal-Mor 2019).  
Virulence factors encoded within different SPIs contribute to the whole genome of Salmonella to a 
comparably high amount with approximately 4 % (Bowe et al. 1998; Dos Santos, Ferrari, and Conte-
Junior 2019). As the first and initial step in virulence evolution, Salmonella pathogenicity island-1 
(SPI-1) was obtained by plasmid- or phage-mediated horizontal gene transfer (Bäumler et al. 1998). 
SPI-1 was likely acquired by a common ancestral to all Salmonella serotypes early in evolutionary 
divergence, since it is present in all phylogenetic lineages of the genus Salmonella, but absent from 
closely related bacteria like E. coli (Mills, Bajaj, and Lee 1995). Effector proteins encoded by SPI-1 were 
described to mediate mechanisms used by Salmonella during the intestinal phase of infection in 
previous studies. This includes invasion of intestinal epithelial cells both in vivo and in vitro, thereby 
enabling an early key step in Salmonella pathogenesis (Galan and Curtiss 1989; Watson et al. 1995; 
Zhang et al. 2014). In accordance to this, attainment of SPI-1 enabled intestinal infections as a new 
potential reservoir for Salmonella (Bäumler et al. 1997). In a second evolutionary key step, two species 
emerged within the genus Salmonella, distinguishable by presence (S. enterica) or absence (S. bongori) 
of a second virulence determinant SPI-2. Divergence of their lineages was accompanied by an impact 
on disease potential, since the key feature enabled by possession of SPI-2 virulence factors is enabling 
invasion of deeper body tissue and systemic dissemination of S. enterica subspecies (Hensel et al. 1997; 
Ochman and Groisman 1996). While S. bongori and S. enterica subspecies II, IIIa, IIIb, IV, VI, and VII are 
predominantly isolated from cold-blooded animals like e.g. reptiles, serovars of S. enterica subsp. I are 
capable of infecting a large range of different warm-blooded animals and are frequently detected as 
colonizers or pathogens of the intestinal tract of mammals and birds (Bäumler and Fang 2013). This 
expansion in host range is considered the third step in evolution of Salmonella virulence (Figure 1) 
(Roumagnac et al. 2006).  
1.3 Pathogenesis of non-typhoidal Salmonella (NTS) 
To date, differences in the genome of distinct S. enterica subsp. enterica serovars, like S. Typhi and 
S. Typhimurium, is of particular research interest in various studies, aiming in unraveling possible 
causes for different forms of disease caused by individual serotypes (Bäumler and Fang 2013; Gal-Mor, 
Boyle, and Grassl 2014; Sabbagh et al. 2010). However, major steps in infection and disease 
progression of invasive non-typhoidal Salmonella (iNTS) infections and typhoid fever are identical. 
Infection of mice with S. Typhimurium, usually causing gastroenteritis in humans, resembles systemic 
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dissemination observed in typhoid fever patients (Tsolis, Kingsley, et al. 1999). An infection is 
presumably acquired by ingestion of contaminated food (Gomez et al. 1997). Certain groups are at an 
increased risk of suffering from iNTS infections, including children under the age of 5, elderly and 
immunosuppressed people (Eng et al. 2015). In these risk groups, chances of the pathogen penetrating 
the epithelial cell lining of the intestinal tract after entering the digestive tract are elevated, which 
might lead to life-threatening conditions, including bacteremia, meningitis and osteomyelitis (Church 
et al. 1998; Yang et al. 2002). Infections of young children display significantly higher morbidity and 
mortality than observed in adults. 
Salmonellae initiate their own engulfment into non-phagocytic enterocytes in the small intestine via 
SPI-1 effector proteins (Hansen-Wester, Stecher, and Hensel 2002). Activation of signal transduction 
pathways by bacterial SPI-1 virulence factors induces reorganization of the actin cytoskeleton of the 
host cell, leading to membrane ruffling and absorption of the pathogen (Monack, Mueller, and Falkow 
2004; Takaya et al. 2003). After crossing the epithelial barrier, Salmonella gains access to the 
underlying lamina propria and residing immune cells such as neutrophils and macrophages (Vazquez-
Torres et al. 1999). Invasion, survival and even replication in these host cells facilitates systemic 
dissemination to the liver, spleen, bone marrow and gallbladder (Johnson, Mylona, and Frankel 2018; 
Mastroeni et al. 2003). Furthermore, Salmonella persists inside host cells as a crucial feature of 
pathogenesis (Bakowski, Braun, and Brumell 2008). This persistence, immune evasion and intracellular 
survival inside the host cell is accomplished via SPI-2 effector proteins, thereby conferring NTS 
pathogenesis, as discussed later (1.4). 
Different reasons render infants and toddlers highly susceptible to iNTS infections. The gastrointestinal 
tract of men and mice is rather immature at birth (Birchenough et al. 2017; Walthall et al. 2005). The 
gut barrier shields the sterile body interior from the environment, thereby providing the first line of 
defense to iNTS and mucosal resistance of the gut epithelium to NTS is a complex and multifactorial 
system (Houghteling and Walker 2015; Macierzanka et al. 2014; Viggiano et al. 2015; Zhang, Hornef, 
and Dupont 2015). Cellular and humoral arms of immunity, the gut epithelial layer as well as the gut 
microbiota have been discussed to contribute to the so-called “colonization resistance”, which confers 
a comparably high degree of resistibility to Salmonella infections in healthy, immunocompetent, adult 
individuals (MacLennan et al. 2008; Nyirenda et al. 2014; Vazquez-Torres et al. 1999; Veereman-
Wauters 1996). However, the protective mucus layer in the gut as well as the residing microbiota are 
developed postnatally (Rakoff-Nahoum et al. 2015; Schroeder 2019). In contrast to other studies 
employing the streptomycin mouse model to study Salmonella infections, oral infection of neonate 
mice harboring an immature microbiome is conducted without any antibiotic treatment prior to 
infection (Kaiser et al. 2012; Zhang et al. 2014). Furthermore, maturation of the intestinal tract and 
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development of barrier integrity also involves cellular changes (Kelly, Begbie, and King 1992). Microfold 
(M) cells, constituting a primary entry port for Salmonella, start to mature after birth in mice (Clark et 
al. 1996; Jepson and Clark 2001; Jones, Ghori, and Falkow 1994). This forces the pathogen to switch to 
an alternative invasion strategy in the murine neonatal small intestine via SPI-1-induced uptake by 
epithelial cells, since M cells are not fully developed at an early age (Zhang et al. 2014). Additionally, 
enterocytes of the gut epithelium undergo constant and rapid renewal in later life via proliferation of 
stem cells, e.g. located in the intestinal crypts (Renz, Brandtzaeg, and Hornef 2012). Thereby, barrier 
integrity of the gut epithelium is maintained and NTS infections in adults usually result in self-limiting 
gastroenteritis instead of severe, disseminative infections (Peterson and Artis 2014). To a large extent, 
this is due to continuous desquamation of intestinal enterocytes every 3 to 5 days, accompanied by 
the loss of the intracellular pathogen (Eastwood 1977; Gordon and Hermiston 1994). In mice, the 
villus-crypt architecture of the gut, accompanied by constant epithelial cell renewal, is developed 
between 10 and 12 days after birth, offering chances of prolonged intraepithelial proliferation of 
Salmonella in the murine neonate intestine. As compared to adults, newborns possess a premature 
adaptive immune system. Invasion of the pathogen induces cytokine expression after e.g. recognition 
of structures on the bacterial surface and sensing by pattern recognition receptors (PRRs), promoting 
immune cell infiltration in both adults and infants. Nevertheless, chances for the neonate to die from 
the massive gut inflammation and pathogen dissemination before an adaptive immune response can 
be mounted to control the infection are substantially higher than in immunocompetent, healthy adults 
(Bermudez-Brito et al. 2012; Hornef and Fulde 2014; Machado et al. 2014). In this context, failure in 
an appropriate T cell maturation in HIV patients and deficiencies in the adaptive immune system were 
attributed to an increased probability of NTS to disseminate systemically and cause bacteremia and 
other life-threatening consequences (Morpeth, Ramadhani, and Crump 2009; Preziosi et al. 2012). This 
immaturity of the host, especially the gut and the immune system, augments vulnerability to NTS 
infections in the neonate.  
1.4 Salmonella pathogenicity island-2 (SPI-2) 
1.4.1 Genetics  
In contrast to other SPIs, SPI-1 and SPI-2 encode an own type three secretion system (T3SS) besides 
their respective effector proteins and are hence considered the major virulence determinants of 
S. enterica serovars (Ibarra and Steele-Mortimer 2009). T3SSs are complex, syringe-like translocation 
machineries found in different, primarily pathogenic, bacteria like Yersinia and Shigella species and in 
association with a translocon pore that is formed in the target host membrane (Figure 2) (Coburn, 
Sekirov, and Finlay 2007; Mueller, Broz, and Cornelis 2008). In total, more than 20 different protein 
27 
 
compartments are assembled to form a needle-like injection apparatus, facilitating direct insertion of 
effector proteins into the host cell cytosol (Haraga, Ohlson, and Miller 2008). Some of the proteins 
within the T3SS are homologous to those involved in assembly of flagella, suggesting an evolutionary 
relation (Kubori et al. 1998; Marcus et al. 2000).  
The subcellular localization of the multi component structure forming the T3SS to translocate effector 
proteins of SPI-2 into host cells (A) and the genetic structure of the pathogenicity island (B) are 
depicted. The needle-like injection machinery spans the inner and outer membrane of the bacterial 
envelope (shown in yellow). The translocon consisting of SseBCD (red) forms a pore in the host cell 
endosomal membrane and facilitates translocation of effector proteins (violet) directly into the host 
cell cytosol. In addition to little virulence factors encoded within SPI-2 itself, a remarkable proportion 
of effectors translocated by the T3SS of SPI-2 is encoded on separate loci. Some effector proteins rely 
on their respective chaperone (orange) for activation and functionality. Expression of SPI-2 genes and 
other effectors is regulated by the SsrAB two component regulatory system (green), although the 
precise mechanism underlying regulation is not thoroughly understood. Copied from (Kuhle and 
Hensel 2004). 
Figure 2: Schematic representation of the T3SS and genetic structure of SPI-2  
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SPI-2 is located at 30 centisomes of the S. enterica chromosome and of crucial importance after host 
cell invasion as a requirement for intracellular replication in cultured epithelial cells and survival in 
macrophages (Deiwick et al. 1998; Hapfelmeier et al. 2005; Ochman et al. 1996). Like other horizontally 
acquired genes, SPI-2 shows a substantially higher A+T content than ancestral Salmonella DNA (Fass 
and Groisman 2009; Shea et al. 1996). It consists of more than 40 different genes, 28 of which are 
secreted effector proteins with different functions and 15 protein subunits to build the T3SS (Coombes 
et al. 2004; Figueira and Holden 2012). The effectors have diverse purposes in terms of host cell 
modulation and manipulation and can be clustered into different functional subgroups in accordance. 
However, certain effectors participate in different processes and comprise further biochemical 
activities (Figueira and Holden 2012). Moreover, distinct effectors share functional capacities and 
generate protein redundancies in terms of certain processes. In some cases, especially in complex 
processes within the host cell, an interplay of effects of various proteins is essential for functionality 
(Hensel, Nikolaus, and Egelseer 1999). In summary, SPI-2 effector protein-mediated host cell 
modulation is a complex machinery with fundamental repercussions on virulence and NTS 
pathogenesis.   
1.4.2 Function and regulation 
As mentioned previously, various host cell processes can be interfered or modulated by SPI-2 effector 
proteins. In general, SPI-2-deficient Salmonella are attenuated in virulence in adult mouse infections 
and diminished in intracellular survival in cultured macrophages as well as replication in epithelial cells, 
since SPI-2 effectors facilitate manipulation of vesicular trafficking of the host cell (Cheminay, 
Mohlenbrink, and Hensel 2005; Leung and Finlay 1991). Once internalized into the intestinal 
epithelium after oral uptake, STy subverts the physiological maturation of its vacuolar compartment 
and its acidic pH to form a specialized intracellular compartment, known as the Salmonella-containing 
vacuole (SCV) (Kolodziejek and Miller 2015; Steele-Mortimer 2008).  
Sustained progress has been made in revealing mechanisms and molecular triggers that lead to 
induction of SPI-2 gene expression (Arpaia et al. 2011). In this context, multiple signals have been 
implicated in induction of SPI-2 expression in vitro, e.g. cation deprivation, low pH and phosphate 
starvation (Cirillo et al. 1998; Deiwick et al. 1999; Rappl, Deiwick, and Hensel 2003). Nevertheless, the 
physiological cues responsible for induction of the SPI-2 T3SS in the phagosome and the degree of their 
necessity remain a matter of debate. SpiR/SsrB is a SPI-2 encoded two-component system, which is 
essential for induction of the T3SS-2 and all effectors within the PI, as well as those encoded outside 
the virulence locus (Worley, Ching, and Heffron 2000). Its expression is controlled by the ancestral 
two-component systems OmpR/EnvZ and PhoP/PhoQ (Garmendia et al. 2003; Heithoff et al. 1999; 
Miller, Kukral, and Mekalanos 1989). In general, microorganisms invade host cells or are ingested by 
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phagocytes like e.g. macrophages and are trapped in a membrane-bound compartment or phagosome. 
Sequential fusion events with a series of endomembrane compartments result in maturation and a 
declined luminal pH, which confers microbicidal properties to the phagosome (Harrison et al. 2003). 
This maturation process is subverted by Salmonella and the pathogen evades the hostile environment 
of the phagosome via its effector proteins (Cuellar-Mata et al. 2002). As a specialized, 
membrane-bound compartment, the SCV provides protection from the host cell’s immune system. It 
allows modulations of vesicular trafficking to bypass lysosomal degradation, enabling intracellular 
survival, persistence and replication of the pathogen through the action of distinct virulence factors 
(Brumell et al. 2002; D'Costa et al. 2015; Garcia-del Portillo and Finlay 1995; McGourty et al. 2012).  
Basically, the SCV is a modified phagosome with low pH and this is exploited as an environmental cue 
to alter the pathogen’s transcription profile (Valdivia and Falkow 1997). Hence, following invasion, 
adaptive responses of the PhoP/PhoQ system harbored by STy sense the phagosomal milieu within the 
bacterial vacuole, such as low pH and magnesium ion (Mg2+) concentration, leading to the expression 
of virulence determinants of SPI-2 (Dalebroux and Miller 2014). This turns the phagosome into a 
replicative niche, the SCV, with virulence factors of SPI-2 transported from the inside of the vacuolar 
compartment across the SCV membrane into the host cell cytosol, where the effector proteins operate 
(Marcus et al. 2000). During disease progression, the pathogen experiences low pH e.g. in the 
phagosomal vacuoles of epithelial cells and macrophages in the gut. This is enabled via the PhoP/PhoQ 
two-component regulatory system, which is also important for survival in the presence of reactive 
oxygen (ROS) or nitrogen species. Hence, null mutations in these genes severely attenuates STy 
virulence in mice infections (Miller, Kukral, and Mekalanos 1989). In addition to constituting an 
immune evasion strategy, virulence factors endowing the intracellular pathogen with vesicular 
trafficking modulation was discussed as an approach to ensure nutrition inside the host cell (Liss et al. 
2017). Besides this, expression of SPI-2 genes in the gut was suggested to contribute to intracellular 
transit from the apical to the basolateral side of polarized epithelial cells in the gut (Brown et al. 2005; 
Muller et al. 2012). 
1.4.3 Host factors influencing pathogenesis of Salmonella 
Pathogens have evolved mechanisms to antagonize the host’s innate immune system in various ways, 
since it is of special importance in limiting microbial replication and pathogen spread before an 
adaptive immune response can be established (Woolhouse et al. 2002). In this context, PRRs sense 
detection of conserved pathogen-associated molecular patterns (PAMPs) on the surface of bacteria 
and hence are crucial for the innate immune system (Medzhitov 2007). Expression of toll-like receptors 
(TLRs) as important members of PRRs, allows recognition of different microbial ligands e.g. by 
enterocytes as well as innate immune cells. Thereby, TLRs link detection to the induction of 
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mechanisms to defeat invading pathogens via production of reactive oxygen and nitrogen species, 
expression of antimicrobial peptides and maturation of dendritic cells (DCs) (Akira, Takeda, and Kaisho 
2001; Iwasaki and Medzhitov 2004). Thus, TLRs significantly contribute to the earliest steps of the host 
response to an infection, but besides antimicrobial sensing, TLR activation can also induce 
non-transcriptional effects, including rapid acidification and maturation of the phagosome (Arpaia et 
al. 2011; Sivick et al. 2014). This acidification was discussed as an inducer for SPI-2 gene expression in 
STy infections, after the ligands of the pathogen have been recognized by mainly TLR2 (lipoproteins), 
TLR4 (lipopolysaccharide, LPS), and TLR5 (flagellin) (Fulde et al. 2018; Hapfelmeier et al. 2005; Kawai 
and Akira 2005; O'Brien et al. 1980; Royle et al. 2003). Failure to rapidly acidify the endosomal 
compartment in TLR-deficient mice led to a striking replication and SCV maintenance deficiency in 
bone marrow macrophages (BMMs) in vitro, due to abrogated induction of SPI-2 expression in the 
absence of TLR2, 4 and 9 (Arpaia et al. 2011). However, TLR-dependent SPI-2 induction was only 
dispensable in the systemic phase of adult STy infections. After oral administration, SPI-2 effectors 
were required to achieve virulence and systemic spread even in TLR-deficient animals (Sivick et al. 
2014). 
The two most prevalent mouse strains BALB/c and C57BL/6 share the feature of a point mutation 
within the Slc11a1 gene, which encodes the natural resistance associated macrophage protein 1 
(NRAMP1) (Gruenheid et al. 1997; Govoni et al. 1996; Vidal et al. 1996). This increases the susceptibility 
to different intracellular pathogens, like Leishmania, Mycobacterium and Salmonella (Araujo et al. 
1998; Hackam et al. 1998). The function and mechanism of this protein remain incompletely 
understood, but it is known that Nramp is expressed exclusively in professional phagocytes and 
encodes an integral membrane protein that shares structural characteristics with ion channels and 
transporters of e g. iron and manganese (Forbes and Gros 2003). The removal of ions from the SCV by 
NRAMP1 might predict bacterial replication, increasing resilience of macrophages with a functional 
Slc11a1 allele isolated from 129sv mice (Cuellar-Mata et al. 2002). 
1.4.4 SPI-2 dependent intracellular lifestyle in vitro and in vivo 
Infection and pathogenesis are multicomponent processes, involving invasion, proliferation, 
replication, cell evasion and dissemination at distinct body sites. To a large extent, these intermediate 
steps are facilitated by expression of virulence factors encoded by SPI-2 as virulence determinants in 
the case of Salmonella in susceptible mice. Pathogenesis of Salmonella strongly depends on the ability 
to invade and replicate within host cells during early phases of the infection, prior to breaching the 
epithelial gut barrier and during systemic dissemination (Shea et al. 1999). In epithelial cells, STy 
exhibits a bimodal lifestyle, either proliferating in its established SCV as an intracellular replicative 
niche or freely in the cytosol (Brumell, Rosenberger, et al. 2001; Steele-Mortimer et al. 2002). 
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Self-induced or host-mediated lysis of the SCV, however, constitutes a double-edged sword for the 
pathogen. On the one hand, hyper replication in the host cell cytosol is a comparably rare phenomenon 
observed in less than 20 % of epithelial cells investigated via a semi-quantitative single-cell analysis 
(Malik-Kale, Winfree, and Steele-Mortimer 2012). In contrast to vacuolar bacteria, in which the SPI-2 
T3SS is induced, cytosolic bacteria have been shown to be transcriptionally different and 
SPI-1-T3SS-induced, although being situated in an intracellular state (Knodler et al. 2010). 
Hyper-replication in the host cell cytosol might eventually result in pyroptosis and epithelial cell death 
marked by loss of the plasma membrane integrity. Following cell lysis, pro-inflammatory cytokines are 
released by activating caspase 1 and by induction of caspase 3/7, bacteria gain access to the 
extracellular space, which might constitute a strategy for further dissemination of invasion-primed 
bacteria (Knodler et al. 2010; Knodler 2015). Several in vitro studies with non-polarized epithelial cells 
have confirmed cytosolic replication of Salmonella contributing to the net growth of the pathogen only 
to a minor extent compared to vacuolar replication, that unequivocally relies on a functional SPI-2 T3SS 
(Malik-Kale, Winfree, and Steele-Mortimer 2012). Hyper-replication is a phenomenon solely 
investigated in cultured epithelial cells, but not phagocytes like macrophages so far and single bacteria 
rather than “clumps” invade host cells in vivo (Grant et al. 2012; Knodler et al. 2010). However, SPI-2 
effectors are undeniable crucial when it comes to macrophage survival after entering the lamina 
propria in the gut and hence, SPI-2-independent replication possibly occurring in epithelial cells of the 
intestinal lining probably plays an inferior role in overall STy pathogenesis (Cirillo et al. 1998; Hensel et 
al. 1998; Fields et al. 1986). Considering this, possession of SPI-2 effectors is regarded as a crucial 
feature for intracellular replication and disease progression of STy, although cytosolic replication works 
irrespective of SPI-2 effector proteins (Chakravortty, Hansen-Wester, and Hensel 2002; Garai, 
Marathe, and Chakravortty 2011; Shea et al. 1996) 
Investigations of SPI-2-deficient Salmonella in the streptomycin mouse model already unraveled a 
necessity of SPI-2 effector proteins for development of full systemic virulence in adult infection 
experiments (Browne et al. 2008). While SPI-1 effectors are required for invasion of non-phagocytic 
epithelial cells, primarily limiting their requirement to breaching the intestinal barrier, SPI-2 becomes 
essential in the post-invasive phase for disease progression in typhoid and enteric fever as well as 
gastroenteritis caused by Salmonella (Malik-Kale, Winfree, and Steele-Mortimer 2012; Marlovits and 
Stebbins 2010). In line with this, SPI-2 mutants in contrast to ∆SPI-1 STy, remain attenuated when the 
intestinal barrier is circumvented by intraperitoneal (i.p.) or intravenous (i.v.) injection. This has been 
suggested to be attributable to the replication deficiency observed in in vitro studies plus an elevated 
vulnerability to killing by macrophages in addition (Fields et al. 1986). These synergistic effects in terms 
of decreased virulence in SPI-2-deficient Salmonella trace back to the same origin. Effector proteins 
that are translocated through the SCV membrane into the host cell cytosol facilitate conversion of the 
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early vacuolar compartment into a replicative niche (1.4.2). Although lysosomal fusion is avoided 
through the action of certain effector proteins, SCVs are still associated with lysosomal markers like 
e.g. LAMP-1 and this association typically precedes replication (Meresse et al. 1999; Steele-Mortimer 
et al. 1999). On the one hand, effectors function in immune evasion and avoidance of lysosomal 
degradation (Lei et al. 2016). Effector proteins modulating endosomal trafficking responsible for 
prevention of fusion with lysosomes also ensure intracellular localization of the SCV in a juxtanuclear 
position. Furthermore, they might contribute to intracellular nutrition by ensuring continuous 
exchange of the SCV with host cell endosomes as a prerequisite for replication (Liss et al. 2017; Noster 
et al. 2019; Popp et al. 2015). Colitis caused by either SPI-1 or SPI-2-deficient STy was less pronounced 
in comparison to a wt STy infection in the streptomycin mouse model, but certain cytokine and 
interleukin expression as mediators of innate immune responses and inflammation could still be 
examined in the absence of decisive virulence proteins of either SPI-1 or SPI-2 (Hapfelmeier et al. 
2005). This confirms that a combination of both efficient invasion and transfer across the epithelial gut 
barrier, as well as evasion from the immune system, are required for functional systemic 
dissemination, replication and disease progression and highlights the role of SPI-1 and SPI-2 for 
virulence in the mouse model. This is further emphasized by various studies stating SPI-2 to be a 
prerequisite for efficient intracellular replication inside vacuoles in tissue culture experiments and the 
adult mouse model (Galan 2001; Shea et al. 1996; Waterman and Holden 2003).  
Intracellular replication inside the SCV is a characteristic feature of S. enterica to rapidly enhance net 
growth. This process requests proper nutrition as a feature of high importance for the pathogen, which 
is also mediated via SPI-2 effectors by formation of tubular extensions known as Salmonella-induced 
filaments (SIFs) (Birmingham et al. 2005; Brumell, Tang, et al. 2001; Liss et al. 2017). Many auxotrophs 
were shown to be attenuated in terms of virulence in adult mice and replication deficiencies were 
examined for mutants depleted in tryptophan, tyrosine, phenylalanine, purines and pyrimidine 
synthesis (Chaudhuri et al. 2009; Thorne and Corwin 1975).    
In total, the typical isolation of Salmonella from lymphatic tissue and secondary lymphoid organs, such 
as the mesenteric lymph node, described in previous studies uniformly indicates that survival of the 
pathogen within macrophages is a critical feature to achieve systemic dissemination and invasive 
infections. Expression and translocation of effector proteins of SPI-2, furthermore, was stated to be 
important to manage intravacuolar replication via SCV formation and maintenance e.g. in HeLa cell 
cultures and resistance to macrophage killing in adult mice (Castanheira and García-Del Portillo 2017; 
Malik-Kale, Winfree, and Steele-Mortimer 2012). Due to physiological, structural, humoral and 
metabolic differences between neonate, juvenile and adult mice, the influence of these effectors in 
neonate NTS infections is to be determined in this study.  
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1.5 Aims of the study  
Although STy has been studied in various in vitro and animal models for ages, knowledge on the 
mechanisms of pathogenesis, precise function of single effector proteins and interaction with host cell 
processes is still fragmentary. However, while a large body of in vitro evidence was collected over the 
past years, it has been difficult to pinpoint inflammatory cues and mechanisms in the infected gut in 
vivo (Hapfelmeier et al. 2005). Furthermore, neither in vitro nor animal infections fully revealed the 
functions of all effector proteins translocated into the host cell and workings of some virulence factors 
are still undefined (Figueira and Holden 2012). This study applies the neonatal mouse infection model 
established previously to gain insights into SPI-2 effector protein functions and their contribution to 
iNTS disease progression in the neonate host, especially during early steps of infection (Zhang et al. 
2014). Unraveling mechanisms involved in the infectious process could ultimately facilitate future 
treatment possibilities and add to the reduction of Salmonella morbidity and mortality in the future.   
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2. Materials and Methods 
2.1 Materials 
2.1.1 Consumables 
1.5 ml tube SARSTEDT AG & Co. KG, Nümbrecht, Germany 
15 ml tube SARSTEDT AG & Co. KG, Nümbrecht, Germany 
5 ml tube Eppendorf, Wesseling-Berzdorf, Germany 
50 ml tube SARSTEDT AG & Co. KG, Nümbrecht, Germany 
agar dish SARSTEDT AG & Co. KG, Nümbrecht, Germany 
cell strainer 100 µm VWR International GmbH, Darmstadt, Germany 
cover slide Carl Roth, Karlsruhe, Germany 
cryo viial SARSTEDT AG & Co. KG, Nümbrecht, Germany 
disposable needle B. Braun Melsungen AG, Melsungen, Germany 
disposable scalpel B. Braun Melsungen AG, Melsungen, Germany 
embedding cassette Carl Roth, Karlsruhe, Germany 
filter tip SARSTEDT AG & Co. KG, Nümbrecht, Germany 
microscope slide Carl Roth, Karlsruhe, Germany 
PCR cap stripes SARSTEDT AG & Co. KG, Nümbrecht, Germany 
PCR tube stripes SARSTEDT AG & Co. KG, Nümbrecht, Germany 
pipette tip SARSTEDT AG & Co. KG, Nümbrecht, Germany 
serological pipette SARSTEDT AG & Co. KG, Nümbrecht, Germany 
syringe filter 0.2 µm SARSTEDT AG & Co. KG, Nümbrecht, Germany 
  
2.1.2 Chemicals and Reagents 
agarose Bio&SELL GmbH, Nürnberg, Germany 
Albumin (fraction) Carl Roth, Karlsruhe, Germany 
ampicillin Carl Roth, Karlsruhe, Germany 
chloramphenicol Sigma Aldrich, Darmstadt, Germany 
ethanol Carl Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid 
(EDTA) Carl Roth, Karlsruhe, Germany 
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glycine Carl Roth, Karlsruhe, Germany 
H2O (nuclease-free) Carl Roth, Karlsruhe, Germany 
isopropanol Carl Roth, Karlsruhe, Germany 
kanamycin Carl Roth, Karlsruhe, Germany 
LB agar Carl Roth, Karlsruhe, Germany 
Luria Broth (LB) Carl Roth, Karlsruhe, Germany 
Oligo(dT) 18 primer eurofins Genomics, Ebersberg, Germany 
paraformaldehyd/ Histofix Carl Roth, Karlsruhe, Germany 
potassium chloride Carl Roth, Karlsruhe, Germany 
potassium dihydrogenphosphate Carl Roth, Karlsruhe, Germany 
Rnase A QIAGEN GmbH, Hilden, Germany 
ROX mix ThermoFisher Scientifics, Hennigsdorf, Germany 
sodium chloride Carl Roth, Karlsruhe, Germany 
sodium citrate Sigma Aldrich, Darmstadt, Germany 
sodium hydrogen phosphate Carl Roth, Karlsruhe, Germany 
TRIzol® reagent ThermoFisher Scientifics, Hennigsdorf, Germany 
Vectashield Antifade mounting 
medium with DAPI VECTOR Laboratories LTD., Peterborough, United Kingdom 
xylol Carl Roth, Karlsruhe, Germany 
 
2.1.3 Devices 
3031 shaking incubator Edmund Bühler GmbH, Bodelshausen, Germany 
3K30 cooling centrifuge Sigma Aldrich, Darmstadt, Germany 
CO2-Incubator Heraeus Function 
Line ThermoFisher Scientifics, Hennigsdorf, Germany 
Fluorescence Zeiss Axiovert 200 M 
Inverted Microscope Carl-Zeiss, Jena, Germany 
Light microcope DMI6000 B Leica Microsystems, Wetzlar, Germany 
NanoDrop 1000 ThermoFisher Scientifics, Hennigsdorf, Germany 
shaking incubator GFL, Burgwedel, Germany 
StepOne Plus Real-Time PCR 
system Applied Biosystems, Hennigsdorf, Germany 
sterile bench Kendro, Langenselbold, Germany 
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T 10 basic ULTRA-TURRAX® 
homogenizer IKA®-Werke GmbH & Co. KG, Staufen, Germany 
T3000 thermocycler Biometra, Jena, Germany 
tabletop centrifuge 5415D Eppendorf, Wesseling-Berzdorf, Germany 
Ultrospec 3000 pro Photometer Amersham Pharmacia Biotech Inc.,  Little Chalfont, United Kingdom 
Vortex genie 2 Scientific Industries, New York, United States 
water bath GFL, Burgwedel, Germany 
2.2 Methods 
2.2.1 Bacterial strains and plasmids 
Bacterial strains of S. enterica subsp. enterica serovar Typhimurium are listed in Table 12. Mutagenesis 
was performed in accordance to Datsenko and Wanner, kindly conducted by Prof. Michael Hensel, 
University of Osnabrück (Datsenko and Wanner 2000). The pFPV-25.1 plasmid was incorporated into 
competent Salmonella by electroporation. For selection and quantification, antibiotic resistance 
cassettes were applied and the respective antibiotic was added to culture media for selection as stated. 
2.2.2 Cryopreservation 
Liquid bacterial cultures in Luria Bertani (LB) broth containing respective antibiotics at given 
concentrations (Table 12) were grown at 37 °C at 200 rpm until reaching the logarithmic phase 
(OD600 nm 0.5 – 0.6). Bacteria were harvested via centrifugation at 4000 x g for 7 min and the pellet 
resuspended in fresh LB medium. Bacterial solutions were mixed with sterile Glycerol to a final 
concentration of 20 % Glycerol in cryovials and stored at -80 °C. For re-cultivation, strains were 
streaked out on LB agar plates and grown overnight at 37 °C.  
2.2.3 Cultivation of Salmonella  
Bacteria were streaked out on LB agar plates containing the respective antibiotic at given 
concentrations and incubated at 37 °C in an incubator overnight. The next day, a single colony was 
picked and incubated in 5 ml LB containing antibiotics. Liquid cultures were grown at 37 °C at vigorous 
shaking (200 rpm) overnight and diluted 1:10 the next morning in fresh medium. Cultures were grown 
again until they reached logarithmic phase (OD600 nm 0.5–0.6). The bacterial pellet was gained via 
centrifugation at 4000 x g for 7 min and washed in 1 x PBS twice. Afterwards, the pellet was thoroughly 
resuspended in fresh PBS, adjusted to an OD600 nm 0.5  –  0.6 and diluted to the desired infectious dose. 




2.2.4 Oral infection of neonate and juvenile mice 
Adult C57BL/6N wild type and B6J.129S1-Slc11a1r/GbrtJ (Nrampr/r, stock no. 027081) mice were 
obtained from Charles River Laboratory (Sulzfeld, Germany) and B6.129P2(SJL)-MyD88tm1.1Defr/J 
(MyD88-/-, stock no. 009088) mice from the Jackson Laboratory (Bar Harbour, USA), respectively. 
Cultivation of bacterial strains was performed as described in the previous section (2.2.3). One-day old 
neonates were orally infected with 1 µl of the adjusted inoculum. The respective infectious doses can 
be abstracted from figure legends in the results section. Neonates were individualized via footpad 
tattoo, the weight and clinical conditions were monitored daily and assessed in accordance to an 
entrenched score sheet for neonate mice (Table 2). 
Table 2: Scoring system for evaluating the health status of neonatal mice during infection 
experiments 
To assess the health status and to avoid excessive stress due to the infection, a scoring system was set 
up. Based on distinct criteria, it allows determination of the overall health condition of an infected 
neonate mouse. The health status was monitored at least once daily. Mice were immediately 
euthanized if no body weight gain was observed over at least two days, the dam cared insufficiently 
(pubs placed dispersed) and motility was severely reduced to stimuli or certainly at grade 4. 
grade description criteria 
  movement skin fostering distribution weight development 
1 active spontaneuos pink dam cares pups lie together 
daily weight 
gain (>10 %) 




gain (5-10 %) 




faint dam cares pups lie together 
reduced body 
weight gain 












no weight gain 
(<5 %) or weight 
loss 
For the infection of older animals (at 6 or 11 days post partum, respectively) the infection volume was 
adjusted according to the mean weight of the litter. In order to do so, a mean weight of 1.5 g for a 
1-day old mouse was estimated, corresponding to 0.66 µl bacterial solution per gram bodyweight.  
At indicated time points after the infection, mice were sacrificed and organ tissue was harvested. Liver, 
spleen, mesenteric lymph node and colon were homogenized in sterile PBS and plated on antibiotic 
containing LB agar plates. Small intestines were either directly homogenized in 1 ml sterile PBS, used 
for primary cell isolation in case of replica plating for quantification (2.2.5) or fixed in 




2.2.5 BSA/gold application to neonates to backtrace vesicular trafficking 
One-day old neonates were either orally infected with a low infection dose of ΔSPI-2 Salmonella or left 
untreated. At 3 days p.i., a solution of BSA gold nanoparticles in sterile PBS was orally applied to the 
animals every 8 hours for 24 hours in total (corresponding to three treatments) at a volume of 8 µl per 
treatment. Mice were sacrificed at 4 dpi, the intestinal tracts removed, fixed in 4 % pfa for 48 hours 
and prepared for transelectronmicroscopic analysis kindly conducted by Urska Repnik, University of 
Oslo, and Dr. Mark Kühnel, Hannover Medical School as described later in this study (2.2.8).  
2.2.6 Infection with tagged salmonellae 
Twenty-two individual strains were tagged with a 4 nucleotide sequence, introducing an artificial stop 
codon into the endogenous proV gene as already described (Lim et al. 2014). Each strain was grown 
individually in liquid LB as stated in 2.2.3 and adjusted to an OD600 nm of 0.5 corresponding to the 
logarithmic growth phase. Bacterial suspensions were mixed at equal ratios and sterile Glycerol (final 
concentration 20 %) was added to the culture suspension. The mixed inocula were shock-frozen in 
liquid nitrogen and stored at -80 °C until usage afterwards. Prior to infection, one aliquot was thaw on 
ice and used as inoculum for 5 ml LB supplemented with chloramphenicol (CM, c=10 µg/ml) overnight. 
The mixed tag culture was diluted 1:20 the next morning and incubated at 37 °C and 200 rpm until 
reaching the logarithmic phase. The culture was washed as described (2.2.3) and adjusted to an 
OD600 nm of 0.5. To determine the total bacterial number within the inoculum, the bacterial solution 
was plated on CM containing LB agar plates and grown overnight at 37 °C. Colonies were counted the 
next morning and the inoculum on agar plates was prepared for tag sequencing as stated later in this 
section. The tags and their relative contribution to the reads of the inocula can be abstracted from 




Table 3: Tags applied in WITS infection of neonatal mice in and their relative contribution to the 
infection inocula 
In total, 22 isogenic strains in the STy ATCC 14028 wt or ΔsseB background carried a 4 nucleotide tag 
in their endogenous proV gene to discriminate them via sequencing of samples. Unequal distribution 
of tags to the infection inocula was compensated by calculating an appropriate factor. By this means, 
the overall number of reads in the inoculum (139000 for wt and 127488 for ΔSPI-2 WITS in total) was 
divided by the number of tags, resulting in a theoretical tag distribution assuming equal and ideal 
mixtures (6318 reads per tag wt background, 5793 reads per tag ΔSPI-2 background). The actual 
number of reads in the inoculum was divided by this value, resulting in individual factors used for 









AAGA 5341 1.18   9555 0.61 
AAGT 5458 1.16   9698 0.60 
ACAA 411 15.37   312 18.57 
ACCC 7552 0.84   3781 1.53 
AGGC 8413 0.75   2278 2.54 
ATCT 2135 2.96   5187 1.12 
CAAC 10768 0.59   7367 0.79 
CCAC 9304 0.68   2858 2.03 
CCCC 6970 0.91   5976 0.97 
CCCT 5679 1.11   11172 0.52 
CGAA 20047 0.32   14678 0.39 
CGGT 7993 0.79   8454 0.69 
CTAC 6846 0.92   3791 1.53 
GCCC 3214 1.97   2004 2.89 
GGGA 2406 2.63   8178 0.71 
GTGC 4487 1.41   2974 1.95 
GTTA 8747 0.72   4626 1.25 
TAAT 3750 1.68   6261 0.93 
TAGA 8848 0.71   6948 0.83 
TGCA 4753 1.33   3797 1.53 
TGGA 4589 1.38   3493 1.66 
TTTC 1289 4.90   4060 1.43 
The WITS with the STy wt background were diluted 1:1000 in sterile PBS before oral application to 
1-day old mice. SPI-2-deficient WITS were applied undiluted in a volume of 1 µl per neonate (infectious 
doses as stated in Figure 7). The animals were monitored daily and sacrificed at 4 days post infection 
(p.i.). Liver, spleen and mesenteric lymph node (MLN) were removed and directly homogenized in 
sterile PBS. The intestinal content was harvested via thoroughly rinsing the small intestinal tubes with 
sterile PBS and collecting the flow through. Organ material was plated on CM containing agar plates to 
abtain approximately 1000 CFU/plate. The plates were incubated at 37 °C overnight and formed 
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colonies were washed off by adding 4 ml PBS per plate and subsequently incubated at room 
temperature (RT) on a shaker at 300 rpm. Bacteria were collected via centrifugation and the pellet was 
used for gDNA isolation using Master pure kit (epicentre, Madison, Wisconsin, USA). First, the pellet 
was resuspended in 600 µl lysis buffer, incubated at 80 °C for 5 min and chilled on ice for 3 min. RNAse 
(2 µg) was added and incubated at 37 °C for one hour. Afterwards MPC Protein Precipitation Reagent 
(Master pure kit) was mixed with the solution and phase separation was achieved via centrifugation. 
Nucleic acids were washed in 70 % ethanol and the pellet containing gDNA resuspended in nuclease-
free water. In the next step, the proV gene was amplified via PCR with primers described previously 
(see Appendix) (Lim et al. 2014). Ten ng of gDNA from each sample was used as template for a two-step 
PCR reaction in order to obtain an amplicon library fully compatible to the multiplexing Illumina TruSeq 
DNA sequencing protocol. The PCR reaction mix and protocol for initial amplification of the proV gene 
from organ homogenates are depicted in Table 4 and Table 5. 
Table 4: PCR reaction mix 
Ingredients for preparation of PCR in order to amplify proV from Salmonella gDNA from infection 
experiments of neonate mice with tagged strains (WITS). 
reagent volume supplier 
DreamTaqTM buffer (10x) 3 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
proV forward primer 1 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
proV reverse primer 1 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
dNTPs 1 µl Carl Roth, Karlsruhe, Germany 
DreamTaqTM polymerase 
(5U/µl) 0.125 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
gDNA 1 µl (10 ng) - 
H2O nuclease-free ad 30 µl Carl Roth, Karlsruhe, Germany 
 
Table 5: PCR protocol for amplification of proV from gDNA extracted from organ homogenates after 
mixed tag infection. 
step temperature time cycle repeats 
initital 
denaturation 98 °C 2 min 
 
denaturation 95 °C 30 sec 
40 x annealing 60 °C 20 sec 
elongation 72 °C 30 sec 
final elongation 72 °C 2 min  




The samples were sequenced on Illumina a MiSeq system using MiSeq Reagent Kits (73 cycles/323 
cycles) at the Center for Biotechnology (CeBiTec) at the university of Bielefeld.  
Over- or underrepresentation of individual tags due to unequal contributions to the initial inoculum 
were compensated by multiplying the number of reads per tag with the factor calculated beforehand 
(Table 3). For graphical illustration, tags with ≥1 % of reads are represented by an individual color, 
underrepresented tags are pooled as “others” (Figure 7).  
2.2.7 Primary intestinal cell isolation 
Primary intestinal epithelial cells were isolated from small intestinal tracts of orally infected neonates 
as previously described (Lotz et al. 2006). Intestinal tissue of the neonates were removed and cut into 
small pieces. Tissue was incubated in 30 mM EDTA PBS at 37 °C for 10 min. Vigorous shaking for 30 sec 
detached the epithelial cells from the underlying tissue. Cells were harvested by centrifugation at 
1500 x g for 10 min at 4 °C. Afterwards, cell pellets were resuspended in 10 ml of 10% FCS/PBS and cell 
suspensions were passed through a 100 µm nylon cell strainer and either plated on LB containing 
antibiotic plates for quantification of bacteria in intestinal tissue or collected by centrifugation for 
transcriptional analysis afterwards (1500 x g, 10 min, 4 °C). The cell pellet was washed in PBS, collected 
via centrifugation, the cells were then resuspended in Trizol reagent and stored at -80 °C until usage. 
2.2.8 Gene expression analysis 
Total RNA was extracted from primary intestinal by phenol/chloroform extraction method. Trizol 
frozen cells (see previous section) were thaw on ice and incubated for 5 min. Afterwards 200 µl 
chloroform were added were added per tube, samples were vortexed thoroughly and then incubated 
at RT for 2 min, in which phase separation occurred. The samples were centrifuged at 12000 x g for 15 
min at 4 °C and the RNA-containing supernatant was conferred to a new tube. Following, 500 µl 
Isopropanol were added and the mixture was incubated at RT for 10 min and centrifuged again at 
12000 x g for 15 min at 4 °C. The resulting pellet was washed twice in ethanol and harvested by 
centrifugation at 7500 x g for 5 min at RT. The entire supernatant was removed and the pellet dried at 
RT for 15 min. Then, the RNA was dissolved in water and further employed for cDNA synthesis. In order 
to prepare cDNA, isolated RNA was mixed with oligo d(T) primers, incubated at 65 °C for 5 min and 
chilled on ice for 1 min. Afterwards, the solution was mixed with 7,5 µl Mastermix (for composition 
see Table 6) and incubated to cDNA synthesis at 42 °C for 1 hour, followed by a 10 min incubation 




Table 6: Mastermix composition for cDNA synthesis 
The ingredients for cDNA synthesis of extracted RNA and their respective volumes are listed.  
reagent volume per sample supplier 
RT buffer (5x) 4 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
dNTPs 2 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
Rnase inhibitor 0.5 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
reverse transcriptase 1 µl ThermoFisher Scientifics, Hennigsdorf, Germany 
The cDNA was diluted with nuclease-free water and applied in gene expression analysis by Taqman 
based quantitative real-time PCR with the Taqman probes listed in Table 8. The gene expression was 
compared to uninfected, age-matched control animals and normalized to the housekeeping gene Hprt. 
Quantitative real-time PCR (qRT-PCR) was carried out with a PCR protocol described in Table 7. 
Table 7: PCR protocol for Taqman based quantitative real-time PCR 
Reading steps to determine threshold cycle (Ct) were set before (pre-PCR read) as well as after 
(post-PCR read) the whole PCR and after each annealing step.  
step temperature time cycle repeats 
pre-PCR read 60 °C 30 sec  
initial denaturation 95 °C 15 min  
denaturation 95 °C 15 sec 
40 x 
annealing 60 °C 1 min 
post-PCR read 60 °C 30 sec  
hold 10 °C -  
Table 8: Taqman probes for gene expression analysis 
All probes were obtained from ThermoFisher and target murine genes. Gene expression analysis for 
the respective gene was always normalized to the housekeeping gene Hprt. 
name gene species assay ID supplier 
Hprt Hypoxanthine Phosphoribosyltransferase 1 mouse Mm00446968_m1 
ThermoFisher Scientifics, 
Hennigsdorf, Germany 
Cxcl5 Chemokine (C-X-C motif) chemokine ligand 5 mouse Mm00436451_g1 
ThermoFisher Scientifics, 
Hennigsdorf, Germany 
Cxcl2 Chemokine (C-X-C motif) ligand 2 mouse Mm00436450_m1 
ThermoFisher Scientifics, 
Hennigsdorf, Germany 
Reg3γ Regenerating islet-derived protein 3 gamma mouse Mm00441228_m1 
ThermoFisher Scientifics, 
Hennigsdorf, Germany 
Nos2 Nitric oxide synthase 2 mouse Mm00440495_g1 ThermoFisher Scientifics, Hennigsdorf, Germany 









2.2.9 Immunofluorescence staining 
Small intestinal tissue of neonate mice was fixed in 4 % paraformaldehyde for at least 24 hours and 
embedded in paraffin afterwards. Tissue was cut in 3 µm sections, deparaffinized in xylene and 
rehydrated in ethanol. Antigen retrieval was conducted in 10 mM sodium citrate for 10 min and 
blocking with 10 % serum in PBS/BSA solution prior to immunofluorescence staining. Primary 
antibodies (Table 9) in 5 % BSA/PBS were incubated at RT for one hour followed by washing of samples 
in PBS three times.  
Table 9: Primary antibodies used in this study 
According to the desired target structure combination to be visualized, the listed antibodies were 
applied in respective combinations, as stated in the figure legends within the results section. 
origin species target dilution supplier 
rabbit Salmonella 1:1000 Abcam, Cambridge, United Kingdom 
mouse E-cadherin 1:200 BD Biosciences, Heidelberg, Germany 
chicken GFP 1:500 Abcam, Cambridge, United Kingdom 
Afterwards, the secondary antibodies listed in Table 10 were added at indicated concentrations in 
accordance to the primary antibody combination. Secondary antibodies were attached to a 
fluorophore and incubated on the slices for 1 hour at RT in the dark. The tissue sections were washed 
in PBS, counterstained with Vecta Shield mounting medium containing DAPI to stain the DNA, sealed 
and stored at 4 °C until usage.  
Table 10: Secondary antibodies applied during this study for immunofluorescence stainings 
Secondary antibodies attached to a fluorophore were chosen in accordance to the origin species of the 




species dye dilution supplier 
goat rabbit Alexa Fluor 488 1:200 Jackson ImmunoResearch, West Grove, Pennsylvenia, United States 
goat mouse Alexa Fluor 568 1:200 Jackson ImmunoResearch, West Grove, Pennsylvenia, United States 
donkey chicken FITC 1:200 Jackson ImmunoResearch, West Grove, Pennsylvenia, United States 
goat rabbit Alexa Fluor 568 1:1000 ThermoFisher Scientifics, Hennigsdorf, Germany 
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Samples were analysed in a Zeiss DMI600b fluorescence micropcope. Images were processed using 
LAS X software (Leica, Wetzlar, Germany) and ImageJ Fiji (NIH, USA). Pictures were adjusted for 
brightness and contrast. 
2.2.10 Transmission electron microscopy 
Infected small intestinal tissue samples obtained from neonatal mice were processed by Urska Repnik, 
University of Oslo. Samples were fixed in 150 mM HEPES, pH 7.35, containing 4 % formaldehyde and 
0.1 % glutaraldehyde at room temperature for 1 hour and subsequently stored overnight in fixative at 
4 °C. Following, samples were dehydrated in acetone and embedded in EPON. Sixty nm sections were 
mounted onto formvar-coated copper grids, stained with 4 % uranyl acetate and lead citrate as 
previously described by Reynolds and visualized in a Morgagni TEM (FEI), operated at 80 kV (Reynolds 
1963). In addition, Dr. Mark Kühnel, Hannover Medical School performed transmission electron 
microscopy as described previously (Zhang et al. 2014). 
2.2.11 Ethic statement 
All animals were handled in accordance with regulations defined by FELASA and the national animal 
welfare body GV-SOLAS. In vivo experiments were performed in compliance with the German animal 
protection law (TierSchG) and approved by the local animal welfare committee. Approvals G0293/15 
and T0284/15 of the Landesamt für Gesundheit und Soziales Berlin, Germany, 
33.14.42502-04-12/0693 of the Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit Oldenburg, Germany, as well as 81-02.04.2017.A397 of the Landesamt für 
Natur, Umwelt und Verbraucherschutz, North Rhine Westfalia. 
2.2.12 Statistical analysis 
Any statistical analysis of data during this study was conducted using GraphPad Prism 8 software. 
Results of bacterial growth in organ tissues and gene expression analysis display individual animals plus 
the median if not indicated otherwise  For comparison of two independent groups, student’s t-test 
with Mann-Whitney-U-test was applied, whereas statistical differences of data sets within experiments 
containing three or more distinct groups were determined via one-way ANOVA and Dunn’s post-test. 
In either case, differences p≥0.05 were considered not significant (ns), * p≥0.01, ** p≥0.001, 




3.1 Functions of SPI-2 in the neonate host 
The effector proteins encoded by the Salmonella pathogenicity island-2 (SPI-2) are known to be a 
requirement for development of systemic virulence in adult mice for ages (Coburn et al. 2005). We 
were particularly interested in the properties of SPI-2 effectors in the pathogenesis of NTS infections 
in the neonate host and therefore compared virulence of the SPI-2-deficient STy mutant versus the 
wildtype strain in the first place.  
3.1.1 SPI-2 effector protein translocation is crucial for systemic spread in 
neonates 
After oral application to neonate mice, the ∆SPI-2 mutant S. Typhimurium (STy) strain showed 
significantly attenuated virulence in infected mice within the first 11 days after infection, whereas 
more than 50 % (n=10) of animals infected with the same dose of wt STy succumbed to the causes of 
the infection within the first 5 days (Figure 3 A). Correspondingly, bacterial loads of systemic tissue as 
well as the mesenteric lymph node (MLN) were markedly reduced in the mutant as compared to the 
wt strain (p>0.0001, p=0.0023, p>0.0005, Figure 3 B-D). In stark contrast to this observation, 
colonization of the small intestinal enterocytes (IECs) and colon are highly similar between wt and 
SPI-2-deficient bacteria (Figure 3 E-F). By trans-complementation, the virulent systemic phenotype of 




Figure 3: SPI-2 is essential for development of systemic virulence in the neonate host.  
(A) Neonate mice orally infected with 102 CFU wt (dashed line, n=20) or SPI-2-deficient Salmonella 
(solid line, n=18) were monitored daily for their degree of severity according to a well-established 
scoring system (Table 2) and the survival rate was calculated in accordance. Four days p.i. (dpi), mice 
infected at 1 day post partum (p.p.) with wt (squares), ∆sseB STy (circles) or a complemented ΔsseB 
mutant strain (triangles) were sacrificed and replica plating of liver (B), spleen (C), mesenteric lymph 
node (MLN, D), intestinal enterocytes (IECs, E) and colon (F) homogenates revealed bacterial loads of 
different tissue compartments. ANOVA with Dunn’s multiple post-test was applied to calculate 
statistical significances as indicated, a p-value > 0.05 is indicated by “ns”.  
3.1.2 The influence of host maturation on SPI-2-independent infection  
In the adult murine model, attenuated virulence of ∆SPI-2 STy after oral inoculation has been 
accompanied by the inability to disseminate to systemic sites (Shea et al. 1999). In these animals, 
colonization resistance is overcome by antibiotic treatment prior to infection (Kaiser et al. 2012), a 
redundant step in neonatal mice that have not established a protective intestinal microbiota thus far. 
Infection of slightly older, but still suckling mice with a weight adapted inoculum of ∆SPI-2 STy did not 
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yield detectable bacterial load in neither liver nor spleen (p=0.0004, p>0.0001, Figure 4 A-B). In 
addition, the number of mutant bacteria in the MLN as well as SI and isolated enterocytes was 
significantly reduced when compared to the neonatal infection (Figure 4 C-E). Different anatomical 
distributions of ∆SPI-2 bacteria became more apparent with increasing host age. Whereas both the 
proximal and distal part of the intestine are similarly loaded after a neonatal ∆sseB STy infection, the 
distal part displayed higher bacterial densities than the proximal part in both intestinal enterocytes 
and whole organ homogenates of older mice infected at 6 and 11 days post partum (p.p.) (Figure 4 
F-G). Overall, bacterial burden of the intestinal enterocytes was markedly reduced in older mice, as 
compared to neonates (p=0.0196, p>0.0001).  
Mice were orally infected with a weight-adapted dose of ∆sseB Salmonella at 1, 6 or 11 days p.p.. At 4 
days p.i., mice were sacrificed and organ loads were determined by replica plating for liver (A), spleen 
(B) and MLN (C). Concerning the small intestine (SI), whole organ homogenates (E+G) were compared 
to isolated intestinal enterocytes (D+F) from the bisected other half of the SI of the very same animal. 
ANOVA with Dunn´s multiple post-test was used for statistical analysis, a p-value ≥ 0.05 is considered 
not significant, indicated as “ns”. The bacterial load of the proximal part of the SI and IECs was 
compared to the distal part of the same compartment (F-G). Student`s t-test was used for statistics.  




3.1.3 Salmonella-induced inflammation in the neonate gut 
After depletion of the resident microbiota by streptomycin treatment (Barthel et al. 2003), the invasion 
of primarily M (microfold) cells in the gut (Haraga, Ohlson, and Miller 2008) by Salmonella induces 
massive inflammation and upregulation of different cytokines in adult mice (Kaiser et al. 2012; LaRock, 
Chaudhary, and Miller 2015; Miki et al. 2017; Stecher et al. 2005). This ultimately leads to the 
recruitment of immune cells to the lamina propria underlying the epithelial barrier in the intestinal 
tract, probably accelerating systemic dissemination of the pathogen (Cheminay, Chakravortty, and 
Hensel 2004). Hence, we next wondered whether an inability of ΔSPI-2 mutant bacteria to cause 
inflammation might explain diminished systemic spread and attenuated virulence in the neonate host 
at least to some degree (3.1.1).   
Similar to progression of NTS infections in adult mice, infection of neonate mice with wt Salmonella 
yielded a significant upregulation of Cxcl5 (p=0.033), Cxcl2 (p=0.0004), RegIIIγ (p=0.0053), Nos2 
(p=0.0017) and Saa3 (p=0.0016), but not Ccl2 (Figure 5 A-F). In contrast, in the absence of SPI-2, only 
certain antimicrobial factors were significantly higher expressed compared to the uninfected control 
(RegIIIγ, p=0.0417; Nos2, p=0.0225 and Saa3, p=0.0193), whereas other cytokines tested were 
expressed to a similar extent (Figure 5 A-F). Although the SPI-2-deficient mutant did not cause any 
mortality (Figure 3 A), a dramatic induction of RegIIIγ expression was caused by infection of the 
neonate host. Peaking at 4 dpi, RegIIIγ levels remained elevated, but simultaneously, expression also 
increased under physiological conditions with maturation of the host (Figure 5 G). These processes 
lead to similar RegIIIγ levels in ∆SPI-2-infected and uninfected mice at the age of 19 days p.p. (Figure 
5 G).  
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Quantitative RT PCR of uninfected control mice (ctrl, green circles) and mice neonatally infected with 
either 102 CFU wt (squares) or SPI-2-deficient Salmonella (circles) at 4 dpi. Expression of C-X-C motif 
chemokine 5 (Cxcl5, A), Cxcl2 (B), regenerating islet-derived protein 3 gamma (RegIIIγ, C), inducible 
nitric oxide synthase 2 (Nos2, D), CC-chemokin-ligand-2 (Ccl2, E) and serum amyloid A 3 (Saa3, F) 
normalized to the expression of the housekeeping gene Hprt is depicted as relative (rel.) expression. 
ANOVA with Dunn´s multiple post test was used for statistical analysis, a p-value ≥ 0.05 is considered 
not significant and indicated as “ns”. Additionaly, quantitative RT PCR for expression of RegIIIγ mRNA 
in intestinal enterocytes isolated at indicated time points after neonatal infection with ∆SPI-2 STy was 
performed (G). One-day old mice were infected with 102 CFU ΔSPI-2 mutants (black circles) or 
age-matched uninfected control animals, which were left untreated (green circles). The given results 
represent the median values from two independent experiments (n=8 per group infected, n=3 
uninfected control animals). The expression was normalized to the housekeeping gene Hprt. 




3.2 The peculiar phenotype of SPI-2-deficient Salmonella 
The colonization rate of the small intestine and colon of neonatal mice infected with wt or 
SPI-2-deficient Salmonella was highly comparable (Figure 3 D-E). Earlier studies demonstrated 
expression and functional secretion of SPI-2 to be a necessity for intracellular survival and replication 
of STy in isolated macrophages (Cirillo et al. 1998) and epithelial cell lines (Groisman and Ochman 
1996). We next aimed at the further clarification of the consequences of lacking SPI-2 effectors in the 
neonate intestine in more detail.  
3.2.1 SPI-2-independent SCV formation in the neonatal small intestine 
To minimize histological changes caused by the progressive infection and inflammation in wt infected 
neonates (Figure 3 B-D, Figure 5 A-F), we focused on a time point at 4 dpi. for further investigations, 
where the majority of wt infected mice displayed clear signs of systemic infection, but did not succumb 
to the consequences yet (Figure 3 A). Immunofluorescence staining of tissue sections from wt and 
∆sseB infected neonates at this time point clearly indicates the accumulation of mutant bacteria inside 
an infected epithelial cell, as holds true for wt Salmonella (Figure 6 A). After invasion of a 
non-phagocytic intestinal epithelial cell by translocation of SPI-1 effectors (Zhang et al. 2014), 
Salmonella replicates within a specialized, membrane-bound compartment known as the 
Salmonella-containing vacuole (SCV, 1.4.2) (Vazquez-Torres, Xu, et al. 2000). Although sseB-deficient 
Salmonella are unable to translocate the entire SPI-2 effector protein subset, SCV formation does not 
seem to be impaired in the neonate gut (Figure 6 B).  Furthermore, SCVs formed by mutant bacteria 
are approximately 5 times bigger than vacuoles of wt bacteria at the same time point (p>0.0001, Figure 
6 C). Transmission electron microscopic pictures of ∆SPI-2-infected cells in the neonate small intestine 
encourage the finding of an intact vacuole surrounding various mutants inside an infected enterocyte 
(Figure 6 D). Apposite to the attenuated virulence of mutant as compared to the wt strain, the brush 
border of infected cells remained completely intact (Figure 6 D iii). Although functional translocation 
of effector proteins from the inside of the SCVs into the host cell cytosol is no longer possible in the 
mutant due to a fragmentary translocon (Figure 2), expression of SPI-2 is not impaired and intracellular 
expression of effector proteins remains functional, demonstrated by infection with a GFP-reporter 
strain (Figure 6 E). This proves intact SCV formation in the small intestine of neonatal mice in the 
absence of SPI-2 effector protein translocation.  
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Immunofluorescence of small intestinal tissue sections of wt (i) and ∆SPI-2 STy (ii) infected mice 4 days 
after oral administration reveals bacterial accumulation, that can be considered as 
Salmonella-containing vacuoles (SCVs) inside infected enterocytes in both types of infection (A). Scale 
bars represent 5 µm. The compare of the number (B) and size (C) of SCVs in small intestinal sections of 
wt and ΔSPI-2 STy reveals no significant difference in SCV formation between wt and mutant bacteria. 
At least 20 fields of view from 3 different animals were investigated for determination of SCV number 
and at least 40 SCVs from 3 different animals were measured for SCV sizes. Results represent median 
values, significance was calculated with the student’s t-test ns, p>0.05. Transmission electron 
microscopy pictures of SCVs from Salmonella ΔSPI-2 infected mice by Dr. Mark Kühnel also hint to 
membrane enclosed accumulations of bacteria inside an infected host cell (D). White arrows in (ii) and 
(iv) indicate an intact membrane entirely surrounding the SCV. Bars represent 20 µm (i), 1 µm (ii), 2 
µm (iii) and 0.5 µm (iv). Immunostainings of SPI-2-deficient Salmonella carrying a gfp-reporter allele 
under the control of the promoter of the SPI-2 effector protein SsaG. Single channels of DNA (i, blue), 




Salmonella (ii, red) GFP (iii, green) and a merged channel image (iv) are depicted (E). Bars represent 10 
µm.  
3.2.2 The absence of SPI-2 influences dissemination and distribution of 
subpopulations in invasive NTS infections 
Expansion of knowledge regarding pathogenesis of invasive Salmonella infections has progressively 
gathered research attention.  A study by Lim and colleagues made use of mixed infection with tagged 
Salmonella to reveal dynamics of the infection process with special respect to bottleneck formation in 
distinct steps of pathogenesis and distribution of tagged Salmonella in different tissue compartments 
(Lim et al. 2014). We utilized mixed infection with individually tagged wt and ∆SPI-2 Salmonella in order 
to prove improper transmigration of the epithelial barrier in the neonate small intestine by the mutant, 
resulting in diminished systemic spread and attenuated virulence.  
Dissemination of wt and SPI-2-deficient tagged Salmonella was investigated in neonatal mice at 4 days 
p.i. in the next step. As not all 22 subpopulations contributed equally to the infection inoculum, their 
relative proportion was calculated and considered for further evaluation. In order to do so, the number 
of reads of an individual tag was multiplied with a factor calculated beforehand to compensate for 
over- or underrepresentation already present in the inoculum (see Table 3, Figure 7 A). Distributions 
of individual tagged bacteria in different organ compartments of infected mice are depicted in pie 
diagrams (Figure 7 B-C). Only those tags with more than 1 % of the overall reads per sample were taken 
into account and are displayed with a distinct color in the pie diagram, whereas underrepresented 
samples are summarized in grey.  
Infection of neonate mice by Salmonella and especially the colonization of the intestine as the first 
step in pathogenesis obviously represents a process of non-Darwinian selection, since the isolated tags 
between different animals in the same compartment can vary strikingly (e.g. wt infected animal IV vs 
V). Besides this, overrepresentation of a subpopulation of WITS in the intestinal tract does not 
necessarily lead to an equal proportion of it in systemic organs for neither wt nor SPI-2-deficient 




Neonatal mice were orally infected with 104 CFU ∆sseB or 103 CFU wt Salmonella. The different 
contribution of each of the 22 individually tagged subpopulations in the inoculum is depicted in A. Each 
colour represents a distinct tag (Table 3). At 4 days p.i., homogenates of liver, spleen and MLN as well 
as small intestinal flushings were plated and all colonies harvested by washing. gDNA was isolated and 
the proV gene amplified. The amplicons were sequenced by MiSeq. Pie diagrams depict the relative 
proportion (2.2.4.2, Table 3) of the different SPI-2-deficient (B, n=7) or wt (C, n=5) WITS in investigated 
organ compartments of individual animals labeled I-VII or I-V, respectively, with all compartments of 
one animal in the same row. Each color represents an individual tag conducing to more than 1 % to 
the overall reads per sample. Underrepresented tags are collectively shown in grey as “others”.  
The different Salmonella subpopulations within distinct tissue compartments of the same animal were 
compared in more detail afterwards to investigate the role of SPI-2 in pathogenesis and systemic 
spread a little further. Hence, the individual tags detected in more than one organ within the same 
host and the resulting sequence identity among distinct tissues is contrasted between wt and ∆sseB 
infection (Figure 8 A-D). For the wt infection, sequence identities are high, especially between liver and 
spleen (mean value 88 % tag identity, Figure 8 A) and moderate for liver vs SI content (mean value 
64 % tag identity, Figure 8 B), spleen vs SI content (mean value 69 % tag identity, Figure 8 C) and MLN 
vs SI content (mean value 66 % tag identity, Figure 8 D). In contrast to this, identities between different 





organs within the same host infected with SPI-2-deficient strains are markedly decreased (mean values 
tag identity: liver vs spleen 35 %, liver vs SI content 33 %, spleen vs SI content 25 % and MLN vs SI 
content 60 %). As already indicated in Figure 7, populations and distribution of different tags among 
distinct tissues clearly show overlaps and similarities for wt-infected neonates, whereas 
subpopulations in organs of ∆sseB-infected mice are highly different, especially when comparing SI 
content to systemic compartments. By comparison of tag identities, this observation could be further 
validated.  
The colonization of systemic organs, lymphoid tissue and small intestinal enterocytes during early 
phases of the infection with tagged Salmonella is shown in Figure 8 E-H. At 2 dpi, bacterial burden in 
liver (Figure 8 E), spleen (Figure 8 F) and IECs (Figure 8 H) is similar in wt and SPI-2-deficient WITS and 
slightly increased in the mutant infection in the MLN (Figure 8 G). Between 2 and 4 dpi, a significant 
increase in the number of wt bacteria could be detected in all investigated organ compartments that 
was absent in the SPI-2-depleted tagged strains. This suggests an initial dissemination event after oral 
infection independent of SPI-2 effector protein translocation that is fueled during disease progression 
via SPI-2 effectors. Bearing in mind previous experiments, this seems to be limited to the neonatal 
period (Figure 4). Considering the different distribution of subpopulations between the two types of 
infection (Figure 7), a bottleneck for invading Salmonella seems to be imposed in neonates beyond the 
gut, similar to pathogenesis in adult mice (Lim et al. 2014). Overall, populations among different organs 
display high similarities in wt-background WITS infection, whereas subpopulations in systemic organs 
are distinct from the tag distribution in the intestine and MLN in the absence of SPI-2. 
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One-day old mice were orally infected with 104 (A-D) or 103 (E-H) CFU ∆sseB or 103 CFU wt Salmonella. 
The identity of tags from mixed infection with indivudually tagged Salmonella in the wt or ∆SPI-2 
background among different organs of the same animal are shown to display differences or simiartities 
in the distributions of subpopulations in the different tissues by violin diagrams. Only those tags with 
more than 1% of the reads were considered and their degree of identity between liver and spleen (A), 
liver and SI content (B), spleen and SI content (C) or MLN and SI content (D) was calculated per 
infection. Given plots respresent the median values (bold dashed line) and the sample distribution is 
indicated by the different quantiles (dotted lines within violins). The number of bacteria in different 
organs at 2 (open symbols) and 4 dpi (closed symbols) after oral infection with tagged strains are 
compared between wt (squares) and ∆sseB mutant (circles) in liver (E), spleen (F), MLN (G) and SI 
content (H). Student`s t-test to determine significant differences, a p-value ≥0.05 is displayed by 
labelling “ns”.  
 
3.2.3 MYD88 is not required for intracellular replication of ∆SPI-2 bacteria 
Neonates, in contrast to adults, harbor an immature immune system, especially regarding the adaptive 
immune response. As the gut is probably the most important interface between the sterile body 
interior and the environment, fast reactivity to invading pathogens is of particular importance for host 
survival. Especially during early stages of an infection, the innate immune system is highly essential in 
controlling replication of invading bacteria and their spread before an adaptive response can be 
initiated. Many TLRs, as potent receptors of the innate immune response, are known to be involved in 
recognition of Salmonella, including TLR2 (Tukel et al. 2005), TLR4 (O'Brien et al. 1980) and TLR5 
(Feuillet et al. 2006; Fulde et al. 2018; Uematsu et al. 2006). Hence, knockout of single TLRs or their 
Figure 8: SPI-2 effectors strongly influence systemic distribution of Salmonella. 
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adapter protein myeloid differentiation primary response 88 (MYD88) ultimately yields increased 
susceptibility in orally exposed adult mice (Sivick et al. 2014). In addition, the expression of SPI-2 and 
intracellular replication as well as SCV formation has been stated to be dependent on the acidification 
of the SCV, conceivably achieved via MYD88-dependent signaling cascades in bone marrow 
macrophages (BMMs) (Arpaia et al. 2011; Hapfelmeier et al. 2005). Due to these previous 
observations, we aimed at the identification of the role of MYD88-dependent TLR-signaling in neonate 
mice after SPI-2 mutant infection in the next step.   
The oral infection of Myd88 knockout (KO) mice with ∆SPI-2 Salmonella yielded comparable bacterial 
burden in the systemic organs as compared to B6N wildtype mice infected with the mutant strain.  
Slightly higher bacterial burden was detected in the spleens of Myd88 KO neonates (p=0.0043, Figure 
9 B), whereas colonization of liver, MLN and colon are unaffected in the absence of MYD88-signaling 
cascades. More mutants could be isolated from small intestinal tissue of Myd88-deficient neonates 
(p=0.0289, Figure 9 D). These findings already indicate that possession and secretion of SPI-2 effectors 
is non-essential for bacterial survival even in the absence of MYD88. We next examined whether a lack 
of downstream TLR-signaling via MYD88 influences the capability to establish and maintain SCVs inside 
infected host cells in the neonatal intestine, as has been suggested in earlier studies for BMMs (Arpaia 
et al. 2011). Immunofluorescence of ∆SPI-2 infected small intestinal sections of neonatally infected 
Myd88-/- mice validates SCV formation without MYD88-dependent TLR-signaling at 4 days p.i. (Figure 
9 F-H). Neither the number of SCVs (Figure 9 F) nor their size (Figure 9 G) differed significantly from 
SCV formation in B6N neonates with intact MYD88 cascade, identifying the adaptor protein as 
non-essential in terms of SCV development in the neonate gut.  
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Figure 9: ΔSPI-2 STy can colonize the neonate gut and form SCVs in the absence of MYD88.  
One-day old B6N wt or knockout mice lacking the adaptor protein MYD88 were orally infected with 
102 CFU ∆sseB STy. Four days p.i., mice were euthanized, and bacterial loads investigated via replica 
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plating in liver (A), spleen (B), MLN (C), isolated intestinal enterocytes (D) and colon (E). Small intestinal 
tissue sections were stained as described (2.2.7) and the number (F) of SCVs in at least 20 fields of view 
from 3 different animals were determined, plus at leat 40 SCVs from 3 different animals for SCV size 
calculation (G). Student’s t-test with Mann-Whitney-U was used for statistical analysis to compare KO 
to B6N wt mice infected with ∆SPI-2 mutants, p≥0.05 is indicated by “ns”. Immunfluorescence of SCVs 
formed by ∆SPI-2 bacteria in Myd88-/- mice (H) reveals no difference in SCV formation capabilities of 
the mutant in the absence of MYD88 compared to B6N wt mice (Figure 6 A ii). Salmonella shown in 
green, E-cadherin in red, counterstaining with DAPI for DNA in blue, scalebar corresponds to 10 µm.  
3.2.4 The influence of functional NRAMP1 on NTS dissemination beyond 
the gut 
The commonly used mouse strain C57BL/6 allows versatile manipulations of host genetics in terms of 
receptors like TLRs, cytokines like e.g. interleukins or other messengers and mediators of the adaptive 
and innate immune response. However, one major shortcoming in the examination of pathogenesis of 
intracellular bacteria is a point mutation in Slc11a1 gene, leading to nonfunctional expression of 
natural resistance-associated macrophage protein 1 (NRAMP1), expressed primarily in late 
phagolysosomes of macrophages, but also in neutrophils and DCs (Blackwell et al. 2000; Canonne-
Hergaux et al. 2002; Forbes and Gros 2001). Mutations, e.g. by an amino acid substitution in C57BL/6 
and BALB/c mice resulting in a non-functional protein, have been associated with the innate 
susceptibility of mice to infection with a group of unrelated intracellular parasites, including 
Mycobacterium bovis, Salmonella Typhimurium, and Leishmania donovani (Vidal et al. 1995). 
Furthermore, polymorphisms in Nramp1 were demonstrated in association with increased 
susceptibility to tuberculosis and certain autoimmune disorders in humans (Bellamy et al. 1998; 
Blackwell et al. 2001). Consequently, we were interested in the degree of influence of a functional 
NRAMP1 in the neonate host and especially in NRAMP1-mediated killing influenced by the presence 
or absence of SPI-2. 
As expected, comparison of wt Salmonella infection in B6N wt (NRAMP1 negative) and Nramp+ 
age-matched mice revealed significantly lower viable bacterial counts in systemic tissue in the 
presence of functional NRAMP1 (p<0.0001 and p=0.0004, Figure 10 A-B), whereas colonization of the 
gut and mesenteric lymph node is unaffected by the presence or absence of a functional allele (Figure 
10 C-E). In contrast to this, if SPI-2 is depleted, functional NRAMP1 is irrelevant for bacterial burden in 
any investigated tissue (Figure 10 A-E). Overall, this indicates that the pathogen’s virulence factor set 




One-day old C57BL/6N (black symbols) or Nramp1r/r mice harboring a functional Nramp1 allele (red 
symbols) were orally challenged with 102 CFU wt (squares) or SPI-2-deficient (circles) Salmonella. At 4 
days p.i., mice were sacrificed and the bacterial burden of given organ compartments was determined 
via replica plating for liver (A), spleen (B), MLN (C), IECs (D) and colon (E).  
 
Table 11: Ratio of wt vs ∆SPI-2 Salmonella in B6N and NRAMP1+ neonatal mice 
Results from oral infection experiments with wt and ∆SPI-2 Salmonella in B6N and Nramp1+ mice as 
ratios between wt STy CFU/ml compared to ∆sseB CFU/ml (Figure 10). A ratio of e.g. 2.28 indicates 
2.28 x more wt bacteria in the respective organ as compared to tissue isolated from neonates infected 
with the mutant strain. The mean of each column is shown in bold letters in the last row.  
liver spleen MLN SI colon 
B6N Nramp+ B6N Nramp+ B6N Nramp+ B6N Nramp+ B6N Nramp+ 
5.68 11.34 2.28 0.57 4.84 1.90 0.11 0.33 5.55 4.49 
1.09 18.43 545.63 0.11 17.78 17.36 0.15 0.44 0.28 0.30 
409.39 17.64 212.80 2.53 512.88 17.43 0.28 0.44 1.35 2.60 
1069.99 16.69 436.51 0.64 66.51 1.45 0.96 0.17 1.05 0.35 
214.00 7.95 76.39 1.07 24.73 1.48 0.49 0.01 0.06 0.02 
9.89 15.59 4.91 2.16 84.48 17.12 0.14 0.30 0.50 0.09 
225.01 14.61 213.09 1.09 101.62 9.41 0.04 0.19 2.38 8.26 
276.44 12.82 209.77 1.18 116.12 9.46 0.31 0.27 1.60 2.30 
Figure 10: Functions of NRAMP1 in wt and ∆sseB STy pathogenesis 
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3.3 SCV formation and maintenance in the absence of SPI-2 
3.3.1 ∆SPI-2 Salmonella stably maintain SCVs during the suckling period 
Preceding experiments identified SPI-2 as a negotiable factor concerning SCV formation in the neonate 
small intestine (Figure 6). So far, we only investigated one particular time point and next addressed 
the question, whether SCVs could not only be established, but also maintained by bacteria lacking 
modulation strategies ensured by SPI-2 effector proteins (Figueira and Holden 2012).  
Within 12 days after oral application of the ∆SPI-2 mutant, the number of SCVs inside intestinal 
enterocytes of neonatally infected mice remained relatively constant (Figure 11 A). Simultaneously, 
the bacterial vacuoles continuously increased in size (Figure 11 B+C). Between 12 and 14 dpi, a drop in 
both number and size of mutant SCVs was observed. Immunofluorescent microscopy pictures suggest 
an increasing number of bacteria per vacuole during host maturation (Figure 11 C). This hints at 
intracellular replication of SPI-2-deficient STy inside the neonatal enterocytes up to at least 12 dpi.  
One-day old mice were orally infected with 102 CFU ∆sseB Salmonella. At indicated points of time, mice 
were sacrificed and the number (A) and size (B) of SCVs during the neonatal period was determined by 
Figure 11: Maintenance of SCVs in the small intestine during the neonate period 
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immunfluorescence of small intestinal tissue sections. Significance was calculated with ordinary one-
way ANOVA. Representative pictures demonstrate an increase in SCV size during the corse of infection 
with the SPI-2-deficient strain (C). Comparison of intracellular Salmonella (green) at 2 dpi (I, v), 4 dpi 
(ii, vi), 8 dpi (iii, vii) and 12 dpi (iv, viii), vacuoles progressively increase in size, as can be observed in 
enlarged views (v-viii) of i-iv. Counterstaining of DNA (blue) and E-cadherin (red), scale bars with sizes 
as indicated.  
 
3.3.2 Metabolic demands of SPI-2-deficient Salmonella 
Following, we verified intracellular replication in the absence of SPI-2. A prerequisite for replication is 
the generation of biomass. SPI-2 effector proteins, besides other host cell manipulations, allow the 
interaction with the host cell`s microtubule network and conversion of  the endosomal system into an 
extensive network of interconnected tubular vesicles, of which Salmonella-induced filaments (SIFs) 
were described to be linked to efficient nutrition inside the host cell (Liss et al. 2017). Despite lacking 
this property, sufficient nutrient supply seems to be feasible in the neonate gut, as indicated by 
ongoing size increase of mutants’ SCVs (Figure 11). Subsequently, we supposed fusion of the SCV with 
endosomal vesicles of the host cell and conducted an experiment to follow endosomal particles in the 
next step.  
After oral application of gold nanoparticles in BSA/PBS solution at 3 days p.p., their localization was 
stated within vacuoles in the small intestine, most likely taken up into the host cell via micropinocytosis 
and fusion of the endosomal vesicle containing nanoparticles with intracellular storage vacuoles, 
typically seen in the neonatal gut (Figure 12 A-B) (Moon 1972; Skrzypek et al. 2007; Staley and Bush 
1985). If mice were infected with SPI-2-deficient Salmonella prior to nanoparticle application, EM 
pictures clearly demonstrate co-localization of applied gold particles and mutants` SCVs (Figure 12 
C-D). 
Figure 12: Endosomal fusion with vacuoles and SCVs in the neonatal SI epithelium 
One-day old mice were left untreated (A, B) or orally infected with 102 CFU ∆sseB Salmonella (C, D). At 
day 4 p.p. for the uninfected control animals or 3 dpi for infected animals, respectively, a solution of 
gold nanoparticles in BSA/PBS was administered orally every 8 hours. Mice were sacrificed 24 hours 
after first BSA gold administration, small intestinal tracts were removed and prepared for microscopic 
investigations via TEM (2.2.8). Transmission electron microscopy pictures of small intestinal sections 
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reveal localization of gold nanoparticles marked by yellow circles (B, D) kindly created by Urska Repnik. 
Image section in white squares in A and C are enlarged in B and D. Scale bars with sizes as indicated. 
These results indicate a fusion of endosomal particles not only with host cell vacuoles (Figure 12 A-B), 
but with mutants` SCVs as well (Figure 12 C-D). Salmonella is a well-known metabolic generalist, that 
subverts the host`s metabolic pathway for its own proper intracellular nutrition (Dandekar et al. 2012; 
Dandekar et al. 2014). Subsequently, we wanted to examine whether certain metabolites are essential 
for pathogenesis of Salmonella or SCV formation and maintenance in the absence of SPI-2.  
Hereinafter, we compared the infection of neonatal mice with the “single” ∆SPI-2 strain to double 
mutants lacking not only a complete T3SS-2, but in addition a functional mechanism for the uptake of 
peptides, glucose, amino acids or long-chain fatty acids. This comparative approach yielded similar 
bacterial burden in systemic organs, MLN, intestinal enterocytes and colon (Figure 13 A-E), suggesting 
that none of the tested metabolites significantly influences SPI-2-independent pathogenesis of STy. 
Since colonization rates of enterocytes in the small intestine in the absence of certain uptake 
mechanisms were similar to the ∆SPI-2 mutant strain, the assumption of functional SCV establishment 
in the double mutants seemed obvious. Indeed, neither the capability of SCV formation, nor their 
increased size relative to wt Salmonella differed in any tested ∆SPI-2 metabolic mutant strain in 
comparison to the ∆sseB strain (Figure 13 F-I). Hence, we concluded that the uptake of peptides, 
glucose, amino acids or fatty acids is dispensable for Salmonella concerning the first steps in 




One-day old mice were orally infected with 102 CFU of either SPI-2-deficient Salmonella (ΔsseB, black 
circles), or a ∆SPI-2 mutant strain additionally depleted in the uptake of a certain metabolite as follows: 
peptides (pep., yellow circles), glucose (gluc., blue circles), amino acids (a.a., red circles) or long-chain 
fatty acids (f.a., green circles). Mice were sacrificed 4 days p.i. and bacterial dissemination was 
determinded via replica plating of liver (A), spleen (B), MLN (C), IECs (D) and colon (E). Furthermore, 
the number (F) and size (G) of mutants’ SCVs was investigated in small intestinal tissue sections by 
immunofluorescence, representitavely shown for the glukose and glucose-6-phosphate (H) and amino 
acid uptake (I) mutants with Salmonella (green), DNA (blue) and E-cadherin (red). ANOVA with Dunn s` 
post-test, ns = p-value≥0.05. 
Figure 13: Single metabolic pathways are dispensable in neonatal NTS infections. 
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3.4 Transmigration of polarized enterocytes in the neonatal small intestine by 
Salmonella depends on SPI-2 effector proteins 
After the identification of SPI-2 as an expendable factor for intestinal colonization of the neonate gut, 
SCV development (3.2.1) and bacterial replication inside neonatal enterocytes in the SI (Figure 11), we 
wanted to pinpoint the function of SPI-2 in neonatal NTS infections.  
By histological investigations of wt and ∆sseB infected small intestinal tissue sections, we noticed a 
distinctive localization pattern of wt Salmonella, that could not be observed in a mutant infection. 
Immunofluorescence staining of small intestinal tissue infected with wt STy, capable of SPI-2 effector 
protein translocation indicated SCVs found in a basolateral position in relation to the nucleus of the 
host cell (Figure 14 A). This could be further validated by TEM pictures (Figure 14 B). To verify the 
observations, we quantified the localization of wt SCVs inside the host cell at 2 and 4 dpi (Figure 14 C). 
Whereas we detected approximately 75% of wt SCVs in an apical position at 2 dpi (white bar), the 
majority (55 %) of bacterial vacuoles stand basolaterally to the cell nucleus at 4 dpi (black bar) (Figure 
14 C). In contrast to this, SCVs formed by STy depleted of SPI-2 were found exclusively at the apical 
side of infected enterocytes (Figure 14 D) although intact membranes surrounded the huge SCVs of 
∆SPI-2 mutant bacteria, shown by TEM (Figure 14 E). Observations of ∆SPI-2 SCVs in terms of cellular 
localization match immunofluorescence and TEM pictures. Between 2 and 4 dpi, almost 100% of SCVs 
remained located apically inside enterocytes (white bars) (Figure 14 F). Overall, this proposes a 
requirement of SPI-2 effectors for transmigration of enterocytes from apical to basolateral, but not 
intracellular replication.   
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Figure 14: A lack of SPI-2 effectors eradicates SCV transmigration in polarized epithelial cells. 
SCVs formed in neonatal enterocytes in STy wt (A-C) and ΔSPI-2 (D-F) challenged mice at 4 dpi, 
infectious dose 102 CFU. Immunofluorescence (wt in A, ΔSPI-2 in D) of infected small intestinal tissue 
sections with localization of the SCVs (Salmonella, red) in relation to the cell nucles (depicted in blue) 
either at the apical or basolateral side of the polarized epithelial cells. TEM pictures of wt (B) and 
SPI-2-deficient (E) Salmonella in small intestinal tissue of neonatally infected mice at 4 dpi by Urska 
Repnik. Scale bars indicate given sizes, white boxes indicate zoom-ins depicted in the following picture 
(tenfold magnification). Broken lines indicate completely membrane enclosed SCVs inside the host cell, 
stars pinpoint single bacteria, N = nucleus. The SCVs formed by wt and ΔSPI-2 STy were categorized 
according to their localization to the nucleus as indicated in IF pictures (A+D) at 2 and 4 dpi. White bars 
indicate the amount of SCVs in an apical position, black bars SCVs basolateral to the nucleus. At least 
30 different cells from 3 different animals were evaluated. 
3.4.1 Single effectors for interaction with the host cell microtubule 
network are accountable for the SPI-2-dependent intestinal 
phenotype 
In the current work, we successfully verified functional SCV formation in the neonate small intestinal 
epithelium for SPI-2-deficient Salmonella. However, so far, only mutants depleted of the entire 
effector protein subset encoded by SPI-2 due to abrogated translocation by the T3SS-2 were 
investigated and their intestinal phenotype of enlarged SCVs compared to wt Salmonella (3.2.1) could 
not be fully clarified. Hence, we aimed at further identification of specific SPI-2 effectors responsible 
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for the observed phenotype. We therefore investigated single SPI-2 effector mutants in the neonate 
host in the following step. 
According to their purpose concerning modulation and manipulation of the host cell, effector proteins 
of SPI-2 can be clustered into different functional groups (Figueira and Holden 2012). Interestingly, 
those single SPI-2 effector mutants with a significantly decreased bacterial load in systemic organs 
compared to the wt strain, ΔsseF/G, ΔsifA and ΔpipB2, share the feature of a proven interaction with 
the host cell`s microtubule system (Figure 15 A-B). Other SPI-2 effector mutants investigated colonized 
liver and spleen to a similar degree than wt Salmonella at 4 dpi. Unlike the complete ∆SPI-2 mutant, 
ΔsseF/G and ΔpipB2 also exhibited decreased bacterial burden of the small intestinal tract (Figure 15 
C). We checked, whether the single SPI-2 mutants did not only resemble the systemic phenotype of 
∆SPI-2 Salmonella lacking the entire effector protein subset, but also the intestinal phenotype with 
unaffected SCV formation capability, but increased SCV size. Indeed, quantification of mutants` SCVs 
at 2 days p.i. revealed similar numbers in infected intestinal tissue sections as detected for wt 
Salmonella (Figure 15 D). Like the ∆sseB strain (Figure 6 C), single SPI-2 effector mutants investigated 
also formed larger SCVs than the wt strain (Figure 15 E), ΔsseF/G: p=0.0069, ΔsifA: p<0.0001 and 
ΔpipB2: p=0.0237). Summarized, those SPI-2 effector proteins ensuring interaction with microtubules 




Figure 15: Contribution of individual SPI-2 effector proteins to the observed phenotype 
Neonatal mice were orally infected with 102 wt Salmonella or mutants depleted of the indicated SPI-2 
effector protein. Four days p.i., mice were sacrificed and bacterial counts in the liver (A), spleen (B) 
and small intestine (C) were tested by replica plating. Bacterial strains lacking a SPI-2 effector protein 
with a proven interaction with the cellular microtubule system of the host are depicted in red. Results 
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represent median values of 1 to 3 independent experiments. Significance was calculated using ANOVA 
with Dunn`s multiple post-test. Differences with p≥0.05 are considered not significant and valid if not 
indicated otherwise. The number (D) and size (E) of SCVs formed by selected mutants (red circles) at 2 
days p.i. are represented compared to the wt strain (squares) additionally. Numbers were determined 
by evaluation of 20 fields of view from 3 different mice. SCV size was determined by measuring 40 SCVs 
from 3 distinct animals. Results represent median values, significance was calculated by ANOVA with 
Dunn`s multiple post-test. Differences to the wt strain were not significant unless indicated by the 
given p-value.  
Overall, ΔsseF/G, ΔsifA and ΔpipB2 mutant STy resemble the complete SPI-2-deficient phenotype in 
terms of reduced systemic dissemination (Figure 15 A+B), equal colonization of the intestinal tract as 
wt STy (Figure 15 C) as well as SCV formation and intravacuolar replication capability (Figure 15 D+E). 
These results suggest the investigated intestinal SPI-2-dependent phenotype to rely on single SPI-2 
effector proteins involved in microtubule interaction, SCV positioning and host cell transmigration. We 
finally checked, whether a combination of single effectors with an apparent phenotype would result 
in abrogation of enterocyte transmigration and systemic spread of mutants in the neonate. In the next 
step, we investigated the intestinal colonization and systemic dissemination of two multi SPI-2 effector 
mutant combinations that contribute to SCV localization and microtubule interaction (Figueira and 
Holden 2012). Similar to single SPI-2 mutants and the ΔsseB strain, a combination of distinct effectors 
from the same functional group resulted in decreased systemic spread compared to wt bacteria, but 
equal colonization of the gut of infected neonates.  
One-day old neonate mice were orally challenged with 102 CFU multi SPI-2 effector mutant strains and 
compared to bacterial numbers in STy wt (solid squares) and complete SPI-2-deficient mutants 




(circles). Multiple SPI-2 effector-deficient strains were both depleted of sifA, sseF/G and the 
corresponding chaperone sscB plus either pipB2 (labeled ΔpipB2, open triangles) or sseJ (labeled ΔsseJ, 
open rhombs). Animals were sacrificed at 4 dpi and investigated for bacterial number in total liver (A), 
spleen (B), MLN (C), IECs (D) and colon (E). Results indicate individual animals from one litter plus the 





The current study focusses on characterizing functions of Salmonella pathogenicity island-2 (SPI-2) in 
disseminative, non-typhoidal Salmonella infections of the neonate host. We applied a previously 
established oral infection model for neonate mice (Zhang et al. 2014) combined with a mutant 
possessing a genetic defect, rendering bacteria unable in assembling the type three-secretion 
system 2. Deletion of the SPI-2 effector protein subset results in an avirulent infection of the neonate 
with decreased systemic spread (Figure 3), as has been shown for adult mice (Hensel et al. 1995). 
However, SPI-2 mutants successfully established and maintained SCVs inside small intestinal 
enterocytes (Figure 6) clearly exhibiting intracellular replication (Figure 11) independent of 
MYD88-signaling (Figure 9). With similar colonization of the gut, SCVs formed by SPI-2 mutants were 
even significantly bigger in size than wt SCVs. This led us to the conclusion that SPI-2 effectors seem to 
be dispensable for intracellular replication and SCV formation in enterocytes of the neonatal small 
intestine. Certain SPI-2 effectors allow the interaction with the host cell microtubule network. In the 
absence of these modulators, like e.g. SifA, transmigration of enterocytes seems to be hampered, 
yielding to a “dead-end” for mutant bacteria within the SCVs, which finally prevents systemic disease.  
4.1 Functions of SPI-2 in the neonate host 
4.1.1 SPI-2 is crucial for systemic spread in the neonate host 
Attenuation of virulence for SPI-2-deficient Salmonella in the neonate mouse model is in line with the 
well accepted role of SPI-2 in intracellular survival (Gerlach and Hensel 2007) and systemic 
dissemination after oral infection in adult animals (Watson and Holden 2010). Consistent with the 
latter finding, bacterial burdens observed in this study in systemic organs and the MLN of mutants 
were markedly reduced compared to wt bacteria (Figure 3). In the adult gastroenteritis model, 
antibiotic treatment prior to oral Salmonella infection and a high infectious dose of 108 – 109 CFU is 
required for effective NTS infection (Barthel et al. 2003; Miki et al. 2017). Competition of the pathogen 
with the enteric microbiota is omitted in the neonate gut, which is only poorly colonized at the time 
point of oral challenge, explaining the sufficiency of a lower number of bacteria (102 CFU, 2.2.4). In 
general, it is commonly accepted that SPI-2 is of crucial importance in terms of replication in 
macrophages at systemic sites and that, in contrast to a ΔSPI-1 mutant, a SPI-2-deficient strain is 
avirulent in mouse models after intraperitoneal injection (Hensel et al. 1995; Shea et al. 1996; Ochman 
et al. 1996). A study by Grant and colleagues demonstrated the number of SPI-2-depleted bacteria per 
phagocyte to be higher than for wt STy, but that mutants displayed deficiencies in cell-to-cell spread 
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and establishment of new infection foci due to failures in host cell evasion, significantly contributing 
to virulence attenuation in the adult murine model (Grant et al. 2012). 
However, bearing in mind the assumption that successful intracellular replication strongly depends on 
proper SCV formation by SPI-2 effectors, equal colonization of the intestinal tract by wt and ∆SPI-2 STy 
is counterintuitive in the first place. To a large extent, this is attributable to the immature small 
intestinal epithelium constituting a unique environment, especially concerning metabolic demands of 
the intracellular pathogen (Bumann and Schothorst 2017; Noster et al. 2019) discussed later in this 
study (4.3.1). Complementation of sseB restores systemic dissemination capability. Compared to wt 
and SPI-2-deficient bacteria, the number of complemented mutants in intestinal enterocytes was 
slightly elevated, probably due to the incorporated plasmid for episomal expression (Table 13). 
4.1.2 The influence of host maturation on SPI-2-independent NTS 
pathogenesis 
Breaching the epithelial barrier in the intestine is considered the initial step in pathogenesis of 
NTS-infections (Muller et al. 2012). This might be facilitated by different mechanisms, classified into 
either direct, one-step, or two-step invasion strategies. Intestinal cryptopatches and isolated lymphoid 
follicles (ILFs), crucial for the intestinal immune system are formed after birth in mice. Specialized 
epithelial cells, known as microfold (M) cells, reside above ILFs and Peyer's patches and facilitate 
antigen transport from the lumen to the underlying lymphoid cells (Renz, Brandtzaeg, and Hornef 
2012). The invasion of Peyer`s patches via specialized M cells constitutes a potent entry port for 
Salmonella in a two-step process (Hase et al. 2009; Santos and Baumler 2004). In adult mouse NTS 
infections, the most distal Peyer`s patches in the terminal ileum are the primary site of intestinal 
invasion (Carter and Collins 1974; Jones, Ghori, and Falkow 1994). Since differences between proximal 
and distal small intestine as well as between enterocytes isolated from the two distinct gut 
compartments became more apparent with ageing of the host, findings from previous studies are 
supported (Figure 4).  
Zhang and colleagues demonstrated the invasion pathway of Salmonella in mice to be highly age 
dependent. Incomplete M cell development in the neonate host forces bacteria to trigger 
SPI-1-induced enterocyte invasion and utilize an alternative two-step strategy by invading the 
absorptive mucosa, whereas fully mature M cells constitute the primary entry port in older animals 
(Zhang et al. 2014). Hence, a probable explanation for bacterial burden in small intestinal tissue and 
isolated enterocytes of juvenile mice is the onward appearance of functional M cells during host 
maturation (Figure 4 D-G). Nevertheless and in contrast to neonate mice, invasion of epithelial cells 
and SCV formation was not observed if animals were infected at a later age and SPI-2-independent 
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SCV formation only seems feasible at an early neonatal “window of opportunity” and in case 
Salmonella ends up in enterocytes (Renz et al. 2018). M cell frequency gradually increases along the 
proximal-distal axis of the small intestine, peaking in the terminal ileum (Pabst et al. 2005). This 
explicates the observation of more pronounced differences in bacterial loads between proximal and 
distal SI in older animals that could not be observed in neonatal mice (Figure 4 E+G). In addition to 
physiological increase in M cells, Salmonella triggers differentiation of enterocytes into M cells by the 
SPI-1 effector protein SopB (Rouch et al. 2016; Tahoun et al. 2012).  
Furthermore, a number of fundamental differences distinguish the neonate and adult gut epithelium 
in mice, e.g. in terms of the thickness of the protective mucus layer. In adult mice, mucosal 
translocation of Salmonella is strongly affected by the thickness and composition of the intestinal 
mucus (Zarepour et al. 2013; Zhang et al. 2014). Paneth cells, secreting a huge range of antimicrobial 
peptides in the intestinal crypts, are immature in newborn mice. This alters the expression profile 
during host maturation from a striking secretion of e.g. CRAMP in the neonatal period to a broader 
defensive peptide spectrum in the adult mouse (Menard et al. 2008). This shift in secreted 
antimicrobial peptides and the mature mucus layer form a defensive shield in adult mice, conferring 
protection against invading pathogens (Ayabe et al. 2000; Dupont et al. 2015; Salzman et al. 2003; 
Wilson et al. 1999). Finally, exfoliation of enterocytes, that participates in the constant renewal of the 
intestinal epithelium, is not yet established in newborn mice, revealing a major reason for 
gastroenteritis caused by NTS being usually self-limiting in healthy adults (de Santa Barbara, van den 
Brink, and Roberts 2003; Muncan et al. 2011). 
4.1.3 Intestinal inflammation is induced even in the absence of SPI-2 
effectors 
Besides the occurrence of mature M cells at 10 to 12 days p.p. (de Santa Barbara, van den Brink, and 
Roberts 2003; Harper et al. 2011), colonization resistance enabled by the progressively domiciling 
microbiota impedes intestinal invasion by Salmonella. In line with literature, initial enterocyte invasion 
by SPI-1 effectors induces a local inflammatory response within the first 6-8 hours after infection 
(Altmeyer et al. 2010; Bruno et al. 2009; Patel and Galan 2005) even in the absence of SPI-2, but this 
induction is only temporal and strikingly diminished compared to virulent wt bacteria at 4 days p.i. 
(Figure 5). SPI-1-induced activation of mitogen-activated protein kinase (MAPK) pathways leads to an 
enhancement in proinflammatory cytokine production, like e.g. interleukin-8, recruitment of 
polymorphonuclear leukocytes (PMNs) and induction of acute intestinal inflammation and 
macrophage cell death, further exacerbating inflammation (Bruno et al. 2009; Galyov et al. 1997; Lee 
et al. 2000; van der Velden et al. 2000). Gut inflammation caused by penetration of the intestinal 
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barrier by Salmonella was identified as a “double-edged sword” being detrimental and beneficial for 
pathogenesis simultaneously. Antimicrobial substances and reactive oxygen species diminish luminal 
bacteria on the one hand, but foster transmission and bacterial dissemination via the inflammatory 
response on the other hand (Maier et al. 2014; Santos et al. 2009). Exploiting the inflammation enables 
Salmonella to outcompete the inhabitant microbiota by utilizing tetrathionate as an electron acceptor, 
conferring a highly beneficial growth advantage in the lumen of the inflamed gut (Faber et al. 2017; 
Stecher et al. 2007; Winter et al. 2010). Inducing inflammation by intestinal invasion might provide 
benefits for Salmonella in terms of competition with other microbes in older mice rather than in 
neonates, explaining bacterial load of intestinal tissue in mice infected at later time points. However, 
the capability of SPI-2-independent SCV formation in intestinal epithelial cells seems to be limited to 
the neonatal period, as no SCVs were detected in mice infected at later stages. Furthermore, migration 
from the gut to the MLN is impaired in mice infected at 6 and 11 day p.p. and no mutants were detected 
in neither liver nor spleen of these animals (Figure 4 A-C). This leads to the assumption of a 
SPI-2-independent disseminative pathway from lymphoid organs to systemic compartments that is 
solely restricted to the neonatal period.  
4.2 SPI-2-deficient bacteria display an unexpected phenotype in the neonate 
intestine 
Previous studies identified SPI-2 as an indispensable requirement for SCV formation and hence 
effective bacterial growth and replication inside the host (Abrahams, Muller, and Hensel 2006). 
Nevertheless, SPI-2-independent replication in the cytosol of HeLa cells represents an alternative, but 
comparably slow duplication strategy observed in vitro (Malik-Kale, Winfree, and Steele-Mortimer 
2012). Other studies demonstrated Salmonella ∆SPI-2 mutants to be defective for replication in the 
cytosol of fibroblasts or macrophages (Beuzon, Salcedo, and Holden 2002). Indeed, to the best of our 
knowledge, only one particular study claims SPI-2-independent survival and replication of Salmonella 
Typhi in human macrophages (Forest et al. 2010). As SPI-2 was observed to be indispensable for 
replication in various cell lines in vitro in the majority of previous examinations (Ochman et al. 1996; 
Helaine et al. 2010), the assumption of defective replication of mutant Salmonella inside the host 
animal seems obvious (Cirillo et al. 1998; Hensel et al. 1998; Shea et al. 1999). This is underlined by 
studies revealing survival of ∆SPI-2 mutants in liver and spleen tissue, but limited to no detectable net 
growth in numbers (Salcedo et al. 2001; Shea et al. 1999). In line with this, SPI-2-independent SCV 
formation in epithelial cells, as far as we know, has never been observed before (Malik-Kale, Winfree, 
and Steele-Mortimer 2012).  
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Considering this well-accepted dogma, examination of unimpaired SCV formation potential in the 
absence of SPI-2 is quite astonishing (Figure 6). Bearing in mind replication defects of mutants lacking 
the effector proteins of SPI-2 described previously in certain cell lines, this does not seem to be 
applicable in the intestinal epithelium of neonate mice. SCVs formed in the absence of SPI-2 were even 
significantly bigger in size than those formed by wt bacteria with intact SPI-2 T3SS effector 
translocation. High intracellular growth rates of SPI-2-deficient Salmonella have been described after 
intravenous infection of adult mice in CD18+ phagocytes before (Grant et al. 2012). In addition to high 
intracellular bacterial densities of the mutants, hampered cell evasion and bacterial spread compared 
to wt bacteria was monitored. Cytotoxic effects accompanied by functions of SPI-2 effectors proteins, 
like e.g. SseL and SpvB, result in host cell death and hence have been demonstrated to influence the 
number of intracellular bacteria in vitro (Guiney and Fierer 2011; Rytkonen et al. 2007). Nevertheless, 
single effector mutants did not recreate heavily infected cell characteristics of the SPI-2 mutant. This 
includes reduced spread and increased number of mutants per cell in vivo observed in this and other 
studies (Grant et al. 2012). Findings in this neonatal mouse infection model match previous 
observations. However, in contrast to the study by Grant and colleagues, in which breaching the 
intestinal epithelial barrier was bypassed by i.v. injection, infection of neonate mice emphasized the 
urge of SPI-2 effectors to earlier phases of an infection during intestinal growth. Rather than due to 
hampered induction of apoptosis, higher bacterial densities of the mutant resulted from reduced 
cell-to-cell spread. In the absence of a functional NADPH oxidase, the number of infection foci of 
SPI-2-deficient mutants was similar to those in mice effectively producing ROS as a mechanism of 
innate host defense (Mastroeni et al. 2000; Vazquez-Torres, Jones-Carson, et al. 2000). Even though 
phagocytic NADPH activity might explain diminished systemic spread beyond the gut at least in part, 
the high intracellular densities and SCV formation of the SPI-2-deficient mutant in the neonate 
intestinal epithelium as examined in this study remains unclear.  
In agreement with the attenuated systemic phenotype, ΔSPI-2 Salmonella neither affect the brush 
border integrity of SCV-containing enterocytes in the small intestine of neonatal mice (Figure 6 D), nor 
induced any detectable tissue damage.  
4.2.1 Population dynamics of NTS pathogenesis and its dependence on 
SPI-2 effectors 
Co-infections with tagged bacteria offer insights into the dynamics of bacterial populations during the 
course of an infection clearly exceeding possibilities facilitated by “classical” infection experiments 
(Crimmins and Isberg 2012; Grant et al. 2008; Kaiser et al. 2013; Kaiser et al. 2014; Mastroeni and 
Grant 2011). Hence, WITS experiments constitute promising opportunities to gain deeper perceptions 
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into host-pathogen interactions, e.g. in therapeutic aspects and vaccine design (Lim et al. 2014; 
Martinoli, Chiavelli, and Rescigno 2007; Mastroeni et al. 2009; Michetti et al. 1992; Pabst 2012). A 
study by Lim and colleagues successfully identified independent colonization of the Peyer`s patches in 
the intestine, the lymphoid tissue and systemic sites, as well as bottlenecks during the infectious 
process imposed by the host organism in adult STy-infected mice (Lim et al. 2014). Furthermore, 
distinct cells of the innate immune system, decoyed to the lamina propria in the intestine by 
Salmonella-induced inflammation, were shown to be hijacked by the pathogen, carrying bacteria from 
the gut to systemic organs as a “Trojan horse”, thereby enabling systemic dissemination (Maier et al. 
2014).  
Like in other studies, contribution of WITS to the initial inoculum was not equal, but since the number 
of reads was multiplied with a calculated factor for final evaluation, the imbalance in WITS contribution 
to the inocula is counterbalanced and can be neglected (2.2.4). As holds true for the adult host, 
colonization of the neonatal intestine follows non-Darwinian selection processes with identical 
biological fitness and invasion capacities of each of the tested WITS (Figure 7). Obviously, spread of wt 
and SPI-2-deficient Salmonella follows entirely distinct patterns and processes, as demonstrated by 
high similarities among all investigated organ compartments in wt but not ∆SPI-2 infected neonates. 
Considering these findings, a disseminative route of wt bacteria, starting with SPI-1-facilitated 
intestinal enterocyte invasion, SCV formation and intracellular replication, followed by cell evasion and 
access to immune cells in the lamina propria, spread to the MLN and, finally, systemic dissemination, 
accompanied by bacteremia and multi organ failure, seems very likely. Analysis of the SI content, 
especially as compared to the SPI-2 mutant tagged strains infection, revealed unequal distribution of 
isolated tagged strains and an overall reduction in the number of different WITS in the wt background. 
Maier and colleagues already described this effect beforehand. In adult STy WITS infected mice, they 
observed a bottleneck limiting the diversity of the gut luminal pathogen population between day 1-4 
p.i. and a drop in cecal and fecal population densities at day 2 p.i. (Maier et al. 2014; Stecher et al. 
2007). On the one hand, this is partly explainable by the inflammatory response induced by the 
pathogen and, besides this, a phenomenon referred to as “blooming”, since the inflamed environment 
of the gut favors growth of STy in contrast to other bacteria. Nevertheless, even in adult mice harboring 
a mature adaptive immune system additive to the innate inflammatory response, the gut luminal 
pathogen population is only temporarily restricted by inflammation, because STy established 
strategies allowing subversion of the gut luminal inflammation and efficient colonization of this niche 
(Miki and Hardt 2013; Stecher et al. 2007). 
However, in the absence of SPI-2, population dynamics utilizing WITS in the ∆sseB background showed 
low similarities to the wt background WITS traced route of infection. A high proportion of different 
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tagged strains was isolated from the SI content, underlining previous observations and suggesting little 
to no selection in the intestinal lumen (Lim et al. 2014). To a certain extent, this is probably attributable 
to the diminished inflammatory response in the mutant infection compared to the wt (Figure 5) 
(Medzhitov 2007). Despite lacking functional SPI-2 effector translocation and the possibility to interact 
with the host cell`s microtubule network and modify endosomal trafficking by the aid of SPI-2 virulence 
factors, distribution of tags within SI content and the MLN of mutant infected neonates displayed many 
overlaps (Figure 7 B, Figure 8 D). This seems contradictory in the first place and demonstrates a 
SPI-2-independent migration pathway from the gut to lymphatics. On the other hand, infection of 
systemic tissue seems to originate from a different, unrelated pool of bacteria, as already observed for 
wt infection of adult mice using the streptomycin model (Lim et al. 2014; Maier et al. 2014). Salmonella 
Typhi is known to reach the gallbladder and reside in there, which could be applicable for STy as well 
(Ong et al. 2013; Zhang, Hornef, and Fulde 2015). Hence, the detected pool of WITS in systemic 
compartments might arise from the bile ducts, where, like in the intestine, colonization resistance by 
residing commensals is established postnatally and was probably not completed at 1 day p.p. 
(Fremont-Rahl et al. 2013; Jee et al. 2017). Reduced inflammatory host response caused by ∆SPI-2 STy 
infection abolished bottleneck formation in the gut, in contrast to the wt infection, which elicited 
apparent histopathological damage (Figure 5) (Hapfelmeier et al. 2005). These results reflect literature 
knowledge, e.g. that the degree of inflammation fuels WITS-diversity loss and the suggestion that the 
grade of inflammation dictates the efficiency of the intestinal epithelial barrier at least in part 
(Ackermann et al. 2008; Diard et al. 2013; Ilg et al. 2009; Stecher et al. 2008). The key role of 
inflammation in bottleneck imposition and maintenance of barrier integrity is further supported by 
transmission of disseminative features to the SPI-2 mutant tagged strains in mixed infection 
experiments with wt background WITS (Maier et al. 2014). The observed reduction in luminal WITS 
diversity in wt infected adult mice gained in other studies as well as in neonates in this study was 
ascribed to granulocytes and probably ROS-mediated killing mechanisms previously (Maier et al. 2014). 
Tissue infiltration and transmigration of granulocytes into the gut lumen constitutes a hallmark of 
Salmonella-induced inflammation, hence this bottleneck is pronouncedly examined in virulent WITS 
infection, but not in the ∆SPI-2 background (Kaiser et al. 2012). Still, dissemination to the MLN does 
not seem to be impaired in the absence of SPI-2 and might be facilitated via DC-mediated transport of 
Salmonella, as suggested earlier (Voedisch et al. 2009). DCs constitute an innate immune cell 
population beneath the epithelial barrier already present at birth in mice (Torow et al. 2015). 
Consistent with this assumption, luminal sampling of Salmonella within the intestine has been 
proposed as a strategy to overcome the epithelial barrier without SPI-1-mediated cellular invasion 
(Sansonetti 2002).  
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The population similarities within wt infected liver and spleen compared to the SI content most 
probably originate from a disseminative route of bacteria as described before. In more detail, the 
populations isolated from systemic tissue might be the result of accumulative individual, autonomous 
processes: first, bacteria might reach the liver via the bile duct. Second, DCs sample gut luminal 
bacteria or a paracellular pathway is utilized in terms of a “leaky gut” and pending gut closure allows 
spread to the MLN and systemic organs independent of SPI-2 and without intestinal enterocyte 
invasion (Vukavic 1984; Walker 1979). Third, bacteria invade the epithelial layer in the SI, replicate 
within SCVs, evade the host cell and spread systemically in a continuous, self-accelerated process, 
reinforced by massive tissue destruction and immune cell infiltration to the lamina propria. 
Alternatively, single vacuolated bacteria might traverse the epithelial layer without replication inside 
SCVs in the gut in a SPI-2 independent manner. These processes lead to assimilation of the systemic 
population to WITS detected in the intestine. As this population alignment is absent in WITS harboring 
a SPI-2-deficient background, the third pathway is considered the major one for NTS in the neonate 
host. Synergy of different processes sums up to dissemination to systemic organs, supported by the 
finding of an accumulation of bacteria in systemic tissue of wt, but not ΔSPI-2 tagged STy between 2 
and 4 dpi (Figure 8 E-H). 
4.2.2 Functions of MYD88-signaling in NTS pathogenesis in the neonate 
The mammalian host poses various challenges to an invading pathogen, due to its complex nature and 
distinct environments the pathogen is exposed to during the course of infection. As expression of 
virulence factors is highly costly, the extracellular environment is commonly used by a large variety of 
pathogens to regulate their expression profile and rapidly respond to environmental changes (Brown 
et al. 2005). Various signals have been implicated in the transcriptional induction of intracellular SPI-2 
gene expression in other studies (Chakravortty et al. 2005; Deiwick and Hensel 1999). Acidification of 
the phagolysosome belongs to the most prominent host cell stimuli required for functional SPI-2 
effector transcription and translocation (Cirillo et al. 1998; Deiwick et al. 1999; Deiwick and Hensel 
1999; Rappl, Deiwick, and Hensel 2003). In accordance to this, rapid acidification by TLR-signaling has 
been identified to be crucial for intracellular survival, replication and SCV formation of Salmonella in 
BMMs beforehand (Arpaia et al. 2011). Failure to decrease pH inside the vacuole leads to insufficient 
SPI-2 gene induction and hampers intracellular replication of the pathogen in macrophages isolated 
from TLR-deficient mice. More globally, despite replication deficiencies in BMMs lacking TLR2, TLR4 
and TLR9, KO animals were examined to be less susceptible to STy wt infection, because the pathogen 
was unable to induce sufficient SPI-2 gene expression in the absence of TLR-signaling (Arpaia et al. 
2011). Indeed, T3SS-2 was dispensable in the absence of TLR2, 4 and 9 signaling after systemic 
administration via intraperitoneal (i.p.) infection of adult animals and wt and SPI-2-deficient bacteria 
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were isolated in equal amounts from systemic tissue early (Sivick et al. 2014). In contrast to this, oral 
infection mimicking natural NTS infection depends on the SPI-2 T3SS, even in the absence of 
TLR-signaling (Sivick et al. 2014). In the neonate mouse model applied in this study, SPI-2-deficient STy 
were avirulent after oral infection as well, but unlike investigations by Sivick and colleagues, induction 
of SPI-2 gene expression was possible in intestinal enterocytes lacking downstream TLR-signaling via 
MYD88. Furthermore and in contrast to BMMs, replication and SCV formation in the absence of 
functional SPI-2 effector protein translocation was feasible in MYD88 knockout mice (Figure 9 F-G). 
Other studies also examined SPI-2 expression without intracellular acidification or even epithelial 
penetration in the ileal lumen of orally challenged mice (Brown et al. 2005). Hence, acidic pH seems to 
be a potent stimulus rather than crucial necessity to induce SPI-2 gene expression in vivo. In the 
absence of TLR-signaling cascades, other environmental cues are obviously exploited by Salmonella to 
induce SPI-2 gene expression (Sivick et al. 2014). 
Besides facilitating rapid phagosomal acidification, recognition of Salmonella and other invading 
pathogens via PRRs as a central part of the innate immune system is of crucial importance in neonates. 
This holds true with special respect to the immature and time consuming adaptive immune response 
(Woolhouse et al. 2002). TLRs recognize a variety of conserved microbial ligands associated with 
invading pathogens, so-called PAMPs (Janeway 1989; Medzhitov 2007). Recognition of S. Typhimurium 
is primarily mediated by TLR2, TLR4 and TLR5, binding lipoproteins, lipopolysaccharides and flagellin, 
respectively (Fulde et al. 2018; Royle et al. 2003; Vazquez-Torres et al. 2004). According to literature, 
mice depleted in TLRs, especially TLR4, display higher susceptibilities to STy infection (Weiss et al. 
2004). Still, unlike previous studies, intracellular replication and SCV formation in the neonate intestine 
is obviously feasible in the absence of MYD88-signaling cascades. At least in part, this might be 
attributable to TRIF-dependent signaling via TLR4 in MYD88 KO mice (Stockinger et al. 2014). This can 
not be excluded by our findings, but still seems rather unlikely considering the fact that SCV formation 
of the ΔSPI-2 mutant is highly similar in the presence and absence of MYD88 (Figure 9 F-H). Recognition 
of bacterial ligands by cell surface or endosomal TLRs can initiate signaling cascades via MYD88, 
ultimately leading to e.g. cytokine, chemokine or antimicrobial peptide production (Newton and Dixit 
2012). Bearing in mind initial upregulation of inflammatory cytokines upon enterocyte invasion in the 
absence of SPI-2 (Figure 5), this study emphasizes the uniqueness of the neonate intestinal epithelium, 
allowing formation of a replicative compartment in the absence of a huge subset of virulence factors 
and host cell derived innate immune signaling.  
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4.2.3 Contribution of functional NRAMP1 to NTS pathogenesis in the 
presence and absence of SPI-2 effectors 
Adult NTS-susceptible C57BL/6 mice, which express the mutant Nramp1D169 allele, were identified 
being unable to control acute infection with STy after i.p. or oral inoculation (Loomis et al. 2014). As 
demonstrated earlier, this is rather due to counteraction of NRAMP1 against the ability of Salmonella 
to prevent lysosomal degradation inside the SCV. This allows the normal degradative pathway of 
macrophages to proceed and eradicate the pathogen in the presence of functional NRAMP1 (Cuellar-
Mata et al. 2002). Furthermore, NRAMP1 alters the maturation pattern of the SCV in cultured 
phagocytic cells, like RAW264.7, and can mediate the up-regulation of SPI-2 virulence genes in the 
murine typhoid model (Zaharik et al. 2002). Nevertheless, Zaharik and colleagues described a necessity 
for SPI-2 effector translocation for functional replication in splenic tissue of Nramp+/+ mice.  
As one would expect considering absence of NRAMP1 in cells of the epithelial barrier lining, effects by 
possession of functional NRAMP1 of mice only became apparent beyond the gut in systemic tissue and 
lymphatics, harboring immune cells such as macrophages, neutrophils and DCs expressing the ion 
channel in their cell membranes (Fritsche et al. 2012). Like in the adult host, incorporation of a working 
Nramp1 dramatically reduced bacterial burden in systemic tissue in the fully virulent wt Salmonella 
strain infection (Figure 10 A-C). The number of ΔSPI-2 mutants, as compared to the wt strain, was 
reduced in Nramp+ neonates, although to a smaller extent than in the absence of NRAMP1-mediated 
killing (Table 11, Figure 10). However, genetic background of the pathogen had a far greater impact on 
bacterial loads in systemic organs than the host’s genotype. Infection experiments were terminated 
after 4 days, nevertheless complete protection to STy wt infection in Nramp+ neonates is rather 
unlikely. More probable, higher effectivity in killing the pathogen by macrophages and leukocytes only 
delays pathogenesis but flooding of bacteria from the intestine into the blood stream and systemic 
organs remains lethal to the immature host. Furthermore, as demonstrated earlier, greater 
splenomegaly, blood neutrophil and monocyte counts, as well as higher proinflammatory serum 
cytokine and chemokine responses were investigated in adult mice C57BL/6 Nramp1G169 with restored 
NRAMP1 compared to Sv129S6 mice with an intact allele. This suggests that other host factors, besides 
NRAMP1, are involved in resistance against NTS infection (Brown et al. 2013; Loomis et al. 2014). 
4.3 SCV formation and maintenance in the absence of SPI-2 
The major understanding of NTS pathogenesis states that distinct virulence systems operate during 
the intestinal and systemic phases of infection and that these virulence systems display little overlap 
in their spatiotemporal activation (Brown et al. 2005). Our studies so far demonstrated that SPI-2 is 
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dispensable in terms of SCV formation and intracellular replication in the neonate intestine (Figure 6). 
However, during maturation, major changes influence physiology of the intestinal epithelium (Chassin 
et al. 2010; Renz, Brandtzaeg, and Hornef 2012). We decided to investigate consequences of intestinal 
development on intracellular SPI-2 mutants in the next step and examined mutants` SCVs until 
weaning. Surprisingly, SCVs are not only stably maintained during the first 12 days after oral challenge 
of neonates, but furthermore even progressively increase in size (Figure 11). This was completely 
unexpected, as one major function of SPI-2 effectors is the formation of tubular extensions, called 
Salmonella-induced filaments (SIFs) from the SCV, thereby rendering it a replicative niche by ensuring 
appropriate nutrient supply (Birmingham et al. 2005; Brumell, Tang, et al. 2001; Krieger et al. 2014). 
Although this is no longer feasible in the absence of a functional SPI-2 T3SS, mutants preserved their 
intracellular vacuolar compartment and increased in numbers inside infected enterocytes, most 
probably due to ongoing bacterial replication. Since the number of SCVs remained relatively stable, 
but establishment of new SCVs due to luminal re-infection seems very unlikely (3.1.2), the most 
probable explanation for the observed phenotype is initial SPI-1-mediated enterocyte invasion, 
SPI-2-independent SCV formation and intracellular replication. Although an initial inflammatory 
response via e.g. RegIIIγ expression could be monitored in the absence of SPI-2, expression adjusted 
to levels detected in uninfected control mice over time (Figure 5), indicating no harm to the host cell 
by intracellular SPI-2 mutants and supported by the finding of intact cell membrane and brush border 
(Figure 6 D). The drop in SCV number between 12 and 14 days p.i. perhaps results from intestinal 
maturation, involving stem cell development, intestinal crypt formation and cell renewal (Renz, 
Brandtzaeg, and Hornef 2012). Nascent desquamation leads to the loss of infected epithelial cells and 
intestinal clearance over time.  
4.3.1 Unique metabolic properties of the neonatal intestinal epithelium 
influence metabolic demands of Salmonella 
As for very many other pathogens, survival of Salmonella highly depends on successful adaptation to 
the different environmental features that bacteria need to face during pathogenesis. This especially 
holds true concerning intracellular metabolism and bacterial proliferation inside the host cell. 
Salmonella is known as a metabolic generalist, capable of utilizing a huge variety of distinct substances, 
including e.g. mono- and disaccharides, fatty acids and peptides (Dandekar et al. 2012; Dandekar et al. 
2014).  However, in the current understanding, SPI-2 effectors were crucial for intracellular survival in 
terms of formation of tubular extensions from the SCV in different host cells. These tubular, 
membranous extensions from the SCV observed in HeLa cells, termed 'Salmonella-induced filaments' 
or SIFs were shown to contain lysosomal membrane glycoproteins, indicative of vesicular fusion and 
thus might be of particular importance for Salmonella concerning intracellular nutrition (Garcia-del 
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Portillo et al. 1993). Additionally bearing in mind the special properties of the neonatal intestine during 
the suckling period, we wanted to examine intracellular metabolism of Salmonella in the absence of 
SPI-2 in more detail. Increase in SCV size and bacterial numbers per SCV observed in this study is most 
likely attributable to ongoing bacterial replication, and this generation of new biomass depends on the 
utilization of certain metabolites and proper nutrition (Figure 12) (Liss et al. 2017; Sindhwani et al. 
2017). Microcolony formation was demonstrated to result from invasion of a single bacterial cell rather 
than clumps of bacteria as a process of clonal expansion (Grant et al. 2012; Zhang et al. 2018). Opposing 
to this, SPI-2-deficient mutant bacteria were isolated from the intestinal tract of orally challenged 
neonates at a similar rate as wt bacteria, indicating that intracellular nutrition and replication of 
Salmonella is obviously independent of SPI-2 effector protein functions and SIF formation (Figure 3). 
Detection of orally applied gold nanoparticles in BSA/PBS solution in uninfected vacuoles as well as 
SCVs of SPI-2-deficient Salmonella gives hints to the assumption of endosomal or lysosomal vesicles 
fusing with enterocytic vacuoles, as well as membrane-enclosed accumulations of mutants inside the 
host cell (Figure 12). Nevertheless, intracellular mutant bacteria are not killed and degraded by the 
host cell, but instead retain their SCV inside enterocytes without harming the host cell for at least 12 
days p.i. (3.3.1). This resembles recent findings, demonstrating an accumulation of lysosomal proteins, 
like e.g. LAMP1, in the SCV without enrichment in lysosomal hydrolases (Domingues, Holden, and Mota 
2014; Steele-Mortimer 2008). Intestinal growth, dissemination to systemic organs and establishment 
of SCVs of mutants defective in SPI-2 effector translocation as well as the uptake of either sugars, 
peptides, amino acids or long chain fatty acids was almost identical to the behavior and traits of the 
SPI-2 mutant fully functional in uptake of all mentioned substances (Figure 13). As a consequence, 
none of these substances seems to be crucial for SCV formation and intracellular nutrition in the 
neonate host. Usually, attenuated virulence of auxotrophic mutant Salmonella is based on defective 
intracellular replication due to auxotrophies in a murine model of typhoid fever (Fields et al. 1986). In 
these adult animal models, the SCV is commonly considered as a nutritional deprived environment 
(Mastroeni et al. 2009). Functional replication of mutants defective in the uptake of certain common 
metabolites in the neonate gut matches the commonly accepted understanding of the generalized 
metabolic properties and demands of Salmonella observed in other studies (Bowden et al. 2009; Lim 
et al. 2010; Steeb et al. 2013). In neonatal NTS infections, Salmonella appears to be capable of 
exploiting the unique features of the intestinal enterocytes for intracellular survival and proliferation.  
Overall, findings of these studies assemble to the following presumption: Unique metabolic demands 
and transport machineries of the neonate intestine favor strong vacuolation of enterocytes and 
formation of enlarged vacuoles inside the gut in early life of different mammals. Virulence factors 
encoded by SPI-2 enable Salmonella to modulate the host cell system in various ways, including 
82 
 
interactions with the endocytic pathway and manipulation of the endosomal trafficking network 
(Domingues, Holden, and Mota 2014; Figueira and Holden 2012). A population of so-called foetal-type 
enterocytes or vacuolated foetal enterocytes (VFE) is solely found in newborns and vanishes as the 
intestine matures (Moon 1972; Skrzypek et al. 2007). Uptake and transfer of macromolecules from the 
gut lumen across the epithelial barrier responsible for nutrition and acquisition of maternal 
immunoglobulins is a non-selective process (Palm 2019; Walker and Isselbacher 1974). NTS are taken 
up or actively invade enterocytes at the apical side, irrespective of possession of SPI-2. In the neonate, 
Salmonella might accidentally end up in giant vacuoles distinctive of VFEs. Even in the absence of 
effector proteins crucial for virulence in adult and neonate mice and formation of SIFs, host-induced, 
passive processes seem to facilitate fusion of endosomal vesicles with the SCV. Consequently, 
intracellular replication and proliferation of Salmonella is feasible in the absence of SPI-2 effectors and 
establishment of an extensive interconnected tubular network in the neonate gut.  
4.4 SPI-2 effector proteins function in transmigration of enterocytes in the 
neonate small intestine instead of SCV formation 
Considering SPI-2 to be superfluous in terms of SCV formation, we next considered a passive or host 
cell-mediated process concerning vacuole formation inside the neonates` intestinal tracts. So far, we 
identified the phenotype of a SPI-2-deficient Salmonella strain as being entirely different from effects 
observed in macrophages or other isolated cells cultured in vitro. We observed the striking contrast of 
unaffected SCV formation and intracellular bacterial proliferation of the mutant. However, the 
function of SPI-2 in the neonate gut remains ill defined.  
Although the induction and regulation of SIF formation via SPI-2 effectors appears to be crucial in adult 
animals and mature host cells in general, in terms of intracellular nutrition and proliferation, the 
neonate gut constitutes a special environment with regard to metabolic properties and biochemical as 
well as structural characteristics (Noster et al. 2019). Besides the immature intestinal barrier in 
neonate mammals, especially the distal small intestine harbors highly endocytic vacuolated 
enterocytes (Arevalo Sureda et al. 2016). In contrast to adults, macromolecules can be transferred 
across the SI epithelial barrier by transcellular endocytosis from the gut lumen into the blood 
circulation (Kumagai et al. 2011). Previously mentioned VFEs can be recognized by the possession of 
large or giant vacuoles, which can be subdivided into two distinct types: giant transport and giant 
digestive vacuoles (Skrzypek et al. 2018). These enterocytes, enabling important functions in transport 
of maternal immunoglobulins and other molecules across the epithelial barrier, were detected in many 
mammals, including humans, pigs and rodents such as rats and mice (Dekaney, Bazer, and Jaeger 1997; 
Kraehenbuhl, Bron, and Sordat 1979; Moxey and Trier 1979; Muncan et al. 2011). Transport vacuoles 
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engulf luminal content via endocytosis, move to the basal part of the enterocyte and release their 
content via exocytosis into the underlying intercellular space. Digestive vacuoles, in contrast, were 
predominantly detected above the nucleus in piglets and often occupy up to ⅔ of the enterocyte s` 
volume (Skrzypek et al. 2018). During transition from a milk-digesting to a solid food-adapted network 
at weaning, morphological changes are accompanied by functional adaptations, leading to gradual 
disappearance of vacuolated enterocytes and reduced permeability to macromolecules (Remis et al. 
2014; Walthall et al. 2005). This transport of molecules into the blood is non-selective, while biological 
activity of enterocytes is preserved (Babbar et al. 1990; Seifert and Sass 1990). Under these unique 
circumstances, the neonate intestine probably provides ideal conditions for intracellular nutrition and 
replication of NTS, irrespective of certain virulence determinants. 
4.4.1 ∆SPI-2 SCVs occupy an apical position in neonatal intestinal 
enterocytes 
Upon examination of giant ∆SPI-2 SCVs in the neonate gut, we observed a typical localization in an 
apical nuclear position, whereas wt SCVs were also detected basolateral to the host cell nucleus (Figure 
14). Documentation of the SCV positions during the first 4 days of NTS infection revealed that 55 % of 
wt bacteria managed to transmigrate the epithelial cell in the neonate intestine. Against this, the 
overwhelming majority of SPI-2-deficient SCVs remained in an apical position of the infected 
enterocytes without passing the nucleus throughout the observed period (Figure 14). This is not too 
surprising, keeping in mind that different effectors of SPI-2 function in membrane dynamics, vesicular 
trafficking and intracellular positioning of the SCV are missing(Abrahams, Muller, and Hensel 2006; 
Bakowski, Braun, and Brumell 2008; Figueira and Holden 2012; Ramsden, Holden, and Mota 2007; 
Schroeder, Mota, and Meresse 2011). In addition, SPI-2-deficient Salmonella were shown to have high 
tendencies to remain in an apical position within infected enterocytes in adult animals before, whereas 
wt bacteria functionally traversed the epithelium, exited at the basolateral side and gained excess to 
the lamina propria (Muller et al. 2012). However, in adult animals, single cells rather than SCVs where 
detected inside intestinal host cells so far.  
4.4.2 Single SPI-2 effector proteins are responsible for the observed 
phenotype of mutants in the neonatal intestinal epithelium 
Effector proteins of SPI-2 enable a versatile variety of functions concerning interferences and 
alterations of host cell processes.  These  include  maintenance of  SCV membrane integrity and its 
proper localization near the Golgi of host cells, modulations of the host cytoskeleton and restriction of 
immune signaling (Figueira and Holden 2012). Aiming at the identification of the SPI-2 effector eliciting 
the investigated phenotype of enlarged SCVs in the neonate intestine, single SPI-2 effector protein 
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knockout mutants were constructed and applied in the neonate NTS mouse infection model in the next 
step. The impact of certain SPI-2 effectors on virulence has been investigated in other studies 
beforehand, especially using adult mice and bovine infection models (Gulig and Doyle 1993; Gulig et 
al. 1993; Matsui et al. 2001; Rhen, Virtanen, and Makela 1989; Roudier, Fierer, and Guiney 1992; Tsolis, 
Townsend, et al. 1999). Predominantly, attenuated virulence in NTS infections in a SPI-2 effector 
mutant was attributed to a deficiency in maintaining vacuolar membrane integrity inside the host cell, 
leading to SCV disassembly and killing of cytosolic bacteria, e.g. in macrophages (Salcedo et al. 2001).  
Different features of SPI-2 effector proteins need to be considered when interpreting findings from 
single mutant infection experiments. First, the precise function of various effector proteins in terms of 
host cell modulation, manipulation or interference has not been fully unraveled so far and remains 
partially or completely unclear (Figueira and Holden 2012). Second, certain effectors have overlapping 
functions or redundancies. Third, single effector proteins attenuate or oppose the activity of others as 
counter players, for instance shown for the acyltransferase SseJ and SifA (Birmingham et al. 2005; Patel 
et al. 2019; Ruiz-Albert et al. 2002).  
By testing individual effector mutants, we were particularly interested in the identification of effectors 
that resemble the ∆sseB translocon mutant, depleted of translocation of the entire SPI-2 effector 
protein subset with regard to diminished spread to systemic tissue, but equal colonization of the small 
intestinal tract as well as SCV formation and maintenance capabilities like wt STy. Interestingly, 
depletion of the majority of tested effectors had no to little effect on systemic spread compared to wt 
Salmonella, except for ΔsseF/G, ΔsifA and ΔpipB2 isolated in decreased amounts from liver and spleen 
of infected neonates (Figure 15 A-B). Remarkably, all these effector mutants attracted attention by a 
reduced number in the intestine at 4 days p.i. (Figure 15 C). Other effectors involved in F-actin 
meshwork assembly and additional modifications of the host cell cytoskeleton, like SteC, SseI and 
SspH2 (Geddes et al. 2005; Miao and Miller 2000; Miao et al. 2003; Poh et al. 2008; Quezada et al. 
2009; Worley, Ching, and Heffron 2000), or those involved in ubiquitin modification and interference 
with host cell inflammatory responses via NF-κB, like SspH1 (Haraga and Miller 2003, 2006; Rohde et 
al. 2007), significantly contribute to attenuated virulence in the neonate host in sum, but single KO 
mutants displayed no phenotype (Figure 15 A-C). Deletion of the spvR operon, which significantly 
affected virulence in other infection models by facilitating NTS spreading, had no effect on neonate 
NTS pathogenesis (Figure 15) (Gulig and Doyle 1993; Gulig et al. 1993; Roudier, Fierer, and Guiney 
1992; Rhen, Virtanen, and Makela 1989; Matsui et al. 2001).  
A shared feature of single mutants that attracted attention concerning diminished systemic spread in 
the neonate host after oral infection is a proven interaction with the host cell microtubule network, 
SIF formation and extension (Abrahams, Muller, and Hensel 2006; Boucrot et al. 2003; Diacovich et al. 
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2009; Dumont et al. 2010; Henry et al. 2006; Knodler and Steele-Mortimer 2005; Kuhle and Hensel 
2002; Ohlson et al. 2008). On the one hand, a bunch of effectors with an observed phenotype play 
crucial roles in SCV membrane dynamics and integrity (SifA, PipB2) or the positioning of the SCV near 
the Golgi (SseF, SseG) (Beuzon et al. 2000; Deiwick et al. 2006; Stein et al. 1996). Quantification of 
mutant SCVs at 4 days p.i. clearly revealed the necessity of the respective effectors in maintaining SCV 
membrane integrity, for almost no bacterial vacuoles were detected inside enterocytes. However, 
foreshortening of the evaluation time point to 2 days p.i. illustrates the function of SseF/G, SifA and 
PipB2 in SCV membrane stabilization. Mutants lacking these proteins clearly tend to develop bigger 
SCVs than wt STy inside the neonate gut epithelium (Figure 15 D-E). Summarized, mutants deficient in 
SseF/G, SifA or PipB2 bear a resemblance to the ∆SPI-2 phenotype with diminished systemic spread 
and enlarged SCVs inside the SI. The destabilization of the SCV in single effector mutants ultimately 
leads to membrane rupture and bacteria being released into the host cell cytosol. This brings up the 
question of how these effectors contribute to pathogenesis in the neonate host. To clarify this, it is 
important to uncover their general function in host cells first.  
Maturation of SCVs in polarized epithelial cells is accompanied by basolateral movement of the 
vacuoles along host cell microtubules towards the juxtanuclear region. They end up at the 
microtubule-organizing center (MTOC), a structure found in eukaryotic cells from which microtubules 
emerge and where Golgi stacks accumulate (Harrison et al. 2004; Ramsden, Holden, and Mota 2007). 
This SCV drive is dependent on SPI-2 effectors evoking recruitment of dynein to the SCV via the 
interaction of RAB7 and Rap-interacting lysosomal protein (RILP) (Harrison et al. 2004; Guignot et al. 
2004). The maintenance of the specific position of the SCV near the MTOC/Golgi was discussed to 
facilitate bacterial replication, microcolony formation and endosomal-associated vesicular trafficking 
via the SPI-2 effector proteins SseF and SseG (Mota et al. 2009; Salcedo and Holden 2003). Since an 
SseF/G double mutant displays an identical phenotype to single mutants, including attenuated 
virulence and a growth defect in macrophages, both effectors are assumed to contribute to the very 
same function (Deiwick et al. 2006). SseF and SseG are integral membrane proteins that interact and 
thrive dynesin recruitment to microtubule bundles they form, leading to centripetal movement of the 
SCV in non-polarized, cultured epithelial cells (Deiwick et al. 2006; Kuhle and Hensel 2002; Kuhle, 
Jackel, and Hensel 2004). Furthermore, they have also been shown to be involved in SIF formation 
(Kuhle and Hensel 2002). A mutant depleted in either SseF, SseG or both effectors undergoes initial 
juxtanuclear migration and scatters throughout the cell as single bacteria instead of 
membrane-surrounded microcolonies or bacterial bundles (Deiwick et al. 2006; Ramsden, Holden, and 
Mota 2007). This seems to be applicable for the neonate mouse model, as mutants were hardly 
detectable inside SCVs at 4 days p.i. and a slightly reduced amount of bacteria was isolated from the 
gut, although the initial capability to establish SCVs is preserved in the absence of SseF/G (Figure 15 
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C-D). As a consequence, ΔsseF/G mutants are incapable of maintaining vacuolar integrity and the 
resulting instable SCV membranes highlight the role of these effectors in pathogenesis. 
A prominent example of a SPI-2 effector protein enabling various functions in NTS pathogenesis is SifA. 
Harboring a caspase-3 cleavage site, the effector is potentially divided into two functional domains 
with different interaction partners and features (Patel et al. 2019; Srikanth et al. 2010). Membrane 
tubules induced by Salmonella via translocation of the SPI-2 effector SifA have been discussed as a 
potential strategy to subvert the host cell endosomal system beforehand. Although the establishment 
of SIFs is not crucial for nutrition in the neonate enterocyte, SifA mutans gradually lose the vacuolar 
membrane surrounding them several hours after uptake into host cells, probably affecting 
pathogenesis in the adult as well as neonate host (Beuzon, Salcedo, and Holden 2002). Highlighting a 
crucial function of SifA in maintaining SCV membrane integrity, as described for SseF/G in the previous 
paragraph, mutants lacking this effector are released into the cytosol, which might lead to rapid killing 
of the pathogen in certain cell types, e.g. macrophages (Beuzon et al. 2000; Beuzon, Salcedo, and 
Holden 2002). Consequently, SifA mutants display a strong attenuation in virulence in adult mouse 
infections, although no replication defect in epithelial cells was observed in vitro (Stein et al. 1996). 
Interestingly, SPI-2 T3SS null mutants lacking SifA and all other SPI-2 effectors retained intact vacuolar 
membranes, indicating contribution of various effectors to SCV membrane integrity and dynamics 
(Figure 6, Figure 11, Figure 14) (Beuzon et al. 2000). This phenotype observed in other studies was also 
attained in neonate mouse infections with a sifA-deficient mutant (Figure 15). Colonization rates of 
systemic tissue was reduced compared to the wt, however, the mutant displayed difficulties in 
maintaining membrane integrity inside host cells at 4 days p.i., which also explains slightly diminished 
bacterial loads in the gut (Figure 15 C). Like the ∆sseF/G mutant, ∆sifA bacteria were found in bigger 
SCVs compared to wt STy at 2 days p.i., similar to the ∆sseB strain (Figure 15 E). Bearing in mind that 
virulence of ∆sifA Salmonella is not abolished but delayed in the neonate host (data not shown), SPI-2 
effector redundancies are reinforced and other proteins probably still enable systemic spread in the 
absence of SifA. Delayed virulence of the ∆sifA strain might be unraveled considering another 
important function of the effector protein. By binding of the N-terminal region of SifA to the C-terminal 
pleckstrin homology domain of the host cell protein SKIP (SifA and kinesin-interacting protein), 
interaction with the light chain of kinesin is ensured (Diacovich et al. 2009; Dumont et al. 2010; Jackson 
et al. 2008; Ohlson et al. 2008). The motor protein kinesin promotes anterograde transport of vesicles 
along microtubules and the interaction via utilization of SifA probably also allows SCVs to travel along 
the microtubule network to the basolateral side of the intestinal enterocyte (Rosa-Ferreira and Munro 
2011). Hence, a ∆sifA mutant exhibits delayed virulence and decreased systemic loads compared to wt 
Salmonella due to hampered transmigration of enterocytes as one of the first steps in NTS 
pathogenesis in the neonate. A deficiency in SKIP and microtubule interaction abrogates SCV 
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transmigration and SifA-deficient bacteria attract attention by increased SCV size at 2 days p.i. (Figure 
15 D-E). The destabilization of the SCV membrane in the absence of a crucial SPI-2 effector explains 
decreased amounts of detected SCVs in the neonate gut at 4 days p.i. and in addition the lower 
bacterial burden in the SI.  
Another important SPI-2 effector protein participating in vacuolar membrane dynamics adding to the 
function of SifA is PipB2 (Henry et al. 2006). It seems to be responsible for kinesin recruitment to the 
SCV membrane, even in the absence of SifA and its interaction partner SKIP (Boucrot et al. 2003). The 
localization of PipB2 to the SCV membrane has already been revealed, yet the exact function of the 
effector protein has not been determined so far (Knodler et al. 2003). A lack of PipB2 did not alter 
development of the systemic phase of Salmonella infection in adult mouse models, but affected the 
inflammatory response in bovine infections (Knodler et al. 2003; Wood et al. 1998). PipB2 recruits 
kinesin to the SCV membrane and interacts with its light chain, but how it contributes to vacuolar 
membrane stabilization and the process of SCV rupture in the absence of certain effectors is 
incompletely understood (Henry et al. 2006; Knodler and Steele-Mortimer 2005). Although ∆pipB2 
mutants displayed smaller SCVs than mutants deficient in either SseF/G or SifA at 2 days p.i., vacuoles 
of ∆pipB2 STy were bigger than wt SCVs (Figure 15 D-E) and the number of bacteria isolated from liver 
or spleen was markedly reduced as well (Figure 15 A-B). This emphasizes a substantial contribution of 
PipB2 to pathogenesis of NTS in the neonate, probably by promoting transmigration potential ensured 
by the interaction of SifA with the microtubule network via recruitment of kinesin to the SCV 
membrane. In addition, PipB2 may also stabilize the vacuolar compartment. This fits literature findings, 
as inhibition of kinesin activity increased membrane stability around ∆sifA bacteria, but vacuolar 
membrane loss was still observed in the absence of PipB2 in a ∆sifA ∆pipB2 double mutant (Guignot et 
al. 2004; Henry et al. 2006).  
Contribution of different effector proteins and an interplay or counteraction within the same 
functional group is further evidenced by utilization of multiple effector protein-deficient mutants. Four 
different proteins were identified to affect SCV membrane dynamics: SifA, PipB2, SopD2 and SseJ, 
whereas SseF and SseG mainly function in positioning of the vacuole inside the host cell and 
additionally promote formation of microtubule bundles (Figueira and Holden 2012). Interestingly, 
sopD2 deletion did not yield an attenuated phenotype in terms of systemic growth in the neonate 
mouse model, suggesting that its role in maintenance of vacuolar membrane integrity is minor 
compared to SifA or PipB2. Two different combinations of effectors have been investigated in this 
study. In both cases, sseF/G and sifA were deleted and either pipB2 (Figure 16, open triangles) or sseJ 
(Figure 16, open rhombs) additionally. Like already observed in single SPI-2 effector mutant infections, 
the number of bacteria isolated from liver and spleen was diminished compared to the wt STy infection 
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at 4 days p.i. and approximates the ∆sseB mutant, whereas colonization of the intestine was more or 
less identical among all different strains (Figure 16). Furthermore, no SCVs could be detected for either 
of the multi SPI-2 effector mutant 4 days after inoculation, accounting for a vigorous membrane 
destabilization in the absence of these effectors. Anyhow, this holds true for single effector mutants, 
like e.g. ∆sifA STy, and underlines a role in stabilizing the SCV membrane of the proteins previously 
investigated. Findings from multi mutant infections in the neonate emphasize an interplay between 
different effectors and indicate an imbalance observable by membrane rupture if effector activity 
misses a counter player, since the effects can be opposing one another (Ruiz-Albert et al. 2002). By 
deletion of SopD2 in addition to other effectors involved in SCV membrane dynamics and maintenance 
of vacuolar integrity, the SPI-2 null mutant phenotype might therefore be completely reconstructed, 
including enlarged SCVs with intact membrane surroundings, abolished transmigration due to absent 
microtubule network interaction and attenuated virulence in the neonate host.  
Summarized, single SPI-2 effector mutants as well as a combination of different effector proteins from 
one functional group stressed the redundancy of effector functions. Single mutants retained virulence 
and were rather delayed than abolished in eliciting systemic NTS infections. Furthermore, it could be 
proven that some virulence factors rely on an interaction partner and that presence of certain effectors 
was crucial for proper function of another one.  
4.5 Model of SPI-2-dependent pathogenesis in the neonate intestine 
Summarizing the results achieved during this work, we propose an infection model for the function of 
SPI-2 in the first steps of pathogenesis of iNTS infection in the neonate host (Figure 17).  
For the wt strain, a non-phagocytic cell in the neonate intestinal epithelium is invaded via translocation 
of SPI-1 effector proteins, leading to reorganization of the actin cytoskeleton, membrane ruffling and 
bacterial uptake, as demonstrated earlier (Zhang et al. 2014). Invasion of the non-phagocytic host cell 
in a macropinosomal-like fashion results in SCV formation. As a consequence, SPI-2 effector proteins 
will be synthesized and secreted into the host cell cytosol via the T3SS of SPI-2. Certain effectors, like 
SifA, allow the interaction with the host cell microtubule network via the host protein SKIP (Dumont et 
al. 2010). This interaction ensures transmigration of the SCV from apical to basolateral. Following, 
Salmonella evades the enterocyte and gains access to the lamina propria and residing immune cells. 
The pathogen spreads throughout the body, thereby causing a life-threatening invasive infection and 
massive inflammation in the gut (Figure 5, Figure 14, Figure 15, Figure 16).  
In contrast to this, the capability to establish a functional T3SS for secretion of SPI-2 effectors is 
depleted in the investigated ∆sseB mutant. Invasion and SCV formation remain functional in the 
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absence of SPI-2 (Figure 3 D, Figure 6). However, the mutant is unable to assemble a complete needle 
apparatus for SPI-2 effector protein translocation (Figure 17). As a result, interaction with SKIP via SifA 
and resulting host cell transmigration is blocked for the mutant. Despite lacking the entire subset of 
SPI-2 effectors, bacterial replication inside the host cell within SCVs is unaffected (Figure 11). Mutant 
replication proceeds, but SCVs are stuck in an apical position inside the infected enterocyte, because 
SPI-2 effector protein enabled transmigration via subversion of the microtubule network is blocked 
(Figure 11, Figure 14). Although SIF formation via SPI-2 effectors and the resulting modification of the 
host cell’s endosomal system was indispensable in adult mice, the unique nature of endosomal 
trafficking and non-selective transport of macromolecules through the intestinal barrier allows 
sufficient nutrient supply for Salmonella in the neonate gut. By this means, Salmonella might end up 
in giant vacuoles of VFEs, thereby enabling nutrition and proliferation inside the host cell in the 
absence of SPI-2 effectors and the resulting modulations. In case of the SPI-2 mutant strain, SCVs inside 
intestinal enterocytes remain a replicative niche, but a dead-end to the pathogen simultaneously. This 
explains increased sizes of mutant SCVs compared to the wt strain, diminished systemic loads and 




Schemativ comparison of enterocytes in the SI of neonate mice infected with either a wt (A) or 
SPI-2-deficient Salmonella. Salmonella possesses SPIs, allowing first enterocyte invasion, followed by 
translocation of SPI-2 effectors, modulating and manipulating the host cell machinery in various ways, 
including positioning of the SCV in close proximetry to the nucleus (N). A type three secretion system 
(T3SS, blue needle structure) allows translocation of SPI-2 effector proteins, like SifA  (yellow circle) 
from the inside of the SCV into the host cell cytosol as can be seen in enlarged view from grey square. 
The needle-like compartment, consisting of different SPI-2 encoded proteins, spans the bacterial 
membranes and connects the pathogen to the host cytosol (modified from Grant et al., 2012). 
Interaction of effectors with the microtubule network (black dashed lines) via host proteins like SKIP 
Figure 17: Proposed model of SPI-2-dependent enterocyte transmigration in the neonatal SI 
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(red connected circles) enable transmigration of enterocytes and systemic spread of Salmonella. The 
mutant (B) lacks a fully functional T3SS for SPI-2 effector protein translocation. The blocked 
microtubule interaction prevents transmigration, whereas intracellular replication remains possible 





Abrahams, G. L., P. Muller, and M. Hensel. 2006. 'Functional dissection of SseF, a type III effector 
protein involved in positioning the salmonella-containing vacuole', Traffic, 7: 950-65. 
Achtman, M. 2008. 'Evolution, population structure, and phylogeography of genetically monomorphic 
bacterial pathogens', Annu Rev Microbiol, 62: 53-70. 
Achtman, M., J. Wain, F. X. Weill, S. Nair, Z. Zhou, V. Sangal, M. G. Krauland, J. L. Hale, H. Harbottle, A. 
Uesbeck, G. Dougan, L. H. Harrison, S. Brisse, and S. Enterica MLST Study Group. 2012. 
'Multilocus sequence typing as a replacement for serotyping in Salmonella enterica', PLoS 
Pathog, 8: e1002776. 
Ackermann, M., B. Stecher, N. E. Freed, P. Songhet, W. D. Hardt, and M. Doebeli. 2008. 'Self-destructive 
cooperation mediated by phenotypic noise', Nature, 454: 987-90. 
Akira, S., K. Takeda, and T. Kaisho. 2001. 'Toll-like receptors: critical proteins linking innate and 
acquired immunity', Nat Immunol, 2: 675-80. 
Aleksic, S., F. Heinzerling, and J. Bockemuhl. 1996. 'Human infection caused by Salmonellae of 
subspecies II to VI in Germany, 1977-1992', Zentralbl Bakteriol, 283: 391-8. 
Altmeyer, M., M. Barthel, M. Eberhard, H. Rehrauer, W. D. Hardt, and M. O. Hottiger. 2010. 'Absence 
of poly(ADP-ribose) polymerase 1 delays the onset of Salmonella enterica serovar 
Typhimurium-induced gut inflammation', Infect Immun, 78: 3420-31. 
Andrews-Polymenis, H. L., A. J. Bäumler, B. A. McCormick, and F. C. Fang. 2010. 'Taming the elephant: 
Salmonella biology, pathogenesis, and prevention', Infect Immun, 78: 2356-69. 
Araujo, L. M., O. G. Ribeiro, M. Siqueira, M. De Franco, N. Starobinas, S. Massa, W. H. Cabrera, D. 
Mouton, M. Seman, and O. M. Ibanez. 1998. 'Innate resistance to infection by intracellular 
bacterial pathogens differs in mice selected for maximal or minimal acute inflammatory 
response', Eur J Immunol, 28: 2913-20. 
Arevalo Sureda, E., B. Westrom, S. G. Pierzynowski, and O. Prykhodko. 2016. 'Maturation of the 
Intestinal Epithelial Barrier in Neonatal Rats Coincides with Decreased FcRn Expression, 
Replacement of Vacuolated Enterocytes and Changed Blimp-1 Expression', PLoS One, 11: 
e0164775. 
Arpaia, N., J. Godec, L. Lau, K. E. Sivick, L. M. McLaughlin, M. B. Jones, T. Dracheva, S. N. Peterson, D. 
M. Monack, and G. M. Barton. 2011. 'TLR signaling is required for Salmonella typhimurium 
virulence', Cell, 144: 675-88. 
Ayabe, T., D. P. Satchell, C. L. Wilson, W. C. Parks, M. E. Selsted, and A. J. Ouellette. 2000. 'Secretion of 
microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria', Nat Immunol, 
1: 113-8. 
Babbar, H. S., V. M. Jaswal, R. Gupta, and A. Mahmood. 1990. 'Intestinal absorption of macromolecules 
and epithelial cell surface glycosylation in suckling rats nursed on mothers fed low-protein 
diet-I', Biol Neonate, 58: 104-11. 
Baker, S., and G. Dougan. 2007. 'The genome of Salmonella enterica serovar Typhi', Clin Infect Dis, 45 
Suppl 1: S29-33. 
Bakowski, M. A., V. Braun, and J. H. Brumell. 2008. 'Salmonella-containing vacuoles: directing traffic 
and nesting to grow', Traffic, 9: 2022-31. 
Barlow, M., and B. G. Hall. 2002. 'Origin and evolution of the AmpC beta-lactamases of Citrobacter 
freundii', Antimicrob Agents Chemother, 46: 1190-8. 
Barthel, M., S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. 
Russmann, and W. D. Hardt. 2003. 'Pretreatment of mice with streptomycin provides a 
Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen 
and host', Infect Immun, 71: 2839-58. 
Bäumler, A., and F. C. Fang. 2013. 'Host specificity of bacterial pathogens', Cold Spring Harbor 
perspectives in medicine, 3: a010041. 




Bäumler, A. J., R. M. Tsolis, T. A. Ficht, and L. G. Adams. 1998. 'Evolution of host adaptation in 
Salmonella enterica', Infection and immunity, 66: 4579-87. 
Bäumler, A. J., R. M. Tsolis, P. J. Valentine, T. A. Ficht, and F. Heffron. 1997. 'Synergistic effect of 
mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid', 
Infect Immun, 65: 2254-9. 
Bellamy, R., C. Ruwende, T. Corrah, K. P. McAdam, H. C. Whittle, and A. V. Hill. 1998. 'Variations in the 
NRAMP1 gene and susceptibility to tuberculosis in West Africans', N Engl J Med, 338: 640-4. 
Bermudez-Brito, M., S. Munoz-Quezada, C. Gomez-Llorente, E. Matencio, M. J. Bernal, F. Romero, and 
A. Gil. 2012. 'Human intestinal dendritic cells decrease cytokine release against Salmonella 
infection in the presence of Lactobacillus paracasei upon TLR activation', PLoS One, 7: e43197. 
Beuzon, C. R., S. Meresse, K. E. Unsworth, J. Ruiz-Albert, S. Garvis, S. R. Waterman, T. A. Ryder, E. 
Boucrot, and D. W. Holden. 2000. 'Salmonella maintains the integrity of its intracellular vacuole 
through the action of SifA', EMBO J, 19: 3235-49. 
Beuzon, C. R., S. P. Salcedo, and D. W. Holden. 2002. 'Growth and killing of a Salmonella enterica 
serovar Typhimurium sifA mutant strain in the cytosol of different host cell lines', 
Microbiology, 148: 2705-15. 
Biggs, H. M., R. Lester, B. Nadjm, G. Mtove, J. E. Todd, G. D. Kinabo, R. Philemon, B. Amos, A. B. 
Morrissey, H. Reyburn, and J. A. Crump. 2014. 'Invasive Salmonella infections in areas of high 
and low malaria transmission intensity in Tanzania', Clin Infect Dis, 58: 638-47. 
Birchenough, G. M., F. Dalgakiran, L. A. Witcomb, M. E. Johansson, A. J. McCarthy, G. C. Hansson, and 
P. W. Taylor. 2017. 'Postnatal development of the small intestinal mucosa drives age-
dependent, regio-selective susceptibility to Escherichia coli K1 infection', Sci Rep, 7: 83. 
Birmingham, C. L., X. Jiang, M. B. Ohlson, S. I. Miller, and J. H. Brumell. 2005. 'Salmonella-induced 
filament formation is a dynamic phenotype induced by rapidly replicating Salmonella enterica 
serovar typhimurium in epithelial cells', Infect Immun, 73: 1204-8. 
Blackwell, J. M., T. Goswami, C. A. Evans, D. Sibthorpe, N. Papo, J. K. White, S. Searle, E. N. Miller, C. S. 
Peacock, H. Mohammed, and M. Ibrahim. 2001. 'SLC11A1 (formerly NRAMP1) and disease 
resistance', Cell Microbiol, 3: 773-84. 
Blackwell, J. M., S. Searle, T. Goswami, and E. N. Miller. 2000. 'Understanding the multiple functions of 
Nramp1', Microbes Infect, 2: 317-21. 
Booth, I. R. 1985. 'Regulation of cytoplasmic pH in bacteria', Microbiol Rev, 49: 359-78. 
Boucrot, E., C. R. Beuzon, D. W. Holden, J. P. Gorvel, and S. Meresse. 2003. 'Salmonella typhimurium 
SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its 
biological function', J Biol Chem, 278: 14196-202. 
Bowden, S. D., G. Rowley, J. C. Hinton, and A. Thompson. 2009. 'Glucose and glycolysis are required for 
the successful infection of macrophages and mice by Salmonella enterica serovar 
typhimurium', Infect Immun, 77: 3117-26. 
Bowe, F., C. J. Lipps, R. M. Tsolis, E. Groisman, F. Heffron, and J. G. Kusters. 1998. 'At least four percent 
of the Salmonella typhimurium genome is required for fatal infection of mice', Infect Immun, 
66: 3372-7. 
Brenner, F. W., R. G. Villar, F. J. Angulo, R. Tauxe, and B. Swaminathan. 2000. 'Salmonella 
nomenclature', J Clin Microbiol, 38: 2465-7. 
Brown, D. E., S. J. Libby, S. M. Moreland, M. W. McCoy, T. Brabb, A. Stepanek, F. C. Fang, and C. S. 
Detweiler. 2013. 'Salmonella enterica causes more severe inflammatory disease in C57/BL6 
Nramp1G169 mice than Sv129S6 mice', Vet Pathol, 50: 867-76. 
Brown, N. F., B. A. Vallance, B. K. Coombes, Y. Valdez, B. A. Coburn, and B. B. Finlay. 2005. 'Salmonella 
pathogenicity island 2 is expressed prior to penetrating the intestine', PLoS Pathog, 1: e32. 
Browne, S. H., P. Hasegawa, S. Okamoto, J. Fierer, and D. G. Guiney. 2008. 'Identification of Salmonella 
SPI-2 secretion system components required for SpvB-mediated cytotoxicity in macrophages 
and virulence in mice', FEMS Immunol Med Microbiol, 52: 194-201. 
Brumell, J. H., C. M. Rosenberger, G. T. Gotto, S. L. Marcus, and B. B. Finlay. 2001. 'SifA permits survival 
and replication of Salmonella typhimurium in murine macrophages', Cell Microbiol, 3: 75-84. 
94 
 
Brumell, J. H., P. Tang, S. D. Mills, and B. B. Finlay. 2001. 'Characterization of Salmonella-induced 
filaments (Sifs) reveals a delayed interaction between Salmonella-containing vacuoles and late 
endocytic compartments', Traffic, 2: 643-53. 
Brumell, J. H., P. Tang, M. L. Zaharik, and B. B. Finlay. 2002. 'Disruption of the Salmonella-containing 
vacuole leads to increased replication of Salmonella enterica serovar typhimurium in the 
cytosol of epithelial cells', Infect Immun, 70: 3264-70. 
Bruno, V. M., S. Hannemann, M. Lara-Tejero, R. A. Flavell, S. H. Kleinstein, and J. E. Galan. 2009. 
'Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in 
cultured epithelial cells', PLoS Pathog, 5: e1000538. 
Buckle, G. C., C. L. Walker, and R. E. Black. 2012. 'Typhoid fever and paratyphoid fever: Systematic 
review to estimate global morbidity and mortality for 2010', J Glob Health, 2: 010401. 
Bumann, D., and J. Schothorst. 2017. 'Intracellular Salmonella metabolism', Cell Microbiol, 19. 
Byrd, J. A., D. E. Corrier, J. R. Deloach, D. J. Nisbet, and L. H. Stanker. 1998. 'Horizontal Transmission of 
Salmonella typhimurium in Broiler Chicks', The Journal of Applied Poultry Research, 7: 75-80. 
Canonne-Hergaux, F., J. Calafat, E. Richer, M. Cellier, S. Grinstein, N. Borregaard, and P. Gros. 2002. 
'Expression and subcellular localization of NRAMP1 in human neutrophil granules', Blood, 100: 
268-75. 
Carter, P. B., and F. M. Collins. 1974. 'The route of enteric infection in normal mice', J Exp Med, 139: 
1189-203. 
Castanheira, Sónia, and Francisco García-Del Portillo. 2017. 'Salmonella Populations inside Host Cells', 
Frontiers in cellular and infection microbiology, 7: 432-32. 
Chakravortty, D., I. Hansen-Wester, and M. Hensel. 2002. 'Salmonella pathogenicity island 2 mediates 
protection of intracellular Salmonella from reactive nitrogen intermediates', J Exp Med, 195: 
1155-66. 
Chakravortty, D., M. Rohde, L. Jager, J. Deiwick, and M. Hensel. 2005. 'Formation of a novel surface 
structure encoded by Salmonella Pathogenicity Island 2', EMBO J, 24: 2043-52. 
Chassin, C., M. Kocur, J. Pott, C. U. Duerr, D. Gutle, M. Lotz, and M. W. Hornef. 2010. 'miR-146a 
mediates protective innate immune tolerance in the neonate intestine', Cell Host Microbe, 8: 
358-68. 
Chaudhuri, R. R., S. E. Peters, S. J. Pleasance, H. Northen, C. Willers, G. K. Paterson, D. B. Cone, A. G. 
Allen, P. J. Owen, G. Shalom, D. J. Stekel, I. G. Charles, and D. J. Maskell. 2009. 'Comprehensive 
Identification of Salmonella enterica Serovar Typhimurium Genes Required for Infection of 
BALB/c Mice', PLOS Pathogens, 5: e1000529. 
Cheminay, C., D. Chakravortty, and M. Hensel. 2004. 'Role of neutrophils in murine salmonellosis', 
Infect Immun, 72: 468-77. 
Cheminay, C., A. Mohlenbrink, and M. Hensel. 2005. 'Intracellular Salmonella inhibit antigen 
presentation by dendritic cells', J Immunol, 174: 2892-9. 
Church, D. L., H. D. Davies, G. Cadrain, and C. L. Trevenen. 1998. 'Comparative study of three different 
BACTEC culture media for the detection of bacteremia in ambulatory and hospitalized 
children', Can J Infect Dis, 9: 77-82. 
Cirillo, D. M., R. H. Valdivia, D. M. Monack, and S. Falkow. 1998. 'Macrophage-dependent induction of 
the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular 
survival', Mol Microbiol, 30: 175-88. 
Clark, M. A., K. A. Reed, J. Lodge, J. Stephen, B. H. Hirst, and M. A. Jepson. 1996. 'Invasion of murine 
intestinal M cells by Salmonella typhimurium inv mutants severely deficient for invasion of 
cultured cells', Infection and immunity, 64: 4363-68. 
Coburn, B., Y. Li, D. Owen, B. A. Vallance, and B. B. Finlay. 2005. 'Salmonella enterica serovar 
Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of 
infectious enterocolitis', Infect Immun, 73: 3219-27. 
Coburn, B., I. Sekirov, and B. B. Finlay. 2007. 'Type III secretion systems and disease', Clin Microbiol 
Rev, 20: 535-49. 
95 
 
Coleman, O. I., and D. Haller. 2018. 'Bacterial Signaling at the Intestinal Epithelial Interface in 
Inflammation and Cancer', Frontiers in immunology, 8: 1927-27. 
Coombes, B. K., N. F. Brown, Y. Valdez, J. H. Brumell, and B. B. Finlay. 2004. 'Expression and secretion 
of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit 
differential requirements of a functional type III secretion apparatus and SsaL', J Biol Chem, 
279: 49804-15. 
Correia-Gomes, C., T. Economou, T. Bailey, P. Brazdil, L. Alban, and J. Niza-Ribeiro. 2014. 'Transmission 
parameters estimated for Salmonella typhimurium in swine using susceptible-infectious-
resistant models and a Bayesian approach', BMC Vet Res, 10: 101. 
Crimmins, G. T., and R. R. Isberg. 2012. 'Analyzing microbial disease at high resolution: following the 
fate of the bacterium during infection', Curr Opin Microbiol, 15: 23-7. 
Crump, J. A., S. P. Luby, and E. D. Mintz. 2004. 'The global burden of typhoid fever', Bull World Health 
Organ, 82: 346-53. 
Crump, J. A., and E. D. Mintz. 2010. 'Global trends in typhoid and paratyphoid Fever', Clin Infect Dis, 
50: 241-6. 
Crump, J. A., M. Sjolund-Karlsson, M. A. Gordon, and C. M. Parry. 2015. 'Epidemiology, Clinical 
Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management 
of Invasive Salmonella Infections', Clin Microbiol Rev, 28: 901-37. 
Cuellar-Mata, P., N. Jabado, J. Liu, W. Furuya, B. B. Finlay, P. Gros, and S. Grinstein. 2002. 'Nramp1 
modifies the fusion of Salmonella typhimurium-containing vacuoles with cellular 
endomembranes in macrophages', J Biol Chem, 277: 2258-65. 
D'Costa, V. M., V. Braun, M. Landekic, R. Shi, A. Proteau, L. McDonald, M. Cygler, S. Grinstein, and J. H. 
Brumell. 2015. 'Salmonella Disrupts Host Endocytic Trafficking by SopD2-Mediated Inhibition 
of Rab7', Cell Rep, 12: 1508-18. 
Dalebroux, Z. D., and S. I. Miller. 2014. 'Salmonellae PhoPQ regulation of the outer membrane to resist 
innate immunity', Curr Opin Microbiol, 17: 106-13. 
Dandekar, T., F. Astrid, P. Jasmin, and M. Hensel. 2012. 'Salmonella enterica: a surprisingly well-
adapted intracellular lifestyle', Front Microbiol, 3: 164. 
Dandekar, T., A. Fieselmann, E. Fischer, J. Popp, M. Hensel, and J. Noster. 2014. 'Salmonella-how a 
metabolic generalist adopts an intracellular lifestyle during infection', Front Cell Infect 
Microbiol, 4: 191. 
Datsenko, K. A., and B. L. Wanner. 2000. 'One-step inactivation of chromosomal genes in Escherichia 
coli K-12 using PCR products', Proc Natl Acad Sci U S A, 97: 6640-5. 
Davies, R. H., and C. Wray. 1996. 'Persistence of Salmonella enteritidis in poultry units and poultry 
food', Br Poult Sci, 37: 589-96. 
de Santa Barbara, P., G. R. van den Brink, and D. J. Roberts. 2003. 'Development and differentiation of 
the intestinal epithelium', Cell Mol Life Sci, 60: 1322-32. 
Deiwick, J., and M. Hensel. 1999. 'Regulation of virulence genes by environmental signals in Salmonella 
typhimurium', Electrophoresis, 20: 813-7. 
Deiwick, J., T. Nikolaus, S. Erdogan, and M. Hensel. 1999. 'Environmental regulation of Salmonella 
pathogenicity island 2 gene expression', Mol Microbiol, 31: 1759-73. 
Deiwick, J., T. Nikolaus, J. E. Shea, C. Gleeson, D. W. Holden, and M. Hensel. 1998. 'Mutations in 
Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and 
resistance to antimicrobial agents', Journal of bacteriology, 180: 4775-80. 
Deiwick, J., S. P. Salcedo, E. Boucrot, S. M. Gilliland, T. Henry, N. Petermann, S. R. Waterman, J. P. 
Gorvel, D. W. Holden, and S. Meresse. 2006. 'The translocated Salmonella effector proteins 
SseF and SseG interact and are required to establish an intracellular replication niche', Infect 
Immun, 74: 6965-72. 
Dekaney, C. M., F. W. Bazer, and L. A. Jaeger. 1997. 'Mucosal morphogenesis and cytodifferentiation 
in fetal porcine small intestine', Anat Rec, 249: 517-23. 
den Bakker, H. C., A. I. Moreno Switt, G. Govoni, C. A. Cummings, M. L. Ranieri, L. Degoricija, K. Hoelzer, 
L. D. Rodriguez-Rivera, S. Brown, E. Bolchacova, M. R. Furtado, and M. Wiedmann. 2011. 
96 
 
'Genome sequencing reveals diversification of virulence factor content and possible host 
adaptation in distinct subpopulations of Salmonella enterica', BMC Genomics, 12: 425. 
Desai, P. T., S. Porwollik, F. Long, P. Cheng, A. Wollam, V. Bhonagiri-Palsikar, K. Hallsworth-Pepin, S. W. 
Clifton, G. M. Weinstock, and M. McClelland. 2013. 'Evolutionary Genomics of Salmonella 
enterica Subspecies', MBio, 4. 
Diacovich, L., A. Dumont, D. Lafitte, E. Soprano, A. A. Guilhon, C. Bignon, J. P. Gorvel, Y. Bourne, and S. 
Meresse. 2009. 'Interaction between the SifA virulence factor and its host target SKIP is 
essential for Salmonella pathogenesis', J Biol Chem, 284: 33151-60. 
Diard, M., V. Garcia, L. Maier, M. N. Remus-Emsermann, R. R. Regoes, M. Ackermann, and W. D. Hardt. 
2013. 'Stabilization of cooperative virulence by the expression of an avirulent phenotype', 
Nature, 494: 353-6. 
Domingues, L., D. W. Holden, and L. J. Mota. 2014. 'The Salmonella effector SteA contributes to the 
control of membrane dynamics of Salmonella-containing vacuoles', Infect Immun, 82: 2923-
34. 
Dos Santos, A. M. P., R. G. Ferrari, and C. A. Conte-Junior. 2019. 'Virulence Factors in Salmonella 
Typhimurium: The Sagacity of a Bacterium', Curr Microbiol, 76: 762-73. 
Drevets, D. A., P. J. Leenen, and R. A. Greenfield. 2004. 'Invasion of the central nervous system by 
intracellular bacteria', Clin Microbiol Rev, 17: 323-47. 
Dumont, A., E. Boucrot, S. Drevensek, V. Daire, J. P. Gorvel, C. Pous, D. W. Holden, and S. Meresse. 
2010. 'SKIP, the host target of the Salmonella virulence factor SifA, promotes kinesin-1-
dependent vacuolar membrane exchanges', Traffic, 11: 899-911. 
Dupont, A., Y. Kaconis, I. Yang, T. Albers, S. Woltemate, L. Heinbockel, M. Andersson, S. Suerbaum, K. 
Brandenburg, and M. W. Hornef. 2015. 'Intestinal mucus affinity and biological activity of an 
orally administered antibacterial and anti-inflammatory peptide', Gut, 64: 222-32. 
Eastwood, G. L. 1977. 'Gastrointestinal epithelial renewal', Gastroenterology, 72: 962-75. 
Eberth, C. J. %J Archiv für pathologische Anatomie und Physiologie und für klinische Medicin. 1880. 
'Die Organismen in den Organen bei Typhus abdominalis', 81: 58-74. 
Edwards, P. R., D. W. Bruner, and A. B. Moran. 1948. 'Further studies on the occurrence and 
distribution of Salmonella types in the United States', J Infect Dis, 83: 220-31. 
Eguale, T. 2018. 'Non-typhoidal Salmonella serovars in poultry farms in central Ethiopia: prevalence 
and antimicrobial resistance', BMC Vet Res, 14: 217. 
Ehrbar, K., and W. D. Hardt. 2005. 'Bacteriophage-encoded type III effectors in Salmonella enterica 
subspecies 1 serovar Typhimurium', Infect Genet Evol, 5: 1-9. 
Eng, SK., P. Pusparajah, NS. Ab Mutalib, H L. Ser, KG. Chan, and L H. Lee. 2015. 'Salmonella : A review 
on pathogenesis, epidemiology and antibiotic resistance', Frontiers in Life Science, 8: 1-10. 
Faber, F., P. Thiennimitr, L. Spiga, M. X. Byndloss, Y. Litvak, S. Lawhon, H. L. Andrews-Polymenis, S. E. 
Winter, and A. J. Baumler. 2017. 'Respiration of Microbiota-Derived 1,2-propanediol Drives 
Salmonella Expansion during Colitis', PLoS Pathog, 13: e1006129. 
Farooqui, A., A. Khan, and S. U. Kazmi. 2009. 'Investigation of a community outbreak of typhoid fever 
associated with drinking water', BMC Public Health, 9: 476. 
Fass, E., and E. A. Groisman. 2009. 'Control of Salmonella pathogenicity island-2 gene expression', Curr 
Opin Microbiol, 12: 199-204. 
Feasey, N. A., D. Everett, E. B. Faragher, A. Roca-Feltrer, A. Kang'ombe, B. Denis, M. Kerac, E. Molyneux, 
M. Molyneux, A. Jahn, M. A. Gordon, and R. S. Heyderman. 2015. 'Modelling the Contributions 
of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal 
Salmonella Disease in Malawi', PLoS neglected tropical diseases, 9: e0003979. 
Fedorka-Cray, P. J., S. C. Whipp, R. E. Isaacson, N. Nord, and K. Lager. 1994. 'Transmission of Salmonella 
typhimurium to swine', Vet Microbiol, 41: 333-44. 
Feuillet, V., S. Medjane, I. Mondor, O. Demaria, P. P. Pagni, J. E. Galan, R. A. Flavell, and L. Alexopoulou. 
2006. 'Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria', Proc Natl 
Acad Sci U S A, 103: 12487-92. 
97 
 
Fields, P. I., R. V. Swanson, C. G. Haidaris, and F. Heffron. 1986. 'Mutants of Salmonella typhimurium 
that cannot survive within the macrophage are avirulent', Proceedings of the National 
Academy of Sciences of the United States of America, 83: 5189-93. 
Figueira, R., and D. W. Holden. 2012. 'Functions of the Salmonella pathogenicity island 2 (SPI-2) type 
III secretion system effectors', Microbiology, 158: 1147-61. 
Finlay, B. B., and J. H. Brumell. 2000. 'Salmonella interactions with host cells: in vitro to in vivo', Philos 
Trans R Soc Lond B Biol Sci, 355: 623-31. 
Finn, S., O. Condell, P. McClure, A. Amézquita, and S. Fanning. 2013. 'Mechanisms of survival, responses 
and sources of Salmonella in low-moisture environments', Front Microbiol, 4: 331. 
Fitzsimmons, L. F., L. Liu, J. S. Kim, J. Jones-Carson, and A. Vazquez-Torres. 2018. 'Salmonella 
Reprograms Nucleotide Metabolism in Its Adaptation to Nitrosative Stress', MBio, 9. 
Fluit, A. C. 2005. 'Towards more virulent and antibiotic-resistant Salmonella?', FEMS Immunol Med 
Microbiol, 43: 1-11. 
Foley, J. E., U. Orgad, D. C. Hirsh, A. Poland, and N. C. Pedersen. 1999. 'Outbreak of fatal salmonellosis 
in cats following use of a high-titer modified-live panleukopenia virus vaccine', J Am Vet Med 
Assoc, 214: 67-70, 43-4. 
Fookes, M., G. N. Schroeder, G. C. Langridge, C. J. Blondel, C. Mammina, T. R. Connor, H. Seth-Smith, 
G. S. Vernikos, K. S. Robinson, M. Sanders, N. K. Petty, R. A. Kingsley, A. J. Baumler, S. P. Nuccio, 
I. Contreras, C. A. Santiviago, D. Maskell, P. Barrow, T. Humphrey, A. Nastasi, M. Roberts, G. 
Frankel, J. Parkhill, G. Dougan, and N. R. Thomson. 2011. 'Salmonella bongori provides insights 
into the evolution of the Salmonellae', PLoS Pathog, 7: e1002191. 
Forbes, J. R., and P. Gros. 2001. 'Divalent-metal transport by NRAMP proteins at the interface of host-
pathogen interactions', Trends Microbiol, 9: 397-403. 
———. 2003. 'Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) 
expressed at the plasma membrane', Blood, 102: 1884-92. 
Forest, C. G., E. Ferraro, S. C. Sabbagh, and F. Daigle. 2010. 'Intracellular survival of Salmonella enterica 
serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-
2', Microbiology, 156: 3689-98. 
Foster, J. W., and H. K. Hall. 1990. 'Adaptive acidification tolerance response of Salmonella 
typhimurium', J Bacteriol, 172: 771-8. 
———. 1991. 'Inducible pH homeostasis and the acid tolerance response of Salmonella typhimurium', 
J Bacteriol, 173: 5129-35. 
Fremont-Rahl, J. J., Z. Ge, C. Umana, M. T. Whary, N. S. Taylor, S. Muthupalani, M. C. Carey, J. G. Fox, 
and K. J. Maurer. 2013. 'An Analysis of the Role of the Indigenous Microbiota in Cholesterol 
Gallstone Pathogenesis', PLoS One, 8: e70657. 
Fritsche, G., M. Nairz, S. J. Libby, F. C. Fang, and G. Weiss. 2012. 'Slc11a1 (Nramp1) impairs growth of 
Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 
expression', J Leukoc Biol, 92: 353-9. 
Fulde, M., F. Sommer, B. Chassaing, K. van Vorst, A. Dupont, M. Hensel, M. Basic, R. Klopfleisch, P. 
Rosenstiel, A. Bleich, F. Backhed, A. T. Gewirtz, and M. W. Hornef. 2018. 'Neonatal selection 
by Toll-like receptor 5 influences long-term gut microbiota composition', Nature, 560: 489-93. 
Gal-Mor, O. 2019. 'Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal 
Salmonellae', Clin Microbiol Rev, 32. 
Gal-Mor, O., E. C. Boyle, and G. A. Grassl. 2014. 'Same species, different diseases: how and why 
typhoidal and non-typhoidal Salmonella enterica serovars differ', Front Microbiol, 5: 391. 
Gal-Mor, O., and B. B. Finlay. 2006. 'Pathogenicity islands: a molecular toolbox for bacterial virulence', 
Cell Microbiol, 8: 1707-19. 
Galan, J. E. 2001. 'Salmonella interactions with host cells: type III secretion at work', Annu Rev Cell Dev 
Biol, 17: 53-86. 
Galan, J. E., and R. Curtiss, 3rd. 1989. 'Cloning and molecular characterization of genes whose products 




Galanis, E., D. M. Lo Fo Wong, M. E. Patrick, N. Binsztein, A. Cieslik, T. Chalermchikit, A. Aidara-Kane, 
A. Ellis, F. J. Angulo, and H. C. Wegener. 2006. 'Web-based surveillance and global Salmonella 
distribution, 2000-2002', Emerg Infect Dis, 12: 381-8. 
Galyov, E. E., M. W. Wood, R. Rosqvist, P. B. Mullan, P. R. Watson, S. Hedges, and T. S. Wallis. 1997. 'A 
secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and 
mediates inflammation and fluid secretion in infected ileal mucosa', Mol Microbiol, 25: 903-
12. 
Garai, P., S. A. Marathe, and D. Chakravortty. 2011. 'Effectors of Salmonella pathogenicity island 2: An 
island crucial to the life of Salmonella', Virulence, 2: 177-80. 
Garcia-del Portillo, F., and B. B. Finlay. 1995. 'Targeting of Salmonella typhimurium to vesicles 
containing lysosomal membrane glycoproteins bypasses compartments with mannose 6-
phosphate receptors', J Cell Biol, 129: 81-97. 
Garcia-del Portillo, F., M. B. Zwick, K. Y. Leung, and B. B. Finlay. 1993. 'Salmonella induces the formation 
of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells', 
Proc Natl Acad Sci U S A, 90: 10544-8. 
Garmendia, J., C. R. Beuzon, J. Ruiz-Albert, and D. W. Holden. 2003. 'The roles of SsrA-SsrB and OmpR-
EnvZ in the regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion 
system', Microbiology, 149: 2385-96. 
Geddes, K., M. Worley, G. Niemann, and F. Heffron. 2005. 'Identification of new secreted effectors in 
Salmonella enterica serovar Typhimurium', Infect Immun, 73: 6260-71. 
Gerlach, R. G., and M. Hensel. 2007. 'Salmonella pathogenicity islands in host specificity, host 
pathogen-interactions and antibiotics resistance of Salmonella enterica', Berl Munch Tierarztl 
Wochenschr, 120: 317-27. 
Gibani, M. M., C. Britto, and A. J. Pollard. 2018. 'Typhoid and paratyphoid fever: a call to action', Curr 
Opin Infect Dis, 31: 440-48. 
Gibani, M. M., E. Jones, A. Barton, C. Jin, J. Meek, S. Camara, U. Galal, E. Heinz, Y. Rosenberg-Hasson, 
G. Obermoser, C. Jones, D. Campbell, C. Black, H. Thomaides-Brears, C. Darlow, C. Dold, L. Silva-
Reyes, L. Blackwell, M. Lara-Tejero, X. Jiao, G. Stack, C. J. Blohmke, J. Hill, B. Angus, G. Dougan, 
J. Galan, and A. J. Pollard. 2019. 'Investigation of the role of typhoid toxin in acute typhoid 
fever in a human challenge model', Nat Med, 25: 1082-88. 
Gomez, T. M., Y. Motarjemi, S. Miyagawa, F. K. Kaferstein, and K. Stohr. 1997. 'Foodborne 
salmonellosis', World Health Stat Q, 50: 81-9. 
Gordon, J. I., and M. L. Hermiston. 1994. 'Differentiation and self-renewal in the mouse gastrointestinal 
epithelium', Curr Opin Cell Biol, 6: 795-803. 
Gordon, Melita A. 2011. 'Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and 
diagnosis', Current opinion in infectious diseases, 24: 484-89. 
Govoni, G., S. Vidal, S. Gauthier, E. Skamene, D. Malo, and P. Gros. 1996. 'The Bcg/Ity/Lsh locus: genetic 
transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele', 
Infect Immun, 64: 2923-9. 
Graham, S. M., A. L. Walsh, E. M. Molyneux, A. J. Phiri, and M. E. Molyneux. 2000. 'Clinical presentation 
of non-typhoidal Salmonella bacteraemia in Malawian children', Trans R Soc Trop Med Hyg, 
94: 310-4. 
Grant, A. J., F. J. Morgan, T. J. McKinley, G. L. Foster, D. J. Maskell, and P. Mastroeni. 2012. 'Attenuated 
Salmonella Typhimurium lacking the pathogenicity island-2 type 3 secretion system grow to 
high bacterial numbers inside phagocytes in mice', PLoS Pathog, 8: e1003070. 
Grant, A. J., O. Restif, T. J. McKinley, M. Sheppard, D. J. Maskell, and P. Mastroeni. 2008. 'Modelling 
within-host spatiotemporal dynamics of invasive bacterial disease', PLoS Biol, 6: e74. 
Groisman, E. A., and H. Ochman. 1996. 'Pathogenicity islands: bacterial evolution in quantum leaps', 
Cell, 87: 791-4. 
———. 1997. 'How Salmonella became a pathogen', Trends Microbiol, 5: 343-9. 
99 
 
Gruenheid, S., E. Pinner, M. Desjardins, and P. Gros. 1997. 'Natural resistance to infection with 
intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome', 
The Journal of experimental medicine, 185: 717-30. 
Guibourdenche, M., P. Roggentin, M. Mikoleit, P. I. Fields, J. Bockemuhl, P. A. Grimont, and F. X. Weill. 
2010. 'Supplement 2003-2007 (No. 47) to the White-Kauffmann-Le Minor scheme', Res 
Microbiol, 161: 26-9. 
Guignot, J., E. Caron, C. Beuzon, C. Bucci, J. Kagan, C. Roy, and D. W. Holden. 2004. 'Microtubule motors 
control membrane dynamics of Salmonella-containing vacuoles', J Cell Sci, 117: 1033-45. 
Guiney, D. G., and J. Fierer. 2011. 'The Role of the spv Genes in Salmonella Pathogenesis', Front 
Microbiol, 2: 129. 
Gulig, P. A., H. Danbara, D. G. Guiney, A. J. Lax, F. Norel, and M. Rhen. 1993. 'Molecular analysis of spv 
virulence genes of the Salmonella virulence plasmids', Mol Microbiol, 7: 825-30. 
Gulig, P. A., and T. J. Doyle. 1993. 'The Salmonella typhimurium virulence plasmid increases the growth 
rate of salmonellae in mice', Infect Immun, 61: 504-11. 
Habte, L., E. Tadesse, G. Ferede, and A. Amsalu. 2018. 'Typhoid fever: clinical presentation and 
associated factors in febrile patients visiting Shashemene Referral Hospital, southern Ethiopia', 
BMC Res Notes, 11: 605. 
Hackam, D. J., O. D. Rotstein, W. Zhang, S. Gruenheid, P. Gros, and S. Grinstein. 1998. 'Host resistance 
to intracellular infection: mutation of natural resistance-associated macrophage protein 1 
(Nramp1) impairs phagosomal acidification', J Exp Med, 188: 351-64. 
Hale, C. R., E. Scallan, A. B. Cronquist, J. Dunn, K. Smith, T. Robinson, S. Lathrop, M. Tobin-D'Angelo, 
and P. Clogher. 2012. 'Estimates of enteric illness attributable to contact with animals and their 
environments in the United States', Clin Infect Dis, 54 Suppl 5: S472-9. 
Hansen-Wester, I., B. Stecher, and M. Hensel. 2002. 'Type III secretion of Salmonella enterica serovar 
Typhimurium translocated effectors and SseFG', Infect Immun, 70: 1403-9. 
Hapfelmeier, S., B. Stecher, M. Barthel, M. Kremer, A. J. Muller, M. Heikenwalder, T. Stallmach, M. 
Hensel, K. Pfeffer, S. Akira, and W. D. Hardt. 2005. 'The Salmonella pathogenicity island (SPI)-
2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis 
via MyD88-dependent and MyD88-independent mechanisms', J Immunol, 174: 1675-85. 
Haraga, A., and S. I. Miller. 2003. 'A Salmonella enterica serovar typhimurium translocated leucine-rich 
repeat effector protein inhibits NF-kappa B-dependent gene expression', Infect Immun, 71: 
4052-8. 
———. 2006. 'A Salmonella type III secretion effector interacts with the mammalian serine/threonine 
protein kinase PKN1', Cell Microbiol, 8: 837-46. 
Haraga, A., M. B. Ohlson, and S. I. Miller. 2008. 'Salmonellae interplay with host cells', Nat Rev 
Microbiol, 6: 53-66. 
Hardy, A. 1999. 'Food, hygiene, and the laboratory. A short history of food poisoning in Britain, circa 
1850-1950', Soc Hist Med, 12: 293-311. 
Harper, J., A. Mould, R. M. Andrews, E. K. Bikoff, and E. J. Robertson. 2011. 'The transcriptional 
repressor Blimp1/Prdm1 regulates postnatal reprogramming of intestinal enterocytes', Proc 
Natl Acad Sci U S A, 108: 10585-90. 
Harrison, R. E., J. H. Brumell, A. Khandani, C. Bucci, C. C. Scott, X. Jiang, B. B. Finlay, and S. Grinstein. 
2004. 'Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles', 
Mol Biol Cell, 15: 3146-54. 
Harrison, R. E., C. Bucci, O. V. Vieira, T. A. Schroer, and S. Grinstein. 2003. 'Phagosomes fuse with late 
endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role 
of Rab7 and RILP', Mol Cell Biol, 23: 6494-506. 
Hartmann, F. A., R. J. Callan, S. M. McGuirk, and S. E. West. 1996. 'Control of an outbreak of 
salmonellosis caused by drug-resistant Salmonella anatum in horses at a veterinary hospital 
and measures to prevent future infections', J Am Vet Med Assoc, 209: 629-31. 
Hase, K., K. Kawano, T. Nochi, G. S. Pontes, S. Fukuda, M. Ebisawa, K. Kadokura, T. Tobe, Y. Fujimura, 
S. Kawano, A. Yabashi, S. Waguri, G. Nakato, S. Kimura, T. Murakami, M. Iimura, K. Hamura, S. 
100 
 
Fukuoka, A. W. Lowe, K. Itoh, H. Kiyono, and H. Ohno. 2009. 'Uptake through glycoprotein 2 of 
FimH(+) bacteria by M cells initiates mucosal immune response', Nature, 462: 226-30. 
Havelaar, A. H., M. D. Kirk, P. R. Torgerson, H. J. Gibb, T. Hald, R. J. Lake, N. Praet, D. C. Bellinger, N. R. 
de Silva, N. Gargouri, N. Speybroeck, A. Cawthorne, C. Mathers, C. Stein, F. J. Angulo, B. 
Devleesschauwer, and Group World Health Organization Foodborne Disease Burden 
Epidemiology Reference. 2015. 'World Health Organization Global Estimates and Regional 
Comparisons of the Burden of Foodborne Disease in 2010', PLoS Med, 12: e1001923. 
Heithoff, D. M., C. P. Conner, U. Hentschel, F. Govantes, P. C. Hanna, and M. J. Mahan. 1999. 
'Coordinate intracellular expression of Salmonella genes induced during infection', Journal of 
bacteriology, 181: 799-807. 
Helaine, S., J. A. Thompson, K. G. Watson, M. Liu, C. Boyle, and D. W. Holden. 2010. 'Dynamics of 
intracellular bacterial replication at the single cell level', Proc Natl Acad Sci U S A, 107: 3746-
51. 
Hendriksen, S. W., K. Orsel, J. A. Wagenaar, A. Miko, and E. van Duijkeren. 2004. 'Animal-to-human 
transmission of Salmonella Typhimurium DT104A variant', Emerg Infect Dis, 10: 2225-7. 
Henry, T., C. Couillault, P. Rockenfeller, E. Boucrot, A. Dumont, N. Schroeder, A. Hermant, L. A. Knodler, 
P. Lecine, O. Steele-Mortimer, J. P. Borg, J. P. Gorvel, and S. Meresse. 2006. 'The Salmonella 
effector protein PipB2 is a linker for kinesin-1', Proc Natl Acad Sci U S A, 103: 13497-502. 
Hensel, M., T. Nikolaus, and C. Egelseer. 1999. 'Molecular and functional analysis indicates a mosaic 
structure of Salmonella pathogenicity island 2', Mol Microbiol, 31: 489-98. 
Hensel, M., J. E. Shea, A. J. Baumler, C. Gleeson, F. Blattner, and D. W. Holden. 1997. 'Analysis of the 
boundaries of Salmonella pathogenicity island 2 and the corresponding chromosomal region 
of Escherichia coli K-12', J Bacteriol, 179: 1105-11. 
Hensel, M., J. E. Shea, C. Gleeson, M. D. Jones, E. Dalton, and D. W. Holden. 1995. 'Simultaneous 
identification of bacterial virulence genes by negative selection', Science, 269: 400-3. 
Hensel, M., J. E. Shea, S. R. Waterman, R. Mundy, T. Nikolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, 
F. C. Fang, and D. W. Holden. 1998. 'Genes encoding putative effector proteins of the type III 
secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and 
proliferation in macrophages', Mol Microbiol, 30: 163-74. 
Hoelzer, K., A. I. Moreno Switt, and M. Wiedmann. 2011. 'Animal contact as a source of human non-
typhoidal salmonellosis', Vet Res, 42: 34. 
Holt, K. E., J. Parkhill, C. J. Mazzoni, P. Roumagnac, F. X. Weill, I. Goodhead, R. Rance, S. Baker, D. J. 
Maskell, J. Wain, C. Dolecek, M. Achtman, and G. Dougan. 2008. 'High-throughput sequencing 
provides insights into genome variation and evolution in Salmonella Typhi', Nat Genet, 40: 987-
93. 
Hornef, M. W., and M. Fulde. 2014. 'Ontogeny of intestinal epithelial innate immune responses', Front 
Immunol, 5: 474. 
Hornick, R. B., S. E. Greisman, T. E. Woodward, H. L. DuPont, A. T. Dawkins, and M. J. Snyder. 1970. 
'Typhoid fever: pathogenesis and immunologic control', N Engl J Med, 283: 686-91. 
Houghteling, P. D., and W. A. Walker. 2015. 'Why is initial bacterial colonization of the intestine 
important to infants' and children's health?', J Pediatr Gastroenterol Nutr, 60: 294-307. 
Hughes, L. E., E. A. Gibson, H. E. Roberts, E. T. Davies, G. Davies, and W. J. Sojka. 1971. 'Bovine 
salmonellosis in England and Wales', Br Vet J, 127: 225-38. 
Humphrey, T. J., G. C. Mead, and B. Rowe. 1988. 'Poultry meat as a source of human salmonellosis in 
England and Wales. Epidemiological overview', Epidemiol Infect, 100: 175-84. 
Ibarra, J. A., and O. Steele-Mortimer. 2009. 'Salmonella--the ultimate insider. Salmonella virulence 
factors that modulate intracellular survival', Cell Microbiol, 11: 1579-86. 
Ilg, K., K. Endt, B. Misselwitz, B. Stecher, M. Aebi, and W. D. Hardt. 2009. 'O-antigen-negative 
Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits 
colitis in streptomycin-treated mice', Infect Immun, 77: 2568-75. 
Ilyas, B., C. N. Tsai, and B. K. Coombes. 2017. 'Evolution of Salmonella-Host Cell Interactions through a 
Dynamic Bacterial Genome', Front Cell Infect Microbiol, 7: 428. 
101 
 
Issenhuth-Jeanjean, S., P. Roggentin, M. Mikoleit, M. Guibourdenche, E. de Pinna, S. Nair, P. I. Fields, 
and F. X. Weill. 2014. 'Supplement 2008-2010 (no. 48) to the White-Kauffmann-Le Minor 
scheme', Res Microbiol, 165: 526-30. 
Iwasaki, A., and R. Medzhitov. 2004. 'Toll-like receptor control of the adaptive immune responses', Nat 
Immunol, 5: 987-95. 
Jackson, L. K., P. Nawabi, C. Hentea, E. A. Roark, and K. Haldar. 2008. 'The Salmonella virulence protein 
SifA is a G protein antagonist', Proc Natl Acad Sci U S A, 105: 14141-6. 
Jajere, S. M. 2019. 'A review of Salmonella enterica with particular focus on the pathogenicity and 
virulence factors, host specificity and antimicrobial resistance including multidrug resistance', 
Vet World, 12: 504-21. 
Janeway, C. A., Jr. 1989. 'Approaching the asymptote? Evolution and revolution in immunology', Cold 
Spring Harb Symp Quant Biol, 54 Pt 1: 1-13. 
Jee, J., R. Mourya, P. Shivakumar, L. Fei, M. Wagner, and J. A. Bezerra. 2017. 'Cxcr2 signaling and the 
microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary 
atresia', PLoS One, 12: e0182089. 
Jepson, M. A., and M. A. Clark. 2001. 'The role of M cells in Salmonella infection', Microbes Infect, 3: 
1183-90. 
Johnson, R., E. Mylona, and G. Frankel. 2018. 'Typhoidal Salmonella: Distinctive virulence factors and 
pathogenesis', Cell Microbiol, 20: e12939. 
Jones, B. D., N. Ghori, and S. Falkow. 1994. 'Salmonella typhimurium initiates murine infection by 
penetrating and destroying the specialized epithelial M cells of the Peyer's patches', J Exp Med, 
180: 15-23. 
Juven, B. J., N. A. Cox, J. S. Bailey, J. E. Thomson, O. W. Charles, and J. V. Shutze. 1984. 'Survival of 
Salmonella in Dry Food and Feed', J Food Prot, 47: 445-48. 
Kaiser, P., M. Diard, B. Stecher, and W. D. Hardt. 2012. 'The streptomycin mouse model for Salmonella 
diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's 
mucosal immune response', Immunol Rev, 245: 56-83. 
Kaiser, P., R. R. Regoes, T. Dolowschiak, S. Y. Wotzka, J. Lengefeld, E. Slack, A. J. Grant, M. Ackermann, 
and W. D. Hardt. 2014. 'Cecum lymph node dendritic cells harbor slow-growing bacteria 
phenotypically tolerant to antibiotic treatment', PLoS Biol, 12: e1001793. 
Kaiser, P., E. Slack, A. J. Grant, W. D. Hardt, and R. R. Regoes. 2013. 'Lymph node colonization dynamics 
after oral Salmonella Typhimurium infection in mice', PLoS Pathog, 9: e1003532. 
Kawai, T., and S. Akira. 2005. 'Pathogen recognition with Toll-like receptors', Curr Opin Immunol, 17: 
338-44. 
Keerthirathne, T. P., K. Ross, H. Fallowfield, and H. Whiley. 2016. 'A Review of Temperature, pH, and 
Other Factors that Influence the Survival of Salmonella in Mayonnaise and Other Raw Egg 
Products', Pathogens, 5. 
Kelly, D., R. Begbie, and T. P. King. 1992. 'Postnatal intestinal development', BSAP Occasional 
Publication, 15: 63-79. 
Kim, Y. M., B. J. Schmidt, A. S. Kidwai, M. B. Jones, B. L. Deatherage Kaiser, H. M. Brewer, H. D. Mitchell, 
B. O. Palsson, J. E. McDermott, F. Heffron, R. D. Smith, S. N. Peterson, C. Ansong, D. R. Hyduke, 
T. O. Metz, and J. N. Adkins. 2013. 'Salmonella modulates metabolism during growth under 
conditions that induce expression of virulence genes', Mol Biosyst, 9: 1522-34. 
Kingsley, R. A., and A. J. Bäumler. 2000. 'Host adaptation and the emergence of infectious disease: the 
Salmonella paradigm', Mol Microbiol, 36: 1006-14. 
Klotz, S. A., J. H. Jorgensen, F. J. Buckwold, and P. C. Craven. 1984. 'Typhoid fever. An epidemic with 
remarkably few clinical signs and symptoms', Arch Intern Med, 144: 533-7. 
Knodler, L. A. 2015. 'Salmonella enterica: living a double life in epithelial cells', Curr Opin Microbiol, 23: 
23-31. 
Knodler, L. A., and O. Steele-Mortimer. 2005. 'The Salmonella effector PipB2 affects late 
endosome/lysosome distribution to mediate Sif extension', Mol Biol Cell, 16: 4108-23. 
102 
 
Knodler, L. A., B. A. Vallance, J. Celli, S. Winfree, B. Hansen, M. Montero, and O. Steele-Mortimer. 2010. 
'Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia', 
Proc Natl Acad Sci U S A, 107: 17733-8. 
Knodler, L. A., B. A. Vallance, M. Hensel, D. Jackel, B. B. Finlay, and O. Steele-Mortimer. 2003. 
'Salmonella type III effectors PipB and PipB2 are targeted to detergent-resistant microdomains 
on internal host cell membranes', Mol Microbiol, 49: 685-704. 
Kolodziejek, A. M., and S. I. Miller. 2015. 'Salmonella modulation of the phagosome membrane, role 
of SseJ', Cell Microbiol, 17: 333-41. 
Kraehenbuhl, J. P., C. Bron, and B. Sordat. 1979. 'Transfer of humoral secretory and cellular immunity 
from mother to offspring', Curr Top Pathol, 66: 105-57. 
Krieger, V., D. Liebl, Y. Zhang, R. Rajashekar, P. Chlanda, K. Giesker, D. Chikkaballi, and M. Hensel. 2014. 
'Reorganization of the endosomal system in Salmonella-infected cells: the ultrastructure of 
Salmonella-induced tubular compartments', PLoS Pathog, 10: e1004374. 
Kubori, T., Y. Matsushima, D. Nakamura, J. Uralil, M. Lara-Tejero, A. Sukhan, J. E. Galan, and S. I. Aizawa. 
1998. 'Supramolecular structure of the Salmonella typhimurium type III protein secretion 
system', Science, 280: 602-5. 
Kuhle, V., and M. Hensel. 2002. 'SseF and SseG are translocated effectors of the type III secretion 
system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal 
compartments', Cell Microbiol, 4: 813-24. 
———. 2004. 'Cellular microbiology of intracellular Salmonella enterica: functions of the type III 
secretion system encoded by Salmonella pathogenicity island 2', Cell Mol Life Sci, 61: 2812-26. 
Kuhle, V., D. Jackel, and M. Hensel. 2004. 'Effector proteins encoded by Salmonella pathogenicity island 
2 interfere with the microtubule cytoskeleton after translocation into host cells', Traffic, 5: 
356-70. 
Kumagai, N., R. Baba, Y. Sakuma, K. Arita, M. Shinohara, M. Kourogi, S. Fujimoto, and M. Fujita. 2011. 
'Origin of the apical transcytic membrane system in jejunal absorptive cells of neonates', Med 
Mol Morphol, 44: 71-8. 
Langridge, G. C., M. Fookes, T. R. Connor, T. Feltwell, N. Feasey, B. N. Parsons, H. M. Seth-Smith, L. 
Barquist, A. Stedman, T. Humphrey, P. Wigley, S. E. Peters, D. J. Maskell, J. Corander, J. A. 
Chabalgoity, P. Barrow, J. Parkhill, G. Dougan, and N. R. Thomson. 2015. 'Patterns of genome 
evolution that have accompanied host adaptation in Salmonella', Proc Natl Acad Sci U S A, 112: 
863-8. 
Langridge, G. C., J. Wain, and S. Nair. 2012. 'Invasive Salmonellosis in Humans', EcoSal Plus, 5. 
LaRock, D. L., A. Chaudhary, and S. I. Miller. 2015. 'Salmonellae interactions with host processes', Nat 
Rev Microbiol, 13: 191-205. 
Lawley, T. D., D. M. Bouley, Y. E. Hoy, C. Gerke, D. A. Relman, and D. M. Monack. 2008. 'Host 
transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors 
and indigenous intestinal microbiota', Infect Immun, 76: 403-16. 
Lee, C. A., M. Silva, A. M. Siber, A. J. Kelly, E. Galyov, and B. A. McCormick. 2000. 'A secreted Salmonella 
protein induces a proinflammatory response in epithelial cells, which promotes neutrophil 
migration', Proc Natl Acad Sci U S A, 97: 12283-8. 
Lei, L., W. Wang, C. Xia, and F. Liu. 2016. 'Salmonella Virulence Factor SsrAB Regulated Factor 
Modulates Inflammatory Responses by Enhancing the Activation of NF-kappaB Signaling 
Pathway', J Immunol, 196: 792-802. 
Lestari, S. I., F. Han, F. Wang, and B. Ge. 2009. 'Prevalence and antimicrobial resistance of Salmonella 
serovars in conventional and organic chickens from Louisiana retail stores', J Food Prot, 72: 
1165-72. 
Leung, K Y, and B B Finlay. 1991. 'Intracellular replication is essential for the virulence of Salmonella 
typhimurium', Proceedings of the National Academy of Sciences, 88: 11470-74. 
Lim, C. H., S. Voedisch, B. Wahl, S. F. Rouf, R. Geffers, M. Rhen, and O. Pabst. 2014. 'Independent 
bottlenecks characterize colonization of systemic compartments and gut lymphoid tissue by 
salmonella', PLoS Pathog, 10: e1004270. 
103 
 
Lim, S., M. Kim, J. Choi, and S. Ryu. 2010. 'A mutation in tdcA attenuates the virulence of Salmonella 
enterica serovar Typhimurium', Mol Cells, 29: 509-17. 
Liss, V., A. L. Swart, A. Kehl, N. Hermanns, Y. Zhang, D. Chikkaballi, N. Bohles, J. Deiwick, and M. Hensel. 
2017. 'Salmonella enterica Remodels the Host Cell Endosomal System for Efficient 
Intravacuolar Nutrition', Cell Host Microbe, 21: 390-402. 
Loomis, W. P., M. L. Johnson, A. Brasfield, M. P. Blanc, J. Yi, S. I. Miller, B. T. Cookson, and A. M. Hajjar. 
2014. 'Temporal and anatomical host resistance to chronic Salmonella infection is 
quantitatively dictated by Nramp1 and influenced by host genetic background', PLoS One, 9: 
e111763. 
Lotz, M., D. Gutle, S. Walther, S. Menard, C. Bogdan, and M. W. Hornef. 2006. 'Postnatal acquisition of 
endotoxin tolerance in intestinal epithelial cells', J Exp Med, 203: 973-84. 
Machado, J. R., D. F. Soave, M. V. da Silva, L. B. de Menezes, R. M. Etchebehere, M. L. Monteiro, M. A. 
dos Reis, R. R. Correa, and M. R. Celes. 2014. 'Neonatal sepsis and inflammatory mediators', 
Mediators Inflamm, 2014: 269681. 
Macierzanka, A., A. R. Mackie, B. H. Bajka, N. M. Rigby, F. Nau, and D. Dupont. 2014. 'Transport of 
particles in intestinal mucus under simulated infant and adult physiological conditions: impact 
of mucus structure and extracellular DNA', PLoS One, 9: e95274. 
MacLennan, C. A., E. N. Gondwe, C. L. Msefula, R. A. Kingsley, N. R. Thomson, S. A. White, M. Goodall, 
D. J. Pickard, S. M. Graham, G. Dougan, C. A. Hart, M. E. Molyneux, and M. T. Drayson. 2008. 
'The neglected role of antibody in protection against bacteremia caused by nontyphoidal 
strains of Salmonella in African children', J Clin Invest, 118: 1553-62. 
Maier, L., M. Diard, M. E. Sellin, E. S. Chouffane, K. Trautwein-Weidner, B. Periaswamy, E. Slack, T. 
Dolowschiak, B. Stecher, C. Loverdo, R. R. Regoes, and W. D. Hardt. 2014. 'Granulocytes impose 
a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium 
colitis', PLoS Pathog, 10: e1004557. 
Majowicz, S. E., J. Musto, E. Scallan, F. J. Angulo, M. Kirk, S. J. O'Brien, T. F. Jones, A. Fazil, R. M. 
Hoekstra, and Studies International Collaboration on Enteric Disease 'Burden of Illness. 2010. 
'The global burden of nontyphoidal Salmonella gastroenteritis', Clin Infect Dis, 50: 882-9. 
Malik-Kale, P., S. Winfree, and O. Steele-Mortimer. 2012. 'The bimodal lifestyle of intracellular 
Salmonella in epithelial cells: replication in the cytosol obscures defects in vacuolar 
replication', PLoS One, 7: e38732. 
Marcus, S. L., J. H. Brumell, C. G. Pfeifer, and B. B. Finlay. 2000. 'Salmonella pathogenicity islands: big 
virulence in small packages', Microbes Infect, 2: 145-56. 
Marlovits, T. C., and C. E. Stebbins. 2010. 'Type III secretion systems shape up as they ship out', Curr 
Opin Microbiol, 13: 47-52. 
Martinoli, C., A. Chiavelli, and M. Rescigno. 2007. 'Entry route of Salmonella typhimurium directs the 
type of induced immune response', Immunity, 27: 975-84. 
Mastroeni, P., and A. J. Grant. 2011. 'Spread of Salmonella enterica in the body during systemic 
infection: unravelling host and pathogen determinants', Expert Rev Mol Med, 13: e12. 
Mastroeni, P., A. Grant, O. Restif, and D. Maskell. 2009. 'A dynamic view of the spread and intracellular 
distribution of Salmonella enterica', Nat Rev Microbiol, 7: 73-80. 
Mastroeni, P., S. Ugrinovic, A. Chandra, C. MacLennan, R. Doffinger, and D. Kumararatne. 2003. 
'Resistance and susceptibility to Salmonella infections: lessons from mice and patients with 
immunodeficiencies', Reviews in Medical Microbiology, 14: 53-62. 
Mastroeni, P., A. Vazquez-Torres, F. C. Fang, Y. Xu, S. Khan, C. E. Hormaeche, and G. Dougan. 2000. 
'Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in 
experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo', J Exp 
Med, 192: 237-48. 
Matsui, H., C. M. Bacot, W. A. Garlington, T. J. Doyle, S. Roberts, and P. A. Gulig. 2001. 'Virulence 
plasmid-borne spvB and spvC genes can replace the 90-kilobase plasmid in conferring 
virulence to Salmonella enterica serovar Typhimurium in subcutaneously inoculated mice', J 
Bacteriol, 183: 4652-8. 
104 
 
McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. 
Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. 
Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. 
Wilson. 2001. 'Complete genome sequence of Salmonella enterica serovar Typhimurium LT2', 
Nature, 413: 852-6. 
McGourty, K., T. L. Thurston, S. A. Matthews, L. Pinaud, L. J. Mota, and D. W. Holden. 2012. 'Salmonella 
inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function', 
Science, 338: 963-7. 
McNamee, P. T., and J. A. Smyth. 2000. 'Bacterial chondronecrosis with osteomyelitis ('femoral head 
necrosis') of broiler chickens: a review', Avian Pathol, 29: 477-95. 
Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. 
1999. 'Food-related illness and death in the United States', Emerg Infect Dis, 5: 607-25. 
Medzhitov, R. 2007. 'Recognition of microorganisms and activation of the immune response', Nature, 
449: 819-26. 
Menard, S., V. Forster, M. Lotz, D. Gutle, C. U. Duerr, R. L. Gallo, B. Henriques-Normark, K. Putsep, M. 
Andersson, E. O. Glocker, and M. W. Hornef. 2008. 'Developmental switch of intestinal 
antimicrobial peptide expression', J Exp Med, 205: 183-93. 
Meresse, S., O. Steele-Mortimer, B. B. Finlay, and J. P. Gorvel. 1999. 'The rab7 GTPase controls the 
maturation of Salmonella typhimurium-containing vacuoles in HeLa cells', EMBO J, 18: 4394-
403. 
Mezal, E. H., A. Sabol, M. A. Khan, N. Ali, R. Stefanova, and A. A. Khan. 2014. 'Isolation and molecular 
characterization of Salmonella enterica serovar Enteritidis from poultry house and clinical 
samples during 2010', Food Microbiol, 38: 67-74. 
Miao, E. A., M. Brittnacher, A. Haraga, R. L. Jeng, M. D. Welch, and S. I. Miller. 2003. 'Salmonella 
effectors translocated across the vacuolar membrane interact with the actin cytoskeleton', 
Mol Microbiol, 48: 401-15. 
Miao, E. A., and S. I. Miller. 2000. 'A conserved amino acid sequence directing intracellular type III 
secretion by Salmonella typhimurium', Proc Natl Acad Sci U S A, 97: 7539-44. 
Michetti, P., M. J. Mahan, J. M. Slauch, J. J. Mekalanos, and M. R. Neutra. 1992. 'Monoclonal secretory 
immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella 
typhimurium', Infect Immun, 60: 1786-92. 
Miki, T., R. Goto, M. Fujimoto, N. Okada, and W. D. Hardt. 2017. 'The Bactericidal Lectin RegIIIbeta 
Prolongs Gut Colonization and Enteropathy in the Streptomycin Mouse Model for Salmonella 
Diarrhea', Cell Host Microbe, 21: 195-207. 
Miki, T., and W. D. Hardt. 2013. 'Outer membrane permeabilization is an essential step in the killing of 
gram-negative bacteria by the lectin RegIIIbeta', PLoS One, 8: e69901. 
Miller, S. I., A. M. Kukral, and J. J. Mekalanos. 1989. 'A two-component regulatory system (phoP phoQ) 
controls Salmonella typhimurium virulence', Proceedings of the National Academy of Sciences 
of the United States of America, 86: 5054-58. 
Mills, D. M., V. Bajaj, and C. A. Lee. 1995. 'A 40 kb chromosomal fragment encoding Salmonella 
typhimurium invasion genes is absent from the corresponding region of the Escherichia coli K-
12 chromosome', Mol Microbiol, 15: 749-59. 
Mogasale, V., S. N. Desai, V. V. Mogasale, J. K. Park, R. L. Ochiai, and T. F. Wierzba. 2014. 'Case fatality 
rate and length of hospital stay among patients with typhoid intestinal perforation in 
developing countries: a systematic literature review', PLoS One, 9: e93784. 
Mogasale, V., B. Maskery, R. L. Ochiai, J. S. Lee, V. V. Mogasale, E. Ramani, Y. E. Kim, J. K. Park, and T. 
F. Wierzba. 2014. 'Burden of typhoid fever in low-income and middle-income countries: a 
systematic, literature-based update with risk-factor adjustment', Lancet Glob Health, 2: e570-
80. 
Monack, D. M., A. Mueller, and S. Falkow. 2004. 'Persistent bacterial infections: the interface of the 
pathogen and the host immune system', Nat Rev Microbiol, 2: 747-65. 
105 
 
Moon, H. W. 1972. 'Vacuolated villous epithelium of the small intestine of young pigs', Vet Pathol, 9: 
3-21. 
Morpeth, S. C., H. O. Ramadhani, and J. A. Crump. 2009. 'Invasive non-Typhi Salmonella disease in 
Africa', Clin Infect Dis, 49: 606-11. 
Mota, L. J., A. E. Ramsden, M. Liu, J. D. Castle, and D. W. Holden. 2009. 'SCAMP3 is a component of the 
Salmonella-induced tubular network and reveals an interaction between bacterial effectors 
and post-Golgi trafficking', Cell Microbiol, 11: 1236-53. 
Moxey, P. C., and J. S. Trier. 1979. 'Development of villus absorptive cells in the human fetal small 
intestine: a morphological and morphometric study', Anat Rec, 195: 463-82. 
Mueller, C. A., P. Broz, and G. R. Cornelis. 2008. 'The type III secretion system tip complex and 
translocon', Mol Microbiol, 68: 1085-95. 
Muller, A. J., P. Kaiser, K. E. Dittmar, T. C. Weber, S. Haueter, K. Endt, P. Songhet, C. Zellweger, M. 
Kremer, H. J. Fehling, and W. D. Hardt. 2012. 'Salmonella gut invasion involves TTSS-2-
dependent epithelial traversal, basolateral exit, and uptake by epithelium-sampling lamina 
propria phagocytes', Cell Host Microbe, 11: 19-32. 
Muncan, V., J. Heijmans, S. D. Krasinski, N. V. Buller, M. E. Wildenberg, S. Meisner, M. Radonjic, K. A. 
Stapleton, W. H. Lamers, I. Biemond, M. A. van den Bergh Weerman, D. O'Carroll, J. C. 
Hardwick, D. W. Hommes, and G. R. van den Brink. 2011. 'Blimp1 regulates the transition of 
neonatal to adult intestinal epithelium', Nat Commun, 2: 452. 
Newton, K., and V. M. Dixit. 2012. 'Signaling in innate immunity and inflammation', Cold Spring Harb 
Perspect Biol, 4. 
Noster, J., T. C. Chao, N. Sander, M. Schulte, T. Reuter, N. Hansmeier, and M. Hensel. 2019. 'Proteomics 
of intracellular Salmonella enterica reveals roles of Salmonella pathogenicity island 2 in 
metabolism and antioxidant defense', PLoS Pathog, 15: e1007741. 
Nyirenda, T. S., J. J. Gilchrist, N. A. Feasey, S. J. Glennie, N. Bar-Zeev, M. A. Gordon, C. A. MacLennan, 
W. L. Mandala, and R. S. Heyderman. 2014. 'Sequential acquisition of T cells and antibodies to 
nontyphoidal Salmonella in Malawian children', J Infect Dis, 210: 56-64. 
O'Brien, A. D., D. L. Rosenstreich, I. Scher, G. H. Campbell, R. P. MacDermott, and S. B. Formal. 1980. 
'Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene', J 
Immunol, 124: 20-4. 
Ochman, H., and E. A. Groisman. 1996. 'Distribution of pathogenicity islands in Salmonella spp', Infect 
Immun, 64: 5410-2. 
Ochman, H., J. G. Lawrence, and E. A. Groisman. 2000. 'Lateral gene transfer and the nature of bacterial 
innovation', Nature, 405: 299-304. 
Ochman, H., F. C. Soncini, F. Solomon, and E. A. Groisman. 1996. 'Identification of a pathogenicity island 
required for Salmonella survival in host cells', Proc Natl Acad Sci U S A, 93: 7800-4. 
Ohlson, M. B., Z. Huang, N. M. Alto, M. P. Blanc, J. E. Dixon, J. Chai, and S. I. Miller. 2008. 'Structure and 
function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family 
GTPases induce endosomal tubulation', Cell Host Microbe, 4: 434-46. 
Ong, S. Y., C. B. Pratap, X. Wan, S. Hou, A. Y. Rahman, J. A. Saito, G. Nath, and M. Alam. 2013. 'The 
Genomic Blueprint of Salmonella enterica subspecies enterica serovar Typhi P-stx-12', Stand 
Genomic Sci, 7: 483-96. 
Pabst, O. 2012. 'New concepts in the generation and functions of IgA', Nat Rev Immunol, 12: 821-32. 
Pabst, O., H. Herbrand, T. Worbs, M. Friedrichsen, S. Yan, M. W. Hoffmann, H. Korner, G. Bernhardt, R. 
Pabst, and R. Forster. 2005. 'Cryptopatches and isolated lymphoid follicles: dynamic lymphoid 
tissues dispensable for the generation of intraepithelial lymphocytes', Eur J Immunol, 35: 98-
107. 
Palm, W. 2019. 'Metabolic functions of macropinocytosis', Philos Trans R Soc Lond B Biol Sci, 374: 
20180285. 
Patel, J. C., and J. E. Galan. 2005. 'Manipulation of the host actin cytoskeleton by Salmonella--all in the 
name of entry', Curr Opin Microbiol, 8: 10-5. 
106 
 
Patel, S., D. M. Wall, A. Castillo, and B. A. McCormick. 2019. 'Caspase-3 cleavage of Salmonella type III 
secreted effector protein SifA is required for localization of functional domains and bacterial 
dissemination', Gut Microbes, 10: 172-87. 
Pees, M., W. Rabsch, B. Plenz, A. Fruth, R. Prager, S. Simon, V. Schmidt, S. Munch, and P. Braun. 2013. 
'Evidence for the transmission of Salmonella from reptiles to children in Germany, July 2010 
to October 2011', Euro Surveill, 18. 
Peterson, L. W., and D. Artis. 2014. 'Intestinal epithelial cells: regulators of barrier function and immune 
homeostasis', Nat Rev Immunol, 14: 141-53. 
Petrie, L., I. E. Selman, M. Grindlay, and H. Thompson. 1977. 'Salmonellosis in young calves due to 
Salmonella enteritidis', Vet Rec, 101: 398-402. 
Poh, J., C. Odendall, A. Spanos, C. Boyle, M. Liu, P. Freemont, and D. W. Holden. 2008. 'SteC is a 
Salmonella kinase required for SPI-2-dependent F-actin remodelling', Cell Microbiol, 10: 20-30. 
Popoff, M. Y., J. Bockemuhl, and L. L. Gheesling. 2004. 'Supplement 2002 (no. 46) to the Kauffmann-
White scheme', Res Microbiol, 155: 568-70. 
Popp, J., J. Noster, K. Busch, A. Kehl, G. Zur Hellen, and M. Hensel. 2015. 'Role of host cell-derived 
amino acids in nutrition of intracellular Salmonella enterica', Infect Immun, 83: 4466-75. 
Prager, R., S. Mirold, E. Tietze, U. Strutz, B. Knuppel, W. Rabsch, W. D. Hardt, and H. Tschape. 2000. 
'Prevalence and polymorphism of genes encoding translocated effector proteins among 
clinical isolates of Salmonella enterica', Int J Med Microbiol, 290: 605-17. 
Prestinaci, F., P. Pezzotti, and A. Pantosti. 2015. 'Antimicrobial resistance: a global multifaceted 
phenomenon', Pathog Glob Health, 109: 309-18. 
Preziosi, M. J., S. M. Kandel, D. G. Guiney, and S. H. Browne. 2012. 'Microbiological analysis of 
nontyphoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in 
HIV/AIDS patients in San Diego, California', J Clin Microbiol, 50: 3598-603. 
Pui, C. F., W. C. Wong, L. C. Chai, T. Robin, J. Ponniah, M. S. Noor Hidayah, U. Anyi, M. G. Farinazleen, 
Y. K. Cheah, and R. Son. 2011. 'Review Article Salmonella: A foodborne pathogen', Int. Food 
Res. J., 18: 465-73. 
Quezada, C. M., S. W. Hicks, J. E. Galan, and C. E. Stebbins. 2009. 'A family of Salmonella virulence 
factors functions as a distinct class of autoregulated E3 ubiquitin ligases', Proc Natl Acad Sci U 
S A, 106: 4864-9. 
Rabsch, W., H. L. Andrews, R. A. Kingsley, R. Prager, H. Tschape, L. G. Adams, and A. J. Baumler. 2002. 
'Salmonella enterica serotype Typhimurium and its host-adapted variants', Infect Immun, 70: 
2249-55. 
Rakoff-Nahoum, S., Y. Kong, S. H. Kleinstein, S. Subramanian, P. P. Ahern, J. I. Gordon, and R. 
Medzhitov. 2015. 'Analysis of gene–environment interactions in postnatal development of the 
mammalian intestine', Proceedings of the National Academy of Sciences, 112: 1929-36. 
Ramsden, A. E., D. W. Holden, and L. J. Mota. 2007. 'Membrane dynamics and spatial distribution of 
Salmonella-containing vacuoles', Trends Microbiol, 15: 516-24. 
Rappl, C., J. Deiwick, and M. Hensel. 2003. 'Acidic pH is required for the functional assembly of the type 
III secretion system encoded by Salmonella pathogenicity island 2', FEMS Microbiol Lett, 226: 
363-72. 
Remis, N. N., T. Wiwatpanit, A. J. Castiglioni, E. N. Flores, J. A. Cantu, and J. Garcia-Anoveros. 2014. 
'Mucolipin co-deficiency causes accelerated endolysosomal vacuolation of enterocytes and 
failure-to-thrive from birth to weaning', PLoS Genet, 10: e1004833. 
Renz, H., B. D. Adkins, S. Bartfeld, R. S. Blumberg, D. L. Farber, J. Garssen, P. Ghazal, D. J. Hackam, B. J. 
Marsland, K. D. McCoy, J. Penders, I. Prinz, V. Verhasselt, E. von Mutius, J. N. Weiser, D. R. 
Wesemann, and M. W. Hornef. 2018. 'The neonatal window of opportunity-early priming for 
life', J Allergy Clin Immunol, 141: 1212-14. 
Renz, H., P. Brandtzaeg, and M. Hornef. 2012. 'The impact of perinatal immune development on 
mucosal homeostasis and chronic inflammation', Nat Rev Immunol, 12: 9-23. 
Reynolds, E. S. 1963. 'The use of lead citrate at high pH as an electron-opaque stain in electron 
microscopy', J Cell Biol, 17: 208-12. 
107 
 
Rhen, M., M. Virtanen, and P. H. Makela. 1989. 'Localization by insertion mutagenesis of a virulence-
associated region on the Salmonella typhimurium 96 kilobase pair plasmid', Microb Pathog, 6: 
153-8. 
Rice, D. H., T. E. Besser, and D. D. Hancock. 1997. 'Epidemiology and virulence assessment of 
Salmonella dublin', Vet Microbiol, 56: 111-24. 
Rivera-Chavez, F., and A. J. Bäumler. 2015. 'The Pyromaniac Inside You: Salmonella Metabolism in the 
Host Gut', Annu Rev Microbiol, 69: 31-48. 
Rohde, J. R., A. Breitkreutz, A. Chenal, P. J. Sansonetti, and C. Parsot. 2007. 'Type III secretion effectors 
of the IpaH family are E3 ubiquitin ligases', Cell Host Microbe, 1: 77-83. 
Rosa-Ferreira, C., and S. Munro. 2011. 'Arl8 and SKIP act together to link lysosomes to kinesin-1', Dev 
Cell, 21: 1171-8. 
Rouch, J. D., A. Scott, N. Y. Lei, R. S. Solorzano-Vargas, J. Wang, E. M. Hanson, M. Kobayashi, M. Lewis, 
M. G. Stelzner, J. C. Dunn, L. Eckmann, and M. G. Martin. 2016. 'Development of Functional 
Microfold (M) Cells from Intestinal Stem Cells in Primary Human Enteroids', PLoS One, 11: 
e0148216. 
Roudier, C., J. Fierer, and D. G. Guiney. 1992. 'Characterization of translation termination mutations in 
the spv operon of the Salmonella virulence plasmid pSDL2', J Bacteriol, 174: 6418-23. 
Roumagnac, P., F. X. Weill, C. Dolecek, S. Baker, S. Brisse, N. T. Chinh, T. A. Le, C. J. Acosta, J. Farrar, G. 
Dougan, and M. Achtman. 2006. 'Evolutionary history of Salmonella typhi', Science, 314: 1301-
4. 
Royle, M. C., S. Totemeyer, L. C. Alldridge, D. J. Maskell, and C. E. Bryant. 2003. 'Stimulation of Toll-like 
receptor 4 by lipopolysaccharide during cellular invasion by live Salmonella typhimurium is a 
critical but not exclusive event leading to macrophage responses', J Immunol, 170: 5445-54. 
Ruiz-Albert, J., X. J. Yu, C. R. Beuzon, A. N. Blakey, E. E. Galyov, and D. W. Holden. 2002. 'Complementary 
activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar 
membrane', Mol Microbiol, 44: 645-61. 
Rytkonen, A., J. Poh, J. Garmendia, C. Boyle, A. Thompson, M. Liu, P. Freemont, J. C. Hinton, and D. W. 
Holden. 2007. 'SseL, a Salmonella deubiquitinase required for macrophage killing and 
virulence', Proc Natl Acad Sci U S A, 104: 3502-7. 
Sabbagh, S. C., C. G. Forest, C. Lepage, J. M. Leclerc, and F. Daigle. 2010. 'So similar, yet so different: 
uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium 
and Typhi', FEMS Microbiol Lett, 305: 1-13. 
Salcedo, S. P., and D. W. Holden. 2003. 'SseG, a virulence protein that targets Salmonella to the Golgi 
network', EMBO J, 22: 5003-14. 
Salcedo, S. P., M. Noursadeghi, J. Cohen, and D. W. Holden. 2001. 'Intracellular replication of 
Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo', Cell 
Microbiol, 3: 587-97. 
Salzman, N. H., D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins. 2003. 'Protection against enteric 
salmonellosis in transgenic mice expressing a human intestinal defensin', Nature, 422: 522-6. 
Sansonetti, P. 2002. 'Host-pathogen interactions: the seduction of molecular cross talk', Gut, 50 Suppl 
3: III2-8. 
Santos, R. L., and A. J. Baumler. 2004. 'Cell tropism of Salmonella enterica', Int J Med Microbiol, 294: 
225-33. 
Santos, R. L., M. Raffatellu, C. L. Bevins, L. G. Adams, C. Tukel, R. M. Tsolis, and A. J. Baumler. 2009. 'Life 
in the inflamed intestine, Salmonella style', Trends Microbiol, 17: 498-506. 
Schroeder, B. O. 2019. 'Fight them or feed them: how the intestinal mucus layer manages the gut 
microbiota', Gastroenterology report, 7: 3-12. 
Schroeder, N., L. J. Mota, and S. Meresse. 2011. 'Salmonella-induced tubular networks', Trends 
Microbiol, 19: 268-77. 




Shea, J. E., C. R. Beuzon, C. Gleeson, R. Mundy, and D. W. Holden. 1999. 'Influence of the Salmonella 
typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the 
mouse', Infection and Immunity, 67: 213-19. 
Shea, J. E., M. Hensel, C. Gleeson, and D. W. Holden. 1996. 'Identification of a virulence locus encoding 
a second type III secretion system in Salmonella typhimurium', Proc Natl Acad Sci U S A, 93: 
2593-7. 
Sindhwani, A., S. B. Arya, H. Kaur, D. Jagga, A. Tuli, and M. Sharma. 2017. 'Salmonella exploits the host 
endolysosomal tethering factor HOPS complex to promote its intravacuolar replication', PLoS 
Pathog, 13: e1006700. 
Sivick, K. E., N. Arpaia, G. L. Reiner, B. L. Lee, B. R. Russell, and G. M. Barton. 2014. 'Toll-like receptor-
deficient mice reveal how innate immune signaling influences Salmonella virulence strategies', 
Cell Host Microbe, 15: 203-13. 
Skrzypek, T., S. Szymańczyk, K. Ferenc, W. Kazimierczak, K. Szczepaniak, and R. Zabielski. 2018. 'The 
contribution of vacuolated foetal-type enterocytes in the process of maturation of the small 
intestine in piglets. Invited review', Journal of Animal and Feed Sciences, 27: 187-201. 
Skrzypek, T., J. L. Valverde Piedra, H. Skrzypek, W. Kazimierczak, M. Biernat, and R. Zabielski. 2007. 
'Gradual disappearance of vacuolated enterocytes in the small intestine of neonatal piglets', J 
Physiol Pharmacol, 58 Suppl 3: 87-95. 
Sojka, W. J., C. Wray, and I. McLaren. 1986. 'A survey of drug resistance in salmonellae isolated from 
animals in England and Wales in 1982 and 1983', Br Vet J, 142: 371-80. 
Sojka, W. J., C. Wray, J. Shreeve, and A. J. Benson. 1977. 'Incidence of salmonella infection in animals 
in England and Wales 1968--1974', J Hyg (Lond), 78: 43-56. 
Sojka, W. J., C. Wray, J. E. Shreeve, and J. C. Bell. 1983. 'The incidence of salmonella infection in sheep 
in England and Wales, 1975 to 1981', Br Vet J, 139: 386-92. 
Spector, Michael P., and William J. Kenyon. 2012. 'Resistance and survival strategies of Salmonella 
enterica to environmental stresses', Food Research International, 45: 455-81. 
Srikanth, C. V., D. M. Wall, A. Maldonado-Contreras, H. Shi, D. Zhou, Z. Demma, K. L. Mumy, and B. A. 
McCormick. 2010. 'Salmonella pathogenesis and processing of secreted effectors by caspase-
3', Science, 330: 390-93. 
Staley, T. E., and L. J. Bush. 1985. 'Receptor mechanisms of the neonatal intestine and their relationship 
to immunoglobulin absorption and disease', J Dairy Sci, 68: 184-205. 
Stecher, B., M. Barthel, M. C. Schlumberger, L. Haberli, W. Rabsch, M. Kremer, and W. D. Hardt. 2008. 
'Motility allows S. Typhimurium to benefit from the mucosal defence', Cell Microbiol, 10: 1166-
80. 
Stecher, B., A. J. Macpherson, S. Hapfelmeier, M. Kremer, T. Stallmach, and W. D. Hardt. 2005. 
'Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice 
pretreated with streptomycin', Infect Immun, 73: 3228-41. 
Stecher, B., R. Robbiani, A. W. Walker, A. M. Westendorf, M. Barthel, M. Kremer, S. Chaffron, A. J. 
Macpherson, J. Buer, J. Parkhill, G. Dougan, C. von Mering, and W. D. Hardt. 2007. 'Salmonella 
enterica serovar typhimurium exploits inflammation to compete with the intestinal 
microbiota', PLoS Biol, 5: 2177-89. 
Steeb, B., B. Claudi, N. A. Burton, P. Tienz, A. Schmidt, H. Farhan, A. Maze, and D. Bumann. 2013. 
'Parallel exploitation of diverse host nutrients enhances Salmonella virulence', PLoS Pathog, 9: 
e1003301. 
Steele-Mortimer, O. 2008. 'The Salmonella-containing vacuole: moving with the times', Curr Opin 
Microbiol, 11: 38-45. 
Steele-Mortimer, O., J. H. Brumell, L. A. Knodler, S. Meresse, A. Lopez, and B. B. Finlay. 2002. 'The 
invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is 
necessary for intracellular proliferation and vacuole biogenesis in epithelial cells', Cell 
Microbiol, 4: 43-54. 
109 
 
Steele-Mortimer, O., S. Meresse, J. P. Gorvel, B. H. Toh, and B. B. Finlay. 1999. 'Biogenesis of Salmonella 
typhimurium-containing vacuoles in epithelial cells involves interactions with the early 
endocytic pathway', Cell Microbiol, 1: 33-49. 
Stein, M. A., K. Y. Leung, M. Zwick, F. Garcia-del Portillo, and B. B. Finlay. 1996. 'Identification of a 
Salmonella virulence gene required for formation of filamentous structures containing 
lysosomal membrane glycoproteins within epithelial cells', Mol Microbiol, 20: 151-64. 
Stockinger, S., C. U. Duerr, M. Fulde, T. Dolowschiak, J. Pott, I. Yang, D. Eibach, F. Backhed, S. Akira, S. 
Suerbaum, M. Brugman, and M. W. Hornef. 2014. 'TRIF signaling drives homeostatic intestinal 
epithelial antimicrobial peptide expression', J Immunol, 193: 4223-34. 
Strawn, L. K., M. D. Danyluk, R. W. Worobo, and M. Wiedmann. 2014. 'Distributions of Salmonella 
subtypes differ between two U.S. produce-growing regions', Appl Environ Microbiol, 80: 3982-
91. 
Tahoun, A., S. Mahajan, E. Paxton, G. Malterer, D. S. Donaldson, D. Wang, A. Tan, T. L. Gillespie, M. 
O'Shea, A. J. Roe, D. J. Shaw, D. L. Gally, A. Lengeling, N. A. Mabbott, J. Haas, and A. Mahajan. 
2012. 'Salmonella transforms follicle-associated epithelial cells into M cells to promote 
intestinal invasion', Cell Host Microbe, 12: 645-56. 
Taitt, C. R., Y. S. Shubin, R. Angel, and F. S. Ligler. 2004. 'Detection of Salmonella enterica serovar 
typhimurium by using a rapid, array-based immunosensor', Appl Environ Microbiol, 70: 152-8. 
Takaya, A., M. Suzuki, H. Matsui, T. Tomoyasu, H. Sashinami, A. Nakane, and T. Yamamoto. 2003. 'Lon, 
a stress-induced ATP-dependent protease, is critically important for systemic Salmonella 
enterica serovar typhimurium infection of mice', Infect Immun, 71: 690-6. 
Tanner, J. R., and R. A. Kingsley. 2018. 'Evolution of Salmonella within Hosts', Trends Microbiol, 26: 986-
98. 
Tauxe, R. V. 1997. 'Emerging foodborne diseases: an evolving public health challenge', Emerg Infect 
Dis, 3: 425-34. 
Tennant, S. M., C. A. MacLennan, R. Simon, L. B. Martin, and M. I. Khan. 2016. 'Nontyphoidal salmonella 
disease: Current status of vaccine research and development', Vaccine, 34: 2907-10. 
Thorne, G. M., and L. M. Corwin. 1975. 'Mutations affecting aromatic amino acid transport in 
Escherichia coli and Salmonella typhimurium', J Gen Microbiol, 90: 203-16. 
Torow, N., K. Yu, K. Hassani, J. Freitag, O. Schulz, M. Basic, A. Brennecke, T. Sparwasser, N. Wagner, A. 
Bleich, M. Lochner, S. Weiss, R. Forster, O. Pabst, and M. W. Hornef. 2015. 'Active suppression 
of intestinal CD4(+)TCRalphabeta(+) T-lymphocyte maturation during the postnatal period', 
Nat Commun, 6: 7725. 
Tsolis, R. M., R. A. Kingsley, S. M. Townsend, T. A. Ficht, L. G. Adams, and A. J. Baumler. 1999. 'Of mice, 
calves, and men. Comparison of the mouse typhoid model with other Salmonella infections', 
Adv Exp Med Biol, 473: 261-74. 
Tsolis, R. M., S. M. Townsend, E. A. Miao, S. I. Miller, T. A. Ficht, L. G. Adams, and A. J. Baumler. 1999. 
'Identification of a putative Salmonella enterica serotype typhimurium host range factor with 
homology to IpaH and YopM by signature-tagged mutagenesis', Infect Immun, 67: 6385-93. 
Tsolis, R. M., M. N. Xavier, R. L. Santos, and A. J. Baumler. 2011. 'How to become a top model: impact 
of animal experimentation on human Salmonella disease research', Infect Immun, 79: 1806-
14. 
Tukel, C., M. Raffatellu, A. D. Humphries, R. P. Wilson, H. L. Andrews-Polymenis, T. Gull, J. F. Figueiredo, 
M. H. Wong, K. S. Michelsen, M. Akcelik, L. G. Adams, and A. J. Baumler. 2005. 'CsgA is a 
pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is 
recognized by Toll-like receptor 2', Mol Microbiol, 58: 289-304. 
Uematsu, S., M. H. Jang, N. Chevrier, Z. Guo, Y. Kumagai, M. Yamamoto, H. Kato, N. Sougawa, H. Matsui, 
H. Kuwata, H. Hemmi, C. Coban, T. Kawai, K. J. Ishii, O. Takeuchi, M. Miyasaka, K. Takeda, and 
S. Akira. 2006. 'Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal 
CD11c+ lamina propria cells', Nat Immunol, 7: 868-74. 
Valdivia, R. H., and S. Falkow. 1997. 'Fluorescence-based isolation of bacterial genes expressed within 
host cells', Science, 277: 2007-11. 
110 
 
van der Velden, A. W., S. W. Lindgren, M. J. Worley, and F. Heffron. 2000. 'Salmonella pathogenicity 
island 1-independent induction of apoptosis in infected macrophages by Salmonella enterica 
serotype typhimurium', Infect Immun, 68: 5702-9. 
Vazquez-Torres, A., J. Jones-Carson, A. J. Baumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, 
W. T. Parks, and F. C. Fang. 1999. 'Extraintestinal dissemination of Salmonella by CD18-
expressing phagocytes', Nature, 401: 804-8. 
Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulos, and F. C. Fang. 2000. 'Antimicrobial 
actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental 
salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro', J Exp 
Med, 192: 227-36. 
Vazquez-Torres, A., B. A. Vallance, M. A. Bergman, B. B. Finlay, B. T. Cookson, J. Jones-Carson, and F. C. 
Fang. 2004. 'Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: 
importance of the Kupffer cell network', J Immunol, 172: 6202-8. 
Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D. W. Holden, S. M. Lucia, M. C. Dinauer, P. Mastroeni, and 
F. C. Fang. 2000. 'Salmonella pathogenicity island 2-dependent evasion of the phagocyte 
NADPH oxidase', Science, 287: 1655-8. 
Veereman-Wauters, G. 1996. 'Neonatal gut development and postnatal adaptation', European Journal 
of Pediatrics, 155: 627-32. 
Velge, P., A. Wiedemann, M. Rosselin, N. Abed, Z. Boumart, A. M. Chausse, O. Grepinet, F. Namdari, S. 
M. Roche, A. Rossignol, and I. Virlogeux-Payant. 2012. 'Multiplicity of Salmonella entry 
mechanisms, a new paradigm for Salmonella pathogenesis', Microbiologyopen, 1: 243-58. 
Vidal, S. M., E. Pinner, P. Lepage, S. Gauthier, and P. Gros. 1996. 'Natural resistance to intracellular 
infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from 
susceptible (Nramp1 D169) mouse strains', J Immunol, 157: 3559-68. 
Vidal, S., M. L. Tremblay, G. Govoni, S. Gauthier, G. Sebastiani, D. Malo, E. Skamene, M. Olivier, S. Jothy, 
and P. Gros. 1995. 'The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular 
parasites is abrogated by disruption of the Nramp1 gene', J Exp Med, 182: 655-66. 
Viggiano, D., G. Ianiro, G. Vanella, S. Bibbo, G. Bruno, G. Simeone, and G. Mele. 2015. 'Gut barrier in 
health and disease: focus on childhood', Eur Rev Med Pharmacol Sci, 19: 1077-85. 
Voedisch, S., C. Koenecke, S. David, H. Herbrand, R. Forster, M. Rhen, and O. Pabst. 2009. 'Mesenteric 
lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar 
Typhimurium and limit systemic disease in mice', Infect Immun, 77: 3170-80. 
Vukavic, T. 1984. 'Timing of the gut closure', J Pediatr Gastroenterol Nutr, 3: 700-3. 
Waldner, L. L., K. D. MacKenzie, W. Koster, and A. P. White. 2012. 'From Exit to Entry: Long-term 
Survival and Transmission of Salmonella', Pathogens, 1: 128-55. 
Walker, W. A. 1979. 'Gastrointestinal host defence: importance of gut closure in control of 
macromolecular transport', Ciba Found Symp: 201-19. 
Walker, W. A., and K. J. Isselbacher. 1974. 'Uptake and transport of macromolecules by the intestine. 
Possible role in clinical disorders', Gastroenterology, 67: 531-50. 
Walthall, K., G. D. Cappon, M. E. Hurtt, and T. Zoetis. 2005. 'Postnatal development of the 
gastrointestinal system: a species comparison', Birth Defects Res B Dev Reprod Toxicol, 74: 132-
56. 
Wang, Li, Lei Shi, M. J. Alam, Yuhuan Geng, and Lin Li. 2008. 'Specific and rapid detection of foodborne 
Salmonella by loop-mediated isothermal amplification method', Food Research International, 
41: 69-74. 
Wang, Y., K. Y. Huang, and Y. Huo. 2014. 'Proteomic comparison between Salmonella Typhimurium 
and Salmonella Typhi', J Microbiol, 52: 71-6. 
Warsi, O., E. Lundin, U. Lustig, J. Nasvall, and D. I. Andersson. 2019. 'Selection for novel metabolic 
capabilities in Salmonella enterica', Evolution, 73: 990-1000. 
Waterman, S. R., and D. W. Holden. 2003. 'Functions and effectors of the Salmonella pathogenicity 
island 2 type III secretion system', Cell Microbiol, 5: 501-11. 
111 
 
Watson, K. G., and D. W. Holden. 2010. 'Dynamics of growth and dissemination of Salmonella in vivo', 
Cell Microbiol, 12: 1389-97. 
Watson, P. R., S. M. Paulin, A. P. Bland, P. W. Jones, and T. S. Wallis. 1995. 'Characterization of intestinal 
invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the 
invH gene', Infect Immun, 63: 2743-54. 
Weiss, D. S., B. Raupach, K. Takeda, S. Akira, and A. Zychlinsky. 2004. 'Toll-like receptors are temporally 
involved in host defense', J Immunol, 172: 4463-9. 
Wheeler, N. E., P. P. Gardner, and L. Barquist. 2018. 'Machine learning identifies signatures of host 
adaptation in the bacterial pathogen Salmonella enterica', PLoS Genet, 14: e1007333. 
Wilcock, B. P., C. H. Armstrong, and H. J. Olander. 1976. 'The significance of the serotype in the clinical 
and pathological features of naturally occurring porcine salmonellosis', Can J Comp Med, 40: 
80-8. 
Wilson, C. L., A. J. Ouellette, D. P. Satchell, T. Ayabe, Y. S. Lopez-Boado, J. L. Stratman, S. J. Hultgren, L. 
M. Matrisian, and W. C. Parks. 1999. 'Regulation of intestinal alpha-defensin activation by the 
metalloproteinase matrilysin in innate host defense', Science, 286: 113-7. 
Winfield, M. D., and E. A. Groisman. 2004. 'Evolution and Ecology of Salmonella', EcoSal Plus, 1. 
Winter, S. E., P. Thiennimitr, M. G. Winter, B. P. Butler, D. L. Huseby, R. W. Crawford, J. M. Russell, C. 
L. Bevins, L. G. Adams, R. M. Tsolis, J. R. Roth, and A. J. Baumler. 2010. 'Gut inflammation 
provides a respiratory electron acceptor for Salmonella', Nature, 467: 426-9. 
Wood, M. W., M. A. Jones, P. R. Watson, S. Hedges, T. S. Wallis, and E. E. Galyov. 1998. 'Identification 
of a pathogenicity island required for Salmonella enteropathogenicity', Mol Microbiol, 29: 883-
91. 
Woolhouse, M. E., J. P. Webster, E. Domingo, B. Charlesworth, and B. R. Levin. 2002. 'Biological and 
biomedical implications of the co-evolution of pathogens and their hosts', Nat Genet, 32: 569-
77. 
Worley, M. J., K. H. Ching, and F. Heffron. 2000. 'Salmonella SsrB activates a global regulon of 
horizontally acquired genes', Mol Microbiol, 36: 749-61. 
Wray, C., W. J. Sojka, and J. C. Bell. 1981. 'Salmonella infection in horses in England and Wales, 1973 
to 1979', Vet Rec, 109: 398-401. 
Yang, Y. J., M. C. Huang, S. M. Wang, J. J. Wu, C. P. Cheng, and C. C. Liu. 2002. 'Analysis of risk factors 
for bacteremia in children with nontyphoidal Salmonella gastroenteritis', Eur J Clin Microbiol 
Infect Dis, 21: 290-3. 
Zaharik, M. L., B. A. Vallance, J. L. Puente, P. Gros, and B. B. Finlay. 2002. 'Host-pathogen interactions: 
Host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity island-
2 virulence genes', Proc Natl Acad Sci U S A, 99: 15705-10. 
Zarepour, M., K. Bhullar, M. Montero, C. Ma, T. Huang, A. Velcich, L. Xia, and B. A. Vallance. 2013. 'The 
mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella 
enterica serovar Typhimurium colitis', Infect Immun, 81: 3672-83. 
Zhang, K., A. Dupont, N. Torow, F. Gohde, S. Leschner, S. Lienenklaus, S. Weiss, M. M. Brinkmann, M. 
Kuhnel, M. Hensel, M. Fulde, and M. W. Hornef. 2014. 'Age-dependent enterocyte invasion 
and microcolony formation by Salmonella', PLoS Pathog, 10: e1004385. 
Zhang, K., M. Hornef, and M. Fulde. 2015. 'The deadly bite of Salmonella Typhi', EMBO Rep, 16: 887-8. 
Zhang, K., A. Riba, M. Nietschke, N. Torow, U. Repnik, A. Putz, M. Fulde, A. Dupont, M. Hensel, and M. 
Hornef. 2018. 'Minimal SPI1-T3SS effector requirement for Salmonella enterocyte invasion and 
intracellular proliferation in vivo', PLoS Pathog, 14: e1006925. 
Zhang, Kaiyi, Mathias W. Hornef, and Aline Dupont. 2015. 'The intestinal epithelium as guardian of gut 





Table 12: Bacterial strains used in this study. 
Strains of Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) ATCC14028 
applied for investigations of SPI-2 effectors in the neonate mouse model are listed. Deletions of specific 
gene as well as vactor carriage is given. Mutagenesis was performed by Michael Hensel, University of 
Osnabrück, as described previously (Datsenko and Wanner 2000) followed by transformation of 
electrocompetent Salmonella with pFPV-25.1. Antibiotic resistance cassettes: AMP = ampicillin, 
CM = chloramphenicol, KAN = kanamycin. Antibiotics were used for growth selection and replica 
plating at given final concentrations: AMP: 100 µg/ml, CM: 10 µg/ml, KAN: 25 µg/ml. 
strain features resistance reference 
255 ATCC 14028::pFPV-25.1 AMP 
Valdivia et al., 
1998, Zhang et al., 
2014 
268 MvP 643::p3232 AMP + KAN Wang and Kushner, 1991 
293 MvP 643 ΔsseB::FRT pFPV-25.1 AMP this study 
313 MvP 497 ∆sifA::aph pFPV-25.1 AMP + KAN 
Beuzón et al., 
2000; Noster et al., 
2019 
317 MvP 375 ∆sspH1::aph pFPV25.1 AMP + KAN this study 
318 MvP 378 ∆sseI::aph pFPV25.1 AMP + KAN this study 
319 MvP 1033 ∆sseL::aph pFPV-25.1 AMP + KAN this study 
320 MvP 500 sopD::aph pFPV-25.1 AMP + KAN this study 
321 MvP 741 ∆steC::aph pFPV-25.1 AMP + KAN this study 
322 MvP 498 ∆pipB2::aph pFPV25.1 AMP + KAN Knodler et al., 2003 
323 MvP 543 ∆spvR::aph pFPV25.1 AMP + KAN this study 
324 MvP 388 ∆sseF ∆sseG pFPV-25.1 AMP + KAN 
Hansen-Wester et 
al., 2002; Deiwick 
et al., 2006 
326 MvP 376 ∆sspH2::aph pFPV-25.1 AMP + KAN this study 
363 MvP 1848 ∆sscBsseFG::FRT ∆sifA::FRT 
∆sseJ::aph AMP + KAN this study 
364 MvP 1847 ∆sscBsseFG::FRT ∆sifA::FRT 
∆pipB2::aph AMP + KAN this study 
368 MvP 1444 ΔsseB::kanR pM973 AMP + KAN this study 
8718 MvP 643 ΔsseB::FRT ΔfadL pFPV-25.1 AMP Strugnell et al., 2014 
9086 MvP 643 ΔsseB::FRT ΔaroP ΔpheP ΔtyrP Δmtr 
ΔpheA pFPV-25.1 AMP 
Strugnell et al., 
2014 
9090 MvP 643 ΔsseB::FRT Δglk ΔmanXYZ ΔptsG 
ΔuhpT pFPV-25.1 AMP 
Strugnell et al., 
2014 
9118 MvP 643 ΔsseB::FRT Δdpp Δopp ΔydgR ΔygdR 
ΔyhiP pFPV-25.1 AMP 






ATCC 14028::pFPV-25.1 proV tagged (see 
Table 3) AMP + CM Lim et al., 2014 
9892 - 
9913 
MvP 643 ΔsseB::FRT pFPV-25.1 proV tagged 
(see Table 3) AMP + CM this study 
 
Table 13: Plasmids applied in this study 
All plasmids were incorporated to STy by electroporation. 
plasmid features reference 
pFPV-25.1 amp PrpsM::gfpmut3 Valdivia et al., 1998 
p3232 amp pWSK30::PsseAsseB Hölzer and Hensel, 2010 
pM973 amp PssaG::gfpmut2 Hapfelmeier et al., 2005 
 
Table 14: Primer sequences for amplification of proV according to (Lim et al. 2014) 
proV for ACACTCTTTCCCTACACGACGCTCTTCCGATCTACAGGACGAAGACCGTGAATATGG 
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